1/3 meter (distance vision finding)&C0475806
130-nm albumin-bound paclitaxel&C1527223
nab-paclitaxel&C1527223
ADO-TRASTUZUMAB&C3643461
Intra-abdominopelvic structure and/or anterior abdominal wall&C0000726
abdominopelvic regions&C0000726
Abdominopelvic region&C0000726
Abdomen, NOS&C0000726
abdominal&C0000726
ABDOMEN&C0000726
Abdomen&C0000726
Abdominal wall structure&C0836916
Accelerated partial breast irradiation (procedure)&C3896696
APBI - accelerated partial breast irradiation&C3896696
Accelerated Partial Breast Irradiation&C3896696
APBI&C3896696
Challenge Agent Characterization Domain&C0001246
Actinium, NOS&C0001246
Actinium&C0001246
actinio&C0001246
Effective protective ability (finding)&C2712083
Actual Effective Protective Ability&C2712083
Effective Protective Ability&C2712083
RNDx individual coping impairment (diagnosis)&C1999002
RNDx individual coping impairment&C1999002
Ineffective coping (individual)&C1999002
Individual Coping Impairment&C1999002
Actual Negative Coping&C1999002
Ineffective coping&C1999002
Inability to cope&C1999002
Unable (to);cope&C1999002
Unable to cope&C1999002
Cannot cope&C1999002
LEUKEMIA, LYMPHOCYTIC, ACUTE&C0023449
Leukaemias acute lymphocytic&C0023449
Acute Lymphocytic Leukemias&C0023449
Acute lymphocytic leukaemia&C0023449
Leukaemia;acute lymphocytic&C0023449
Leukemia, Acute Lymphocytic&C0023449
ACUTE LYMPHOCYTIC LEUKEMIA&C0023449
Acute lymphocytic leukemia&C0023449
Acute lymphatic leukaemia&C0023449
Acute lymphatic leukemia&C0023449
Adenoidal structure&C0001428
Tonsils, Pharyngeal&C0001428
Tonsil, Pharyngeal&C0001428
Pharyngeal Tonsil&C0001428
Adenoid, NOS&C0001428
Adenoidal&C0001428
Adenoids&C0001428
Adenoid&C0001428
Medication compliance (observable entity)&C2364172
Adherence To Medication Regime&C2364172
Drug compliance good (finding)&C2364172
Medication regimen adherence&C2364172
Adherence, Prescription&C2364172
Prescription Adherences&C2364172
Medication concordance&C2364172
Prescription Adherence&C2364172
Adherence, Medication&C2364172
Medication compliance&C2364172
Drug compliance good&C2364172
Medication Adherence&C2364172
Adherence, Drug&C2364172
Drug Adherence&C2364172
adjudicative process and procedure&C0680730
Adjudication&C0680730
Adjuvant Radiation Therapy&C1706721
Adjuvant Protocol&C1510810
Adjuvant Trials&C1510810
Adjuvant Study&C1510810
Adjuvant Trial&C1510810
Adjunctive therapy&C0677850
Adjuvant Therapy&C0677850
Adjuvant Therapy Clinical Trial Setting&C4084850
Adolescent (age group)&C0205653
Adolescent Youth&C0205653
Adolescents&C0205653
ADOLESCENT&C0205653
pubescent&C0205653
adrenal insufficiency (diagnosis)&C0001623
Adrenal gland insufficiency&C0001623
Hypofunction, Adrenal Gland&C0001623
Adrenal gland hypofunction&C0001623
Adrenal insufficiency, NOS&C0001623
Adrenal insufficiency NOS&C0001623
Hypoadrenalism (disorder)&C0001623
Adrenal Insufficiencies&C0001623
adrenal; insufficiency&C0001623
insufficiency; adrenal&C0001623
ADRENAL INSUFFICIENCY&C0001623
INSUFFICIENCY ADRENAL&C0001623
ADRENAL HYPOFUNCTION&C0001623
Adrenal failure&C0001623
Hypoadrenalism&C0001623
Adriamycin-cyclophosphamide regimen&C1879503
Doxorubicin/Cyclophosphamide&C1879503
Adriamycin-Cytoxan Regimen&C1879503
AC Regimen&C1879503
CA Regimen&C1879503
Advanced HER2 Low Breast Adenocarcinoma&C5555766
Advanced HER2-Low Breast Adenocarcinoma&C5555766
Advanced HER2 Low Breast Carcinoma&C5555766
Advanced HER2-Low Breast Carcinoma&C5555766
Advanced Malignant Neoplasm&C0877373
Advanced Cancer&C0877373
L-alanine:2-oxoglutarate aminotransferase&C0001899
Alanine-2-Oxoglutarate Aminotransferase&C0001899
Alanine aminotransferase (substance)&C0001899
ALAT - Alanine aminotransferase&C0001899
Glutamate pyruvate transaminase&C0001899
ALT - Alanine aminotransferase&C0001899
Transaminase, Glutamic-Alanine&C0001899
Glutamic Alanine Transaminase&C0001899
Glutamic Pyruvic Transaminase&C0001899
Glutamic-Alanine Transaminase&C0001899
Glutamic-Pyruvic Transaminase&C0001899
Aminotransferase, Alanine&C0001899
Alanine Aminotransferase&C0001899
Transaminase, Alanine&C0001899
Alanine Transaminase&C0001899
alanine transaminase&C0001899
alts&C0001899
GPT&C0001899
Hydrogen ion decrease&C0221106
Alkalemia (disorder)&C0221106
increasing ph&C0221106
Acid deficit&C0221106
increased ph&C0221106
ELEVATED PH&C0221106
increase ph&C0221106
pH increase&C0221106
Alkalaemia&C0221106
ALKALEMIA&C0221106
Alkalemia&C0221106
Baseosis&C0221106
Alkaline phosphatase (substance)&C0002059
Alkaline phosphomonoesterase&C0002059
ALP - Alkaline phosphatase&C0002059
alkaline phosphatase (ALP)&C0002059
AP - Alkaline phosphatase&C0002059
Phosphatase, Alkaline&C0002059
alkaline phosphatases&C0002059
ALKALINE PHOSPHATASE&C0002059
Alkaline Phosphatase&C0002059
phosphomonoesterase&C0002059
Glycerophosphatase&C0002059
Alk Phos&C0002059
AlkPhos&C0002059
ALKP&C0002059
Alpelisib-Fulvestrant Regimen&C5237483
Alpelisib/Fulvestrant Regimen&C5237483
Fulvestrant/Alpelisib Regimen&C5237483
Alpelisib-Fulvestrant&C5237483
Alpelisib/Fulvestrant&C5237483
Piqray/Faslodex&C5237483
ALZHEIMER'S DISEASE&C0002395
Alzheimer's Disease&C0002395
Alzheimers Diseases&C0002395
Alzheimers Disease&C0002395
Disease;Alzheimers&C0002395
ALZHEIMER DISEASE&C0002395
Abnormal absence of menstruation&C0002453
Amenorrhoea, unspecified&C0002453
Absence of menstruation&C0002453
Amenorrhea, unspecified&C0002453
absence; menstruation&C0002453
MENSES LACK OF&C0002453
lack of menses&C0002453
Amenorrhoea&C0002453
AMENORRHEA&C0002453
Amenorrhea&C0002453
amenia&C0002453
American Society of Clinical Oncology&C1515948
Anabolism, function (observable entity)&C0220781
Biosynthetic Process&C0220781
Anabolism, function&C0220781
Biosynthesis&C0220781
Biosynthetic&C0220781
Biogenesis&C0220781
Anabolism&C0220781
Synthesis&C0220781
Anatomic Node&C0746922
noded&C0746922
NODE&C0746922
Anaemia, unspecified&C0002871
Anemia, unspecified&C0002871
Anemia, NOS&C0002871
anaemias&C0002871
ANAEMIA&C0002871
anemias&C0002871
ANEMIA&C0002871
Anemia&C0002871
Product containing angiotensin-converting enzyme inhibitor (product)&C0003015
Angiotensin-converting enzyme inhibitor agent, NOS&C0003015
Angiotensin I-Converting Enzyme Inhibitors&C0003015
Antagonists, Angiotensin Converting Enzyme&C0003015
Angiotensin Converting Enzyme Antagonists&C0003015
Angiotensin converting enzyme--Inhibitors&C0003015
Angiotensin-Converting Enzyme Antagonists&C0003015
Enzyme Inhibitors, Angiotensin-Converting&C0003015
Inhibitors, Angiotensin Converting Enzyme&C0003015
Inhibitors, Angiotensin-Converting Enzyme&C0003015
Angiotensin Converting Enzyme Inhibitors&C0003015
Angiotensin-Converting Enzyme Inhibitors&C0003015
Angiotensin Converting Enzyme Inhibitor&C0003015
Angiotensin-Converting Enzyme Inhibitor&C0003015
Inhibitor, Kininase II&C0003015
Kininase II Inhibitor&C0003015
ACE inhibitor&C0003015
Asymmetry of the breasts&C1854013
Breast asymmetry&C1854013
ANISOMASTIA&C1854013
Anisomastia&C1854013
ANOREXIA&C0003123
Anorexia&C0003123
Anthracycline Antineoplastic Antibiotic&C0003234
Anthracycline antibiotic antineoplastic&C0003234
Chemotherapy, Cancer, Anthracyclines&C0003234
chemotherapeutics anthracyclines&C0003234
anthracyclines (medication)&C0003234
Anthracycline Antibiotics&C0003234
anthracycline antibiotic&C0003234
Anthracycline&C0003234
Antibodies, Monoclonal, Humanized&C2985546
Humanized Monoclonal Antibody&C2985546
Antibodies, Humanized&C2985546
Humanized Antibodies&C2985546
Antioestrogen therapy&C0854638
therapy, antiestrogen&C0854638
Antiestrogen Therapy&C0854638
Chemotherapeutic Anticancer Agents&C0003392
Agents, Cancer Chemotherapy&C0003392
Chemotherapy Agents, Cancer&C0003392
Drugs, Cancer Chemotherapy&C0003392
Cancer Chemotherapy Drug&C0003392
agents antineoplastics&C0003392
ANTINEOPLASTIC AGENTS&C0003392
Agent, Antineoplastic&C0003392
Antineoplastic Agents&C0003392
agents antineoplastic&C0003392
Antineoplastic Agent&C0003392
Antineoplastic Drugs&C0003392
Drug, Antineoplastic&C0003392
Antineoplastic Drug&C0003392
Agents, Anticancer&C0003392
Anticancer Agents&C0003392
Antineoplastics&C0003392
Antineoplastic&C0003392
Aortic (valve) insufficiency&C0003504
AORTIC VALVE, INSUFFICIENCY&C0003504
Insufficiency, Aortic Valve&C0003504
AORTIC VALVE REGURGITATION&C0003504
Aortic Valve Insufficiency&C0003504
Incompetence, Aortic Valve&C0003504
Aortic valve incompetence&C0003504
insufficiency; aortic&C0003504
AORTIC INSUFFICIENCY&C0003504
Aortic Regurgitation&C0003504
Aortic Incompetence&C0003504
Incompetence;aortic&C0003504
Aortic valve stenosis (disorder)&C0003507
Aortic valve stenosis, NOS&C0003507
Stenosis of aortic valve&C0003507
aortic valvular stenosis&C0003507
Aortic valve--Stenosis&C0003507
Stenoses, Aortic Valve&C0003507
Valve Stenosis, Aortic&C0003507
AORTIC VALVE STENOSIS&C0003507
Aortic Valve Stenoses&C0003507
Aortic Valve Stenosis&C0003507
Stenosed aortic valve&C0003507
Stenoses, Aortic&C0003507
AORTIC STENOSIS&C0003507
inhibition therapy, aromatase&C0280674
Aromatase Inhibition Therapy&C0280674
Aromatase Inhibition&C0280674
Substance with aromatase inhibitor mechanism of action (substance)&C0593802
Substance with aromatase inhibitor mechanism of action&C0593802
Product containing aromatase inhibitor (product)&C0593802
Aromatase inhibitor-containing product&C0593802
Androstenedione Aromatase Inhibitor&C0593802
Estrogen Synthetase Inhibitor&C0593802
Estrogen Synthase Inhibitor&C0593802
Inhibitors, Aromatase&C0593802
Aromatase Inhibitors&C0593802
Inhibitor, Aromatase&C0593802
Aromatase Inhibitor&C0593802
L-aspartate:2-oxoglutarate aminotransferase&C0004002
Aspartate aminotransferase (substance)&C0004002
Glutamate oxaloacetate transaminase&C0004002
Transaminase, Glutamic-Oxaloacetic&C0004002
ASAT - Aspartate aminotransferase&C0004002
Glutamic Oxaloacetic Transaminase&C0004002
Glutamic-Oxaloacetic Transaminase&C0004002
Transaminase, Glutamate-Aspartate&C0004002
glutamic aspartic transaminase&C0004002
AST - Aspartate transaminase&C0004002
Aminotransferases, Aspartate&C0004002
aspartate transaminase (AST)&C0004002
Aspartate Aminotransferase&C0004002
Aspartate Transaminase&C0004002
Aspartate transaminase&C0004002
Transaminase A&C0004002
AST&C0004002
TELANGIECTASIA, CEREBELLO-OCULOCUTANEOUS&C0004135
Ataxia Telangiectasia Syndrome&C0004135
ATAXIA, TELANGIECTASIA&C0004135
Ataxia Telangiectasia&C0004135
Ataxia-telangiectasia&C0004135
Louis Bar syndrome&C0004135
Louis-Bar syndrome&C0004135
ATD&C0004135
Autoimmune Syndrome Type II, Polyglandular&C0085860
POLYGLANDULAR AUTOIMMUNE SYNDROME, TYPE II&C0085860
Autoimmune Polyglandular Syndrome Type II&C0085860
Polyglandular Type II Autoimmune Syndrome&C0085860
Polyglandular autoimmune syndrome type II&C0085860
Polyglandular autoimmune syndrome, type 2&C0085860
Syndrome, Schmidt's&C0085860
Schmidt's Syndrome&C0085860
Syndrome, Schmidt&C0085860
SCHMIDT SYNDROME&C0085860
syndrome schmidt&C0085860
APS type 2&C0085860
Structure of axillary fossa (body structure)&C0004454
Axillary region structure&C0004454
Axillary region&C0004454
Fossa axillaris&C0004454
Axillary fossa&C0004454
axillary&C0004454
armpits&C0004454
AXILLA&C0004454
Armpit&C0004454
Axilla&C0004454
Axillary lymph node structure&C0729594
Axillary lymph node group&C0729594
Axillary lymph node, NOS&C0729594
Axillary Lymph Nodes&C0729594
lymph nodes axillary&C0729594
AXILLARY LYMPH NODE&C0729594
axillary nodes&C0729594
Axillary Node&C0729594
Malignant lymphoma, B-cell type&C0079731
Lymphomas non-Hodgkin's B-cell&C0079731
B-cell non-Hodgkin's lymphoma&C0079731
Non-Hodgkin's B-Cell Lymphoma&C0079731
b cell lymphoma non hodgkin's&C0079731
B-cell lymphoma NOS&C0079731
Lymphomas, B-Cell&C0079731
B-Cell Lymphomas&C0079731
Lymphoma, B Cell&C0079731
Lymphoma, B-Cell&C0079731
b cell lymphomas&C0079731
b-cell lymphomas&C0079731
lymphoma; B-cell&C0079731
B cell lymphoma&C0079731
B-Cell Lymphoma&C0079731
cell b lymphoma&C0079731
lymphoma b-cell&C0079731
Epothilone-B BMS 247550&C0879430
BMS 247550&C0879430
BMS-247550&C0879430
BMS247550&C0879430
Breast Cancer Type 1 Susceptibility Gene Mutation&C1511022
Breast Cancer 1, Early Onset Gene Mutation&C1511022
Breast Cancer 1 Gene Mutation&C1511022
Mutation of the BRCA1 Gene&C1511022
BROVCA1 Gene Mutation&C1511022
BRCA1 Gene Mutation&C1511022
BRCA1 Mutation&C1511022
protein phosphatase 1, regulatory subunit 53&C0376571
BRCA1/BRCA2-containing complex, subunit 1&C0376571
BRCA1 DNA REPAIR-ASSOCIATED PROTEIN&C0376571
BRCA1, DNA Repair Associated Gene&C0376571
Breast Cancer 1, Early Onset Gene&C0376571
BRCA1 DNA repair associated&C0376571
BREAST CANCER 1 GENE&C0376571
breast cancer 1&C0376571
Genes, BRCA1&C0376571
BRCA1 Genes&C0376571
Gene, BRCA1&C0376571
brca 1 gene&C0376571
BRCA1 Gene&C0376571
BRCA1 gene&C0376571
PPP1R53&C0376571
BRCA1&C0376571
BRCC1&C0376571
RNF53&C0376571
Base sequence (finding)&C0004793
nucleic acid sequencing&C0004793
Sequences, Nucleotide&C0004793
nucleic acid sequence&C0004793
Nucleotide Sequences&C0004793
Sequence, Nucleotide&C0004793
Nucleotide Sequence&C0004793
nucleotide sequenc&C0004793
Sequences, Base&C0004793
Base Sequences&C0004793
Sequence, Base&C0004793
Base Sequence&C0004793
Seq&C0004793
Benign phyllodes tumor (morphologic abnormality)&C0334501
Cystosarcoma phyllodes, benign&C0334501
Cystosarcoma phyllodes; benign&C0334501
benign; Cystosarcoma phyllodes&C0334501
Benign cystosarcoma phyllodes&C0334501
Benign Phyllodes Neoplasm&C0334501
Phyllodes tumour, benign&C0334501
phyllodes; tumor, benign&C0334501
tumor; phyllodes, benign&C0334501
Benign phyllodes tumour&C0334501
Phyllodes tumor, benign&C0334501
fibroadenoma; phyllodes&C0334501
phyllodes; fibroadenoma&C0334501
Benign Phyllodes Tumor&C0334501
Benign phyllodes tumor&C0334501
Fibroadenoma phyllodes&C0334501
Berenice&C2633005
diagnostic mammogram of both breasts (procedure)&C3862928
diagnostic mammogram of both breasts&C3862928
Bilateral Diagnostic Mammogram&C3862928
mammogram diagnostic bilateral&C3862928
Biopsy - action&C0005558
BX - Biopsy&C0005558
Biopsy, NOS&C0005558
Biopsies&C0005558
Biopsy&C0005558
Biopsy Specimen Radiography&C4527225
Biospecimen Radiography&C4527225
Specimen Radiography&C4527225
Biopsy of the Nipple-Areolar Complex&C4527248
Biopsy of Nipple and Areola&C4527248
Biopsy of NAC&C4527248
Biopsy Procedures on the Skin&C0150866
Biopsy of skin procedure&C0150866
Biopsy of Skin&C0150866
Biosimilars&C4045974
Biosimilar&C4045974
ptosis (physical finding)&C0005745
Upper eyelid drooped&C0005745
Palpebral ptosis&C0005745
Ptosis of eyelid&C0005745
Drooping eyelid&C0005745
Drooping;eyelid&C0005745
Blepharoptosis&C0005745
Droopy eyelids&C0005745
Ptoses, Eyelid&C0005745
Ptosis, Eyelid&C0005745
drooped eyelid&C0005745
ptosis; eyelid&C0005745
Droopy eyelid&C0005745
EYELID PTOSIS&C0005745
Ptosis eyelid&C0005745
Ptosis;eyelid&C0005745
Ptosis&C0005745
Bloody nipple discharge (disorder)&C0541951
bloody nipple discharge (symptom)&C0541951
Sanguineous nipple discharge&C0541951
Sanguinous nipple discharge&C0541951
bloody discharge nipples&C0541951
Bloody nipple discharge&C0541951
NIPPLE DISCHARGE BLOODY&C0541951
bloody discharge nipple&C0541951
nipple bloody discharge&C0541951
EXUDATE NIPPLES BLOODY&C0541951
Nipple exudate bloody&C0541951
Body mass index procedure&C0005893
Body tissue, NOS&C0040300
Body tissue&C0040300
TISSUE&C0040300
Alimentary Bolus&C1186706
Bone Mineral Densities&C0005938
Mass of bone (finding)&C0005938
Density, Bone Mineral&C0005938
Bone Mineral Density&C0005938
Density, Bone&C0005938
Bone Density&C0005938
bone masses&C0005938
BONE MASS&C0005938
DISEASES OF THE BONES&C0005940
the diseases of bones&C0005940
Disease of bone, NOS&C0005940
Diseases of Bones&C0005940
Osteopathia, NOS&C0005940
Bones--Diseases&C0005940
Disease of bone&C0005940
Disease, Bone&C0005940
bones disease&C0005940
Bone Disease&C0005940
Disease;bone&C0005940
Osteopathia&C0005940
Osteopathy&C0005940
Materials, Bone Replacement&C0243003
Replacement Materials, Bone&C0243003
Bone Replacement Materials&C0243003
Material, Bone Replacement&C0243003
Replacement Material, Bone&C0243003
Bone Replacement Material&C0243003
Substitutes, Bone&C0243003
Bone Substitutes&C0243003
Substitute, Bone&C0243003
Bone Substitute&C0243003
Bones and Bone Tissue&C0005931
Bone and Bones&C0005931
Bones and Bone&C0005931
Bone and Bone&C0005931
Brachytherapy - action (qualifier value)&C0006098
Contact radiation therapy procedure, NOS&C0006098
radiation therapy radioactive source&C0006098
Contact radiation therapy procedure&C0006098
Internal Radiation Therapy&C0006098
Radioisotope brachytherapy&C0006098
Plesiotherapy radiation&C0006098
Radiation Brachytherapy&C0006098
Internal Radiation&C0006098
Brachytherapy NOS&C0006098
brachytherapies&C0006098
Brachytherapy&C0006098
Curietherapy&C0006098
Breast structure (body structure)&C0006141
Breast structure&C0006141
Breast anatomy&C0006141
Breasts&C0006141
Mammary&C0006141
Mamma&C0006141
Breast Cancer pN1mi TNM Finding v6&C1707016
pN1mi Carcinoma of the Breast v6&C1707016
pN1mi Cancer of the Breast v6&C1707016
pN1mi Carcinoma of Breast v6&C1707016
pN1mi Breast Carcinoma v6&C1707016
pN1mi Cancer of Breast v6&C1707016
pN1mi Breast Cancer v6&C1707016
familial breast cancer (diagnosis)&C0346153
Familial Cancer of the Breast&C0346153
Hereditary Breast Carcinoma&C0346153
Familial Breast Carcinoma&C0346153
Familial Cancer of Breast&C0346153
Hereditary Breast Cancer&C0346153
BREAST CANCER, FAMILIAL&C0346153
Breast Cancer, Familial&C0346153
Familial breast cancer&C0346153
Breastfed (finding)&C0006147
Breast Feedings&C0006147
Breast Feeding&C0006147
breastfeedings&C0006147
Breastfeeding&C0006147
breast feed&C0006147
Breast Fed&C0006147
breastfeed&C0006147
Lactation&C0006147
Breast Irradiation&C2148528
Prosthetic breast implant (physical object)&C0179412
Prostheses, Mammary, Internal&C0179412
Prosthetic Implants - Breast&C0179412
Breast Prostheses, Internal&C0179412
Breast Prosthesis, Internal&C0179412
Prostheses, Internal Breast&C0179412
Prosthesis, Internal Breast&C0179412
Internal Breast Prostheses&C0179412
Internal Breast Prosthesis&C0179412
Prosthetic breast implant&C0179412
Mammary prosthesis&C0179412
Breast prosthesis&C0179412
Implants, Breast&C0179412
Breast Implants&C0179412
Implant, Breast&C0179412
Breast Implant&C0179412
Solid Papillary Carcinoma of the Breast&C1336027
Breast Solid Papillary Carcinoma&C1336027
Solid Papillary Breast Carcinoma&C1336027
Primary Squamous Cell Carcinoma of the Breast&C1336079
squamous cell carcinoma of breast (diagnosis)&C1336079
Primary Squamous Cell Carcinoma of Breast&C1336079
Primary Squamous Cell Breast Carcinoma&C1336079
Squamous Cell Carcinoma of the Breast&C1336079
Squamous Cell Carcinoma of Breast&C1336079
Squamous Carcinoma of the Breast&C1336079
Breast Squamous Cell Carcinoma&C1336079
Squamous Cell Breast Carcinoma&C1336079
Squamous Carcinoma of Breast&C1336079
Squamous Breast Carcinoma&C1336079
SCC of the Breast&C1336079
SCC of Breast&C1336079
Breast implant-associated anaplastic large cell lymphoma (morphologic abnormality)&C4528210
breast implant associated anaplastic large cell lymphoma (diagnosis)&C4528210
BIA-ALCL - breast implant-associated anaplastic large-cell lymphoma&C4528210
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)&C4528210
Breast implant-associated anaplastic large-cell lymphoma (disorder)&C4528210
Breast Implant-Associated Anaplastic Large Cell Lymphoma&C4528210
Breast implant-associated anaplastic large-cell lymphoma&C4528210
breast implant associated anaplastic large cell lymphoma&C4528210
lymphoma anaplastic large cell breast implant associated&C4528210
Breast implant-associated ALCL&C4528210
Seroma-associated ALCL&C4528210
breast size (physical finding)&C0425782
breast appearance size&C0425782
Size of breast&C0425782
breasts sized&C0425782
breasts size&C0425782
Breast size&C0425782
size breast&C0425782
Breast surgery (qualifier value)&C0851312
Breast surgery specialty&C0851312
Breast surgery&C0851312
Surgery.breast&C0851312
Tissue specimen from breast (specimen)&C0444070
Tissue specimen from breast&C0444070
Breast tissue sample&C0444070
Breast tissue&C0444070
Conservation Therapies, Breast&C0917927
Breast Conservation Therapies&C0917927
Breast Conservation Treatment&C0917927
Conservation Therapy, Breast&C0917927
Surgeries, Breast-Conserving&C0917927
Breast Conservation Therapy&C0917927
Breast-Conserving Surgeries&C0917927
Surgery, Breast Conserving&C0917927
Surgery, Breast-Conserving&C0917927
Breast Conserving Surgery&C0917927
Breast-Conserving Surgery&C0917927
Surgeries, Breast-Sparing&C0917927
Quadrantectomies, Breast&C0917927
Breast Quadrantectomies&C0917927
Surgery, Breast-Sparing&C0917927
Breast-Sparing Surgery&C0917927
Quadrantectomy, Breast&C0917927
Breast Quadrantectomy&C0917927
BCS&C0917927
cancer-associated gene 1 protein, human&C1175872
cancer-testis antigen CAGE-1, human&C1175872
Cancer-Associated Gene 1 Protein&C1175872
Cancer/Testis Antigen 95&C1175872
Cancer/Testis Antigen 3&C1175872
CAGE-1 protein, human&C1175872
CAGE1 protein, human&C1175872
CAGE-1&C1175872
CAGE1&C1175872
CT3&C1175872
Cyclin-Dependent Kinases 4 and 6 Inhibition&C3899807
CDK4/6 Inhibition&C3899807
Cytokine-Inducible SH2-Containing Protein Gene&C1332762
CYTOKINE-INDUCIBLE SH2-CONTAINING PROTEIN&C1332762
cytokine inducible SH2 containing protein&C1332762
cytokine inducible SH2-containing protein&C1332762
CISH Gene&C1332762
CISH gene&C1332762
CIS-1&C1332762
CISH&C1332762
SOCS&C1332762
CIS&C1332762
G18&C1332762
CNDP dipeptidase 2 (metallopeptidase M20 family)&C1539110
NONSPECIFIC DIPEPTIDASE, CYTOSOLIC&C1539110
cytosolic nonspecific dipeptidase&C1539110
carnosine dipeptidase II&C1539110
CARNOSINE DIPEPTIDASE 2&C1539110
CARNOSINASE, TISSUE&C1539110
CARNOSINASE 2&C1539110
carnosinase-2&C1539110
PEPTIDASE A&C1539110
CNDP2 gene&C1539110
FLJ10830&C1539110
HsT2298&C1539110
CNDP2&C1539110
CPGL&C1539110
PEPA&C1539110
CN2&C1539110
General body deterioration&C0006625
cachexia (weight loss)&C0006625
Cachexia, NOS&C0006625
Cachectic&C0006625
CACHEXIA&C0006625
Cachexia&C0006625
Wasting&C0006625
National Cancer Burden&C1516167
Cancer Burden&C1516167
Neoplasm-Associated Pains&C0596240
Neoplasm Associated Pain&C0596240
Neoplasm-Associated Pain&C0596240
Pain, Cancer-Associated&C0596240
Cancer-Associated Pain&C0596240
Pain, Neoplasm-Related&C0596240
Neoplasm-Related Pain&C0596240
Tumor Associated Pain&C0596240
Pain, Oncological&C0596240
Pain, Oncology&C0596240
Oncology Pain&C0596240
Cancer Pains&C0596240
Pain, Cancer&C0596240
Cancer Pain&C0596240
Cancer Therapeutic Procedure&C0920425
Malignant Neoplasm Treatment&C0920425
Malignant Neoplasm Therapy&C0920425
Cancer Treatment&C0920425
cancer therapies&C0920425
Cancer Therapy&C0920425
Fatigue associated with malignant neoplastic disease (finding)&C4274302
Fatigue associated with malignant neoplastic disease&C4274302
Cancer-related Fatigue&C4274302
Cancer-related fatigue&C4274302
Cancer Fatigue&C4274302
CRF&C4274302
Lapatinib Plus Capecitabine Regimen&C4527347
Lapatinib + Capecitabine Regimen&C4527347
Capecitabine/Lapatinib Regimen&C4527347
Lapatinib-Capecitabine Regimen&C4527347
Lapatinib/Capecitabine Regimen&C4527347
Lapatinib/Capecitabine&C4527347
Capecitabine/Margetuximab-cmkb Regimen&C5557263
Capecitabine-Margetuximab Regimen&C5557263
Capecitabine/Margetuximab Regimen&C5557263
Margetuximab/Capecitabine Regimen&C5557263
Capecitabine/Margetuximab-cmkb&C5557263
Margetuximab Plus Capecitabine&C5557263
Capecitabine-Margetuximab&C5557263
Capecitabine/Margetuximab&C5557263
Margetuximab-Capecitabine&C5557263
Margetuximab/Capecitabine&C5557263
Margenza/Xeloda&C5557263
Capecitabine/Neratinib Regimen&C5418306
Neratinib/Capecitabine Regimen&C5418306
Capecitabine-Neratinib&C5418306
Capecitabine/Neratinib&C5418306
Neratinib-Capecitabine&C5418306
Neratinib/Capecitabine&C5418306
Capecitabine/Nerlynx&C5418306
Nerlynx-Capecitabine&C5418306
Capsular Contracture&C1707264
Carboplatin-Paclitaxel Regimen&C1880002
Carboplatin/Paclitaxel Regimen&C1880002
Paclitaxel-Carboplatin Regimen&C1880002
Paclitaxel/Carboplatin Regimen&C1880002
Carboplatin-Taxol Regimen&C1880002
Carboplatin-Paclitaxel&C1880002
Carboplatin/Paclitaxel&C1880002
Paclitaxel-Carboplatin&C1880002
Paclitaxel/Carboplatin&C1880002
Carbo-Tax Regimen&C1880002
Carboplatin-Taxol&C1880002
CaT Regimen&C1880002
PC Regimen&C1880002
TC Regimen&C1880002
Carcinoembryonic Antigen Family Protein&C0007082
Carcinoembryonic antigen (substance)&C0007082
CEA - Carcinoembryonic antigen&C0007082
Antigen, Carcinoembryonic&C0007082
Carcinoembryonic antigens&C0007082
Carcinoembryonic Antigen&C0007082
Lymphocyte antigen CD66E&C0007082
Carcinoembryonic Ag&C0007082
Antigens, CD66e&C0007082
CD66e Ag&C0007082
CD66e&C0007082
CEA&C0007082
Breast carcinoma NOS stage IV&C0278488
BREAST CANCER NOS METASTATIC&C0278488
Breast cancer NOS stage IV&C0278488
Breast carcinoma stage IV&C0278488
Carcinoma breast stage IV&C0278488
breast cancer, metastatic&C0278488
Breast cancer metastatic&C0278488
Metastatic breast cancer&C0278488
breast cancer, stage IV&C0278488
Breast cancer stage IV&C0278488
breast cancer iv stage&C0278488
stage IV breast cancer&C0278488
Carcinoma in situ, site unspecified&C0007099
Intraepithelial carcinoma, NOS&C0007099
Carcinoma, Intraepithelial&C0007099
Intraepithelial Carcinoma&C0007099
Carcinoma in situ tumour&C0007099
Carcinoma in situ, NOS&C0007099
Carcinoma in situ NOS&C0007099
CARCINOMA IN SITU&C0007099
Carcinoma in Situ&C0007099
Carcinoma in-situ&C0007099
in situ carcinoma&C0007099
in-situ carcinoma&C0007099
carcinoma situ&C0007099
Cardiac monitoring (regime/therapy)&C0150496
Monitoring Cardiac Status&C0150496
Cardiac monitoring, NOS&C0150496
Cardiac Monitoring&C0150496
Cardiac monitoring&C0150496
monitoring cardiac&C0150496
Heart Monitoring&C0150496
cardiac monitor&C0150496
Cardiotoxicity (disorder)&C0876994
Cardiac Toxicities&C0876994
Toxicity, Cardiac&C0876994
Cardiac Toxicity&C0876994
Cardiotoxicities&C0876994
Cardiotoxicity&C0876994
CVS disease - cardiovascular system disease&C0007222
Cardiovascular disease, unspecified&C0007222
CARDIOVASCULAR DISORDERS, GENERAL&C0007222
Disorder of cardiovascular system&C0007222
CARDIOVASCULAR DISORDER (NOS)&C0007222
DISORDER CARDIOVASCULAR (NOS)&C0007222
cardiovascular system disease&C0007222
CVD - cardiovascular disease&C0007222
Cardiovascular disorder, NOS&C0007222
Cardiovascular Disorders&C0007222
cardiovascular; disorder&C0007222
Cardiovascular Diseases&C0007222
Cardiovascular disorder&C0007222
CARDIOVASCULAR DISEASE&C0007222
CVD, NOS&C0007222
Cellular Expansion&C0007595
Cellular Growth&C0007595
cell expansion&C0007595
growth of cell&C0007595
Cells--Growth&C0007595
cell growths&C0007595
cells growth&C0007595
Cell Growth&C0007595
growth cell&C0007595
Cell structure (cell structure)&C0007634
Cellular structures&C0007634
Cellular structure&C0007634
Unspecified cells&C0007634
Cells (Biology)&C0007634
Cell structure&C0007634
Normal cell&C0007634
Cell Types&C0007634
Cell Type&C0007634
Cellular&C0007634
THE CELL&C0007634
Cessation&C1880019
Cessation of smoking&C0085134
Smokings, Giving Up&C0085134
Cessation, Smoking&C0085134
Smoking Cessations&C0085134
Smoking, Giving Up&C0085134
Up Smoking, Giving&C0085134
Giving Up Smoking&C0085134
Smoking Cessation&C0085134
Smoking, Quitting&C0085134
Smoking, Stopping&C0085134
Quitting Smoking&C0085134
Stopping Smoking&C0085134
smoke cessation&C0085134
Peas, Partridge&C1017675
Peas, Sensitive&C1017675
Partridge Peas&C1017675
Pea, Partridge&C1017675
Pea, Sensitive&C1017675
Sensitive Peas&C1017675
Chamaecristas&C1017675
Partridge Pea&C1017675
Partridgepeas&C1017675
Sensitive Pea&C1017675
Chamaecrista&C1017675
Partridgepea&C1017675
Fractionations, Chemical&C0016640
Chemical Fractionations&C0016640
Fractionation, Chemical&C0016640
Chemical Fractionation&C0016640
Chemical fractionation&C0016640
fractionation&C0016640
Antineoplastic chemotherapy regimen (regime/therapy)&C0392920
chemotherapeutics regimen (treatment)&C0392920
Antineoplastic chemotherapy regimen&C0392920
neoplasm/cancer pharmacotherapy&C0392920
neoplasm/cancer chemotherapy&C0392920
chemotherapeutics regimen&C0392920
neoplasm pharmacotherapy&C0392920
cancer pharmacotherapy&C0392920
chemotherapy; neoplasm&C0392920
neoplasm; chemotherapy&C0392920
chemotherapy regimens&C0392920
neoplasm chemotherapy&C0392920
Chemotherapy Regimen&C0392920
cancer; chemotherapy&C0392920
chemotherapy; cancer&C0392920
Cancer chemotherapy&C0392920
chemotherapies&C0392920
Chemotherapy&C0392920
chemo&C0392920
Chemotherapy, Adjuvant&C0085533
Drug Therapy, Adjuvant&C0085533
Adjuvant Chemotherapy&C0085533
Adjuvant Drug Therapy&C0085533
Chemotherapy-Induced Alopecia&C5236021
Computerized axial tomography of thorax&C0202823
Computerized tomography of thorax&C0202823
Computerized tomography, thorax&C0202823
CT scan of chest (procedure)&C0202823
Computed tomography of chest&C0202823
Computerized tomogram thorax&C0202823
C.A.T. scan of thorax&C0202823
CT scan of the chest&C0202823
CAT scan of thorax&C0202823
CT scan;chest&C0202823
chest ct scan&C0202823
ct chest scan&C0202823
CT of thorax&C0202823
CT of chest&C0202823
ct thorax&C0202823
thorax ct&C0202823
Chest CT&C0202823
Chest wall structure (body structure)&C0205076
Chest wall structure&C0205076
Chest wall, NOS&C0205076
Wall, Thoracic&C0205076
Thoracic Wall&C0205076
Wall, Chest&C0205076
Chest Wall&C0205076
Clinical Breast Examination&C2347781
Co-morbid conditions&C1275743
Comorbid Condition&C1275743
Cognitive function: initiation (observable entity)&C0589507
Cognitive function: initiation&C0589507
Initiation&C0589507
Cognitive function: planning (observable entity)&C0032074
Cognitive function: planning&C0032074
PLANNING&C0032074
PLAN&C0032074
Sexual Intercourse (Human)&C0009253
Human Sexual Intercourse&C0009253
Sexual intercourse, NOS&C0009253
Intercourse (Sexual)&C0009253
Intercourse, Sexual&C0009253
vaginal intercourse&C0009253
Sexual Intercourse&C0009253
Sexual act, NOS&C0009253
Coitus, NOS&C0009253
Intercourse&C0009253
Coitus&C0009253
Colicin factor (finding)&C1257900
Plasmids, Colicin&C1257900
Colicin Plasmids&C1257900
Factors, Colicin&C1257900
Plasmid, Colicin&C1257900
Colicin Factors&C1257900
Colicin Plasmid&C1257900
Factor, Colicin&C1257900
Colicin Factor&C1257900
Factors, Col&C1257900
Col Factors&C1257900
Factor, Col&C1257900
Col Factor&C1257900
Carcinoma of Large Intestine&C0009402
Carcinoma of the Large Bowel&C0009402
Cancer of Large Intestine&C0009402
Carcinoma of Large Bowel&C0009402
Carcinomas, Colorectal&C0009402
Carcinoma, Colorectal&C0009402
Colorectal Carcinomas&C0009402
Colorectal cancer NOS&C0009402
Large Bowel Carcinoma&C0009402
Colorectal Carcinoma&C0009402
carcinoma colorectal&C0009402
Colon/rectal cancer&C0009402
Colorectal Cancers&C0009402
COLORECTAL CANCER&C0009402
Chemotherapies, Combination&C0013218
Drug Therapies, Combination&C0013218
Therapies, Combination Drug&C0013218
combination pharmacotherapy&C0013218
Combination Chemotherapies&C0013218
Combination Drug Therapies&C0013218
Chemotherapy, Combination&C0013218
Drug Therapy, Combination&C0013218
Therapy, Combination Drug&C0013218
chemotherapy combinations&C0013218
Combination Chemotherapy&C0013218
Combination Drug Therapy&C0013218
chemotherapy combination&C0013218
Drug Polytherapies&C0013218
Drug Polytherapy&C0013218
polychemotherapy&C0013218
Combined Treatment Modalities&C0009429
Modality Therapies, Combined&C0009429
Combined Modality Therapies&C0009429
Combined Modality Treatment&C0009429
Modality Therapy, Combined&C0009429
Combined Modality Therapy&C0009429
Treatment, Multimodal&C0009429
combination therapies&C0009429
multimodality therapy&C0009429
Multimodal Treatment&C0009429
Combination therapy&C0009429
combined treatment&C0009429
cotreatment&C0009429
Intercurrent Illness&C0009488
comorbidities&C0009488
co-morbidity&C0009488
Comorbidity&C0009488
CBC (complete blood count)&C0009555
complete blood count (CBC)&C0009555
Complete blood count, NOS&C0009555
Blood Counts, Complete&C0009555
Counts, Complete Blood&C0009555
FBC - Full blood count&C0009555
Blood Count, Complete&C0009555
Complete Blood Counts&C0009555
Count, Complete Blood&C0009555
Test;full blood count&C0009555
blood test full count&C0009555
full blood count test&C0009555
Complete Blood Count&C0009555
Blood Count Tests&C0009555
Full Blood Count&C0009555
CBC, NOS&C0009555
CBC&C0009555
Extramedullary Spinal Cord Compression&C0037926
SPINAL CORD COMPRESSION SYNDROME&C0037926
Cord compression, unspecified&C0037926
Spinal cord compression, NOS&C0037926
Compression of spinal cord&C0037926
SPINAL CORD, COMPRESSION&C0037926
spinal cord compressions&C0037926
Myelopathy, Compressive&C0037926
SPINAL CORD COMPRESSION&C0037926
compression cord spinal&C0037926
compression spinal cord&C0037926
compressive myelopathy&C0037926
spinal cord; pressure&C0037926
Cord compression NOS&C0037926
cord compression&C0037926
Contrast-enhanced Computed Tomography&C0742919
Computed Tomography with Contrast&C0742919
CT Scan with Contrast&C0742919
contrasted ct scan&C0742919
CT SCAN CONTRAST&C0742919
CT with Contrast&C0742919
contrast ct scan&C0742919
Congenital malformation (disorder)&C0000768
Congenital malformation, NOS&C0000768
Congenital abnormality, NOS&C0000768
Congenital abnormality NOS&C0000768
Developmental Malformation&C0000768
Abnormalities, Congenital&C0000768
Congenital Abnormalities&C0000768
Abnormality, Congenital&C0000768
Congenital anomaly, NOS&C0000768
Congenital malformation&C0000768
Congenital Abnormality&C0000768
Congenital Deformity&C0000768
Developmental defect&C0000768
Defects, Congenital&C0000768
CONGENITAL ANOMALY&C0000768
Congenital Defect&C0000768
Defect, Birth&C0000768
Birth defect&C0000768
dysgenesis&C0000768
deformity&C0000768
Congenital ichthyosiform erythroderma, non-bullous&C0079154
Congenital non bullous ichthyosiform erythroderma&C0079154
Non-bullous congenital ichthyosiform erythroderma&C0079154
Congenital Nonbullous Ichthyosiform Erythroderma&C0079154
Nonbullous Congenital Ichthyosiform Erythroderma&C0079154
Erythroderma Ichthyosiformes, Nonbullous&C0079154
Erythroderma Ichthyosiforme, Nonbullous&C0079154
Nonbullous Erythroderma Ichthyosiformes&C0079154
Nonbullous Erythroderma Ichthyosiforme&C0079154
Congenital ichthyosiform erythroderma&C0079154
Ichthyosis, congenital, nonblistering&C0079154
Congenital non-bullous ichthyosis&C0079154
Congenital lamellar ichthyosis&C0079154
Erythrodermic ichthyosis&C0079154
Ichthyosis lammellaris&C0079154
Ichthyoses, Lamellar&C0079154
Ichthyosis, Lamellar&C0079154
Ichthyose, Lamellar&C0079154
Lamellar Ichthyosis&C0079154
Collodion baby&C0079154
CIE&C0079154
Diseases and Syndromes of Connective Tissue&C0009782
Disorder of connective tissue (disorder)&C0009782
connective tissue disorder diagnosis&C0009782
DISEASES OF THE CONNECTIVE TISSUES&C0009782
Disorder of connective tissue&C0009782
Connective tissues--Diseases&C0009782
Connective Tissue Disorders&C0009782
Diseases, Connective Tissue&C0009782
Connective Tissue Diseases&C0009782
Connective tissue disorder&C0009782
Disease, Connective Tissue&C0009782
CONNECTIVE TISSUE DISEASE&C0009782
Barrier Methods, Contraceptive&C0004764
Barrier Method, Contraceptive&C0004764
barrier contraceptives method&C0004764
barrier method contraception&C0004764
Contraception, Barrier&C0004764
Barrier Contraception&C0004764
barrier methods&C0004764
barrier method&C0004764
Inhibition of Fertilization&C0700589
contraceptives methods&C0700589
Contraceptive Methods&C0700589
Contraceptive methods&C0700589
Birth control method&C0700589
contraceptive method&C0700589
control fertility&C0700589
birth controls&C0700589
contraceptions&C0700589
BIRTH CONTROL&C0700589
Contraception&C0700589
Contraindicated (qualifier value)&C1444657
Contra-indicated&C1444657
Contraindicated&C1444657
Contralateral (qualifier value)&C0441988
Contralateral&C0441988
Core biopsy needle, device (physical object)&C1289798
Core biopsy needle, device&C1289798
biopsies core needle&C1289798
biopsy coring needle&C1289798
Core biopsy needle&C1289798
biopsy core needle&C1289798
needle core biopsy&C1289798
Core needle biopsy (procedure)&C1318309
Large-Core Needle Biopsies&C1318309
Biopsy, Large-Core Needle&C1318309
Large Core Needle Biopsy&C1318309
Large-Core Needle Biopsy&C1318309
Core needle biopsy, NOS&C1318309
Biopsies, Core Needle&C1318309
Needle Biopsies, Core&C1318309
Core Needle Biopsies&C1318309
biopsies core needle&C1318309
biopsy coring needle&C1318309
Biopsy, Core Needle&C1318309
Needle Biopsy, Core&C1318309
Biopsy.core needle&C1318309
Core Needle Biopsy&C1318309
Core needle biopsy&C1318309
biopsy core needle&C1318309
needle core biopsy&C1318309
Core Biopsy&C1318309
Cryotherapy - action (qualifier value)&C4551716
Cryotherapy - physiotherapeutic&C4551716
Therapeutic application of cold&C4551716
Cryotherapy (procedure)&C4551716
Cryotherapy - action&C4551716
Cryotherapy, NOS&C4551716
Cryotherapy NOS&C4551716
Cryotherapies&C4551716
Cryotherapy&C4551716
Cyclophosphamide Regimen&C5204857
Cytoxan Regimen&C5204857
Cystic (qualifier value)&C0205207
Cystic&C0205207
Cytotoxic Chemotherapy&C0677881
Cytotoxic Therapy&C0677881
Cytotoxic&C0677881
Cytotoxic agent (product)&C0304497
Cytotoxic (substance)&C0304497
Cytotoxic agent, NOS&C0304497
Cytotoxic drug, NOS&C0304497
agents cytotoxic&C0304497
Cytotoxic agent&C0304497
agent cytotoxic&C0304497
cytotoxic drugs&C0304497
cytotoxic drug&C0304497
Cytotoxic&C0304497
DNA sequencing&C0162326
Sequences, DNA&C0162326
DNA Sequences&C0162326
Sequence, DNA&C0162326
DNA Sequence&C0162326
Sequences&C0162326
DNA Sequence Rearrangement&C1511695
Rearrangement&C1511695
DATOPOTAMAB DERUXTECAN&C5432272
Datopotamab deruxtecan&C5432272
Dato-DXd&C5432272
Deep Inspiration Breath Hold&C4725719
DIBH&C4725719
Densitometers, Bone, Isotope, Single-Photon Absorptiometry&C0178947
Absorptiometers, Single-Photon&C0178947
Single-Photon Absorptiometers&C0178947
Single-Photon Densitometers&C0178947
SPA Systems&C0178947
Dermal - anatomy qualifier&C0221928
Dermal&C0221928
Dermo-&C0221928
dermo&C0221928
derms&C0221928
DERM&C0221928
Diagnostic radiologic examination, NOS&C0043299
Diagnostic radiologic examination&C0043299
Radiology, Diagnostic X Ray&C0043299
Radiology, Diagnostic X-Ray&C0043299
X Ray Radiology, Diagnostic&C0043299
X-Ray Radiology, Diagnostic&C0043299
Diagnostic X Ray Radiology&C0043299
Diagnostic X-Ray Radiology&C0043299
Diagnostic Radiology&C0043299
X-Rays, Diagnostic&C0043299
Diagnostic X-Rays&C0043299
X Ray, Diagnostic&C0043299
X-Ray, Diagnostic&C0043299
Diagnostic X Ray&C0043299
Diagnostic X-Ray&C0043299
radiographies&C0043299
radiography&C0043299
X-Ray&C0043299
Dissecting aneurysm of the thoracic aorta&C0729233
dissection of thoracic aorta (diagnosis)&C0729233
Dissection of thoracic aorta (disorder)&C0729233
Dissection of Thoracic Aorta&C0729233
Aortic Dissection, Thoracic&C0729233
Dissection, Thoracic Aortic&C0729233
Thoracic Aortic Dissections&C0729233
Aorta Dissection, Thoracic&C0729233
Dissection, Thoracic Aorta&C0729233
Thoracic Aorta Dissections&C0729233
Thoracic Aortic Dissection&C0729233
Thoracic Aorta Dissection&C0729233
aorta dissection thoracic&C0729233
Docetaxel/Carboplatin/Trastuzumab/Pertuzumab Regimen&C4527353
Docetaxel/Carboplatin/Pertuzumab/Trastuzumab&C4527353
Taxotere-Carboplatin-Herceptin-Pertuzumab&C4527353
Taxotere-Carboplatin-Herceptin-Perjeta&C4527353
TCH Plus Pertuzumab Regimen&C4527353
TCH + Pertuzumab&C4527353
TCHP Regimen&C4527353
Docetaxel/Pertuzumab/Trastuzumab Regimen&C4527349
Pertuzumab-Trastuzumab-Docetaxel Regimen&C4527349
Pertuzumab/Trastuzumab/Docetaxel Regimen&C4527349
Pertuzumab + Trastuzumab + Docetaxel&C4527349
Pertuzumab-Trastuzumab-Docetaxel&C4527349
Pertuzumab/Trastuzumab/Docetaxel&C4527349
Taxotere/Herceptin/Pertuzumab&C4527349
THP (Taxotere) Regimen&C4527349
Dose Volume Histogram&C3827011
Dose-dense Doxorubicin/Cyclophosphamide Followed by Dose-dense Paclitaxel&C4683814
Dose-dense Adriamycin/Cytoxan Followed by Dose-dense Taxol&C4683814
Dose-dense AC Followed by Dose-Dense Paclitaxel Regimen&C4683814
Dose-dense AC Regimen Followed by Dose-dense Paclitaxel&C4683814
Dose-dense AC Followed by Dose-dense Paclitaxel&C4683814
DD AC Followed by DD Paclitaxel Regimen&C4683814
Dose-dense ACT Regimen&C4683814
ACT Dose Dense&C4683814
ACT Dose-dense&C4683814
DD ACT Regimen&C4683814
Dostarlimab-gxly Regimen&C5670597
Dostarlimab Regimen&C5670597
Jemperli Regimen&C5670597
Methods, Double-Masked&C0013072
Studies, Double-Masked&C0013072
Double-Masked Methods&C0013072
Methods, Double-Blind&C0013072
Studies, Double-Blind&C0013072
Double Masked Method&C0013072
Double-Blind Methods&C0013072
Double-Blind Studies&C0013072
Method, Double-Blind&C0013072
DOUBLE-BLIND METHOD&C0013072
Double Blind Method&C0013072
Double Masked Study&C0013072
Double-Blind Method&C0013072
Double-Masked Study&C0013072
Study, Double-Blind&C0013072
Double Blind Study&C0013072
Double-Blind Study&C0013072
blind double study&C0013072
Double-Blinded&C0013072
double blind&C0013072
Dyspnea, NOS&C0013404
DYSPNOEA&C0013404
DYSPNEA&C0013404
Dyspnea&C0013404
Epidermal Growth Factor Receptor Negative&C4725782
c-erbB1 Negative&C4725782
ERBB1 Negative&C4725782
EGFR Negative&C4725782
ERBB Negative&C4725782
HER1 Negative&C4725782
Anti-Tyrosine Kinase-Type Cell Surface Receptor HER2 Antibody&C4329777
Tyrosine Kinase-Type Cell Surface Receptor HER2 Antibody&C4329777
Anti-Receptor Tyrosine-Protein Kinase erbB-2 Antibody&C4329777
Receptor Tyrosine-Protein Kinase erbB-2 Antibody&C4329777
Anti-Proto-Oncogene Neu Antibody&C4329777
Anti-HER2/Neu Antibody&C4329777
Anti-c-erbB2 Antibody&C4329777
Anti-HER-2 Antibody&C4329777
Anti-HER2 Antibody&C4329777
Anti-NEU Antibody&C4329777
HER2/Neu Antibody&C4329777
c-erbB2 Antibody&C4329777
ERBB2 Antibody&C4329777
HER-2 Antibody&C4329777
HER2 Antibody&C4329777
NEU Antibody&C4329777
v-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 Gene Amplification Negative&C5204780
Erb-B2 Receptor Tyrosine Kinase 2 Gene Amplification Negative&C5204780
HER2/neu Gene Amplification Negative&C5204780
ERBB2 Gene Amplification Negative&C5204780
HER-2 Gene Amplification Negative&C5204780
HER2 Gene Amplification Negative&C5204780
NEU Gene Amplification Negative&C5204780
ERBB2 Non-Amplified&C5204780
HER2 Non-Amplified&C5204780
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)&C0242957
TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2&C0242957
human epidermal growth factor receptor 2&C0242957
erb-b2 receptor tyrosine kinase 2&C0242957
c-erbB-2 Proto-Oncogenes&C0242957
c-erbB-2 Genes&C0242957
c-erbB-2 Gene&C0242957
erbB 2 Genes&C0242957
Gene, erbb2&C0242957
Genes, HER2&C0242957
ERBB2 Gene&C0242957
ERBB2 gene&C0242957
Gene, HER2&C0242957
Genes, neu&C0242957
HER-2 Gene&C0242957
her 2 neu&C0242957
neu Genes&C0242957
c-erbb-2&C0242957
neu Gene&C0242957
ERBB2&C0242957
HER-2&C0242957
her2&C0242957
NEU&C0242957
NGL&C0242957
Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Center Group&C5236995
ECOG-ACRIN Cancer Research Group&C5236995
ECOG-ACRIN&C5236995
Electromagnetic radiation (physical force)&C0034519
Radiation, Electromagnetic&C0034519
electromagnetic radiations&C0034519
Electromagnetic Radiation&C0034519
Energies, Electromagnetic&C0034519
radiation electromagnetic&C0034519
Electromagnetic Energies&C0034519
Energy, Electromagnetic&C0034519
Electromagnetic Energy&C0034519
Waves, Electromagnetic&C0034519
Electromagnetic Waves&C0034519
Wave, Electromagnetic&C0034519
Electromagnetic Wave&C0034519
electromagnetism&C0034519
wave (radiation)&C0034519
Radiation-Total&C0034519
Radiation&C0034519
Embryo Preservation&C0920498
Neoplasm of endocrine system (disorder)&C0014132
endocrine neoplasm (diagnosis)&C0014132
Neoplasm of endocrine system&C0014132
Neoplasm of endocrine gland&C0014132
Tumour of endocrine system&C0014132
Endocrine Gland Neoplasms&C0014132
Endocrine System Neoplasm&C0014132
Neoplasm, Endocrine Gland&C0014132
Tumour of endocrine gland&C0014132
neoplasm of the endocrine&C0014132
Tumor of endocrine gland&C0014132
endocrine gland tumours&C0014132
endocrine system tumour&C0014132
Endocrine System Tumor&C0014132
Endocrine neoplasm NOS&C0014132
endocrine; neoplasia&C0014132
endocrine neoplasia&C0014132
endocrine neoplasms&C0014132
Endocrine Neoplasm&C0014132
Neoplasm;endocrine&C0014132
Endocrine function (observable entity)&C0678896
endocrine physiological process&C0678896
endocrine physiology&C0678896
endocrine functions&C0678896
Endocrine function&C0678896
effects endocrine&C0678896
endocrine effects&C0678896
endocrine process&C0678896
endocrine effect&C0678896
Endocrine/Metabolic Organ System&C0014136
Endocrine System in General&C0014136
Endocrine system structure&C0014136
endocrine glands system&C0014136
Systema endocrinum&C0014136
Endocrine Systems&C0014136
Endocrine System&C0014136
Endocrine system&C0014136
Hormonal System&C0014136
Endocrine&C0014136
Endoplasmic reticulum (cell structure)&C0014239
Endoplasmic reticulum, NOS&C0014239
endoplasmic reticulum (ER)&C0014239
Reticulum cytoplasmaticum&C0014239
Reticulum endoplasmicum&C0014239
Reticulum, Endoplasmic&C0014239
Endoplasmic Reticulum&C0014239
Ergastoplasm&C0014239
Ephedra, Chinese&C0696758
ephedra huang ma&C0696758
Chinese Ephedra&C0696758
Ephedra sinica&C0696758
Ma-Huang, Cao&C0696758
Cao Ma-Huang&C0696758
Ma Huang&C0696758
huang ma&C0696758
Episodic (qualifier value)&C1455761
Now and then&C1455761
Recurrent&C1455761
Episodic&C1455761
Equivocal result (qualifier value)&C0459423
Equivocal result&C0459423
Eribulin/Margetuximab-cmkb Regimen&C5557264
Eribulin-Margetuximab Regimen&C5557264
Eribulin/Margetuximab Regimen&C5557264
Margetuximab/Eribulin Regimen&C5557264
Margetuximab Plus Eribulin&C5557264
Eribulin-Margetuximab&C5557264
Eribulin/Margetuximab&C5557264
Margetuximab-Eribulin&C5557264
Margetuximab/Eribulin&C5557264
Margenza/Halaven&C5557264
Sensory perception function (observable entity)&C0036658
Sensory function (observable entity)&C0036658
Observation of sensation&C0036658
Feeling - sensation&C0036658
Sensory perception&C0036658
sensory processing&C0036658
Function, Sensory&C0036658
Sensory Function&C0036658
Sensation, NOS&C0036658
Sensations&C0036658
the senses&C0036658
Aesthesia&C0036658
Sensation&C0036658
Esthesia&C0036658
sense&C0036658
Esthetics (discipline)&C0014901
Aesthetics&C0014901
Esthetics&C0014901
aesthetic&C0014901
esthetic&C0014901
Estrogen Receptor Status 0&C4688269
ER Status 0&C4688269
ER IHC 0&C4688269
Nuclear receptor subfamily 3 group A member 1&C0034804
E2R - Oestrogen receptor&C0034804
E2R - Estrogen receptor&C0034804
OR - Oestrogen receptor&C0034804
Oestrogen receptor site&C0034804
Estrogen receptor site&C0034804
OR - Estrogen receptor&C0034804
estrogen receptor (ER)&C0034804
Estrogen--Receptors&C0034804
Receptors, Estrogen&C0034804
Estrogen Receptors&C0034804
Oestrogen receptor&C0034804
Receptor, Estrogen&C0034804
Estrogen Receptor&C0034804
ER-alpha&C0034804
Nuclear Receptor Subfamily 3 Group A Member 1 Negative&C0279756
Estrogen Receptor Alpha Negative&C0279756
Estrogen Receptor 1 Negative&C0279756
Estrogen Receptor Negative&C0279756
Estrogen receptor negative&C0279756
Negative Estrogen Receptor&C0279756
ER Alpha Negative&C0279756
ER-Alpha Negative&C0279756
ESTRR Negative&C0279756
NR3A1 Negative&C0279756
ESR1 Negative&C0279756
ESRA Negative&C0279756
ERA Negative&C0279756
ESR Negative&C0279756
ER Negative&C0279756
ER-&C0279756
Nuclear Receptor Subfamily 3 Group A Member 1 Positive&C0279754
Estrogen Receptor Alpha Positive&C0279754
Estrogen Receptor 1 Positive&C0279754
Estrogen Receptor Positive&C0279754
Estrogen receptor positive&C0279754
Positive Estrogen Receptor&C0279754
ER Alpha Positive&C0279754
ER-Alpha Positive&C0279754
ESTRR Positive&C0279754
NR3A1 Positive&C0279754
ESR1 Positive&C0279754
ESRA Positive&C0279754
ERA Positive&C0279754
ESR Positive&C0279754
ER Positive&C0279754
ER+&C0279754
Excision biopsy (qualifier value)&C0184921
Excisional biopsy (procedure)&C0184921
biopsies excisional&C0184921
BIOPSY EXCISIONAL&C0184921
Biopsy.excisional&C0184921
Excisional Biopsy&C0184921
Biopsy, excision&C0184921
Excision biopsy&C0184921
biopsy excision&C0184921
Excision of axillary lymph nodes group (procedure)&C0193867
Excision of axillary lymph node (procedure)&C0193867
Excision procedures on lymph node of axilla&C0193867
Excision of axillary lymph nodes group&C0193867
Excision of axillary lymph nodes, NOS&C0193867
axillary lymphadenectomy (treatment)&C0193867
Excision of lymph node of axilla&C0193867
Excision of axillary lymph node&C0193867
Axillary Lymph Node Dissection&C0193867
AXILLARY LYMPH NODE RESECTION&C0193867
Excision Axillary Lymph Nodes&C0193867
AXILLARY LYMPH NODE EXCISION&C0193867
Axillary Lymphadenectomy&C0193867
Axillary Node Dissection&C0193867
Axillary Dissection&C0193867
Excision of skin&C2697304
JUNCTION ADHESION MOLECULE, MOUSE, HOMOLOG OF&C1422839
junctional adhesion molecule 1&C1422839
JUNCTION ADHESION MOLECULE 1&C1422839
F11 Receptor Gene&C1422839
F11 receptor&C1422839
F11R Gene&C1422839
F11R gene&C1422839
CD321&C1422839
JAM-1&C1422839
JAM-A&C1422839
PAM-1&C1422839
F11R&C1422839
JAM1&C1422839
JAMA&C1422839
JCAM&C1422839
JAM&C1422839
Whole Body [18]F- Fludeoxyglucose Positron Emission Tomography/Computed Tomography&C4527276
FDG-Positron Emission Tomography/Computed Tomography of the Whole Body&C4527276
Positron Emission Tomography/Computed Tomography, Whole Body, FDG&C4527276
Whole Body FDG-Positron Emission Tomography/Computed Tomography&C4527276
Total-Body Positron Emission Tomography/Computed Tomography&C4527276
Whole-body 18F FDG PET/CT&C4527276
PET/CT, Whole Body, FDG&C4527276
WB PET/CT Scan with FDG&C4527276
Whole Body FDG-PET/CT&C4527276
Whole-body FDG-PET/CT&C4527276
[18]F-FDG PET/CT&C4527276
Female structure (body structure)&C0086287
Female individual, NOS&C0086287
Female individual&C0086287
Female (finding)&C0086287
Female structure&C0086287
Female Gender&C0086287
Female, NOS&C0086287
FEMALE SEX&C0086287
Sex Female&C0086287
Females&C0086287
Female&C0086287
Ability to conceive (observable entity)&C0015895
Fertility, function (observable entity)&C0015895
Ability to conceive&C0015895
Fertility, NOS&C0015895
fecundability&C0015895
fertilities&C0015895
Fecundity&C0015895
Fertility&C0015895
Fertile&C0015895
Fertility care (regime/therapy)&C1171194
RNIx fertility care (treatment)&C1171194
Fertility Preservations&C1171194
Preservation, Fertility&C1171194
Fertility Preservation&C1171194
RNIx fertility care&C1171194
Fertility Care&C1171194
Benign fibroadenoma (morphologic abnormality)&C0178421
fibroadenoma of breast (diagnosis)&C0178421
Fibroadenoma of breast (disorder)&C0178421
Fibroadenoma of the Breast&C0178421
Fibroadenosis of breast&C0178421
FIBROADENOMA OF BREAST&C0178421
Fibroadenoma of breast&C0178421
BREAST, FIBROADENOMA&C0178421
Breast fibroadenomas&C0178421
Breast fibroadenosis&C0178421
Benign fibroadenoma&C0178421
Breast Fibroadenoma&C0178421
adenofibroma breast&C0178421
fibroadenoma breast&C0178421
Breast mouse&C0178421
Fine needle aspiration biopsy - action (qualifier value)&C1510483
Fine needle aspiration biopsy - action&C1510483
fine needle aspiration (procedure)&C1510483
Biopsies, Fine-Needle Aspiration&C1510483
Aspiration Biopsy, Fine-Needle&C1510483
Fine needle aspiration biopsy&C1510483
fine-needle aspiration biopsy&C1510483
FNA - Fine needle aspiration&C1510483
Aspirations, Fine-Needle&C1510483
Aspiration, Fine Needle&C1510483
Aspiration, Fine-Needle&C1510483
Fine-Needle Aspirations&C1510483
aspirations fine needle&C1510483
Aspiration.fine needle&C1510483
Fine Needle Aspiration&C1510483
aspiration fine-needle&C1510483
fine-needle aspiration&C1510483
Aspirate, Fine Needle&C1510483
Fine Needle Biopsy&C1510483
Aspiration biopsy&C1510483
biopsy aspiration&C1510483
Fixation of pendulous breast (procedure)&C0191918
Fixation of pendulous breast&C0191918
BREAST SURGERY MASTOPEXY&C0191918
mastopexy (treatment)&C0191918
Breast Lift&C0191918
MASTOPEXY&C0191918
Focal (qualifier value)&C0205234
Focally&C0205234
Foci of&C0205234
Focused&C0205234
Focal&C0205234
Focus&C0205234
Foci&C0205234
injectable follicle stimulating hormone (FSH)&C0016424
Follicle stimulating hormone, injectable&C0016424
Follicle stimulating hormone injectable&C0016424
FSH&C0016424
Frail&C0871754
Free Flaps, Microsurgical&C0441031
Flap, Microsurgical Free&C0441031
Free Flap, Microsurgical&C0441031
Microsurgical Free Flaps&C0441031
Microsurgical Free Flap&C0441031
Free flap (substance)&C0441031
Free flaps (Surgery)&C0441031
Flaps, Free Tissue&C0441031
Tissue Flaps, Free&C0441031
Flap, Free Tissue&C0441031
Free Tissue Flaps&C0441031
Tissue Flap, Free&C0441031
Free Tissue Flap&C0441031
Flaps, Free&C0441031
Flap, Free&C0441031
Free Flaps&C0441031
flaps free&C0441031
Free Flap&C0441031
Free flap&C0441031
flap free&C0441031
full thickness hole of macula lutea (diagnosis)&C2733564
Full thickness hole of macula lutea (disorder)&C2733564
Full thickness hole of macula lutea&C2733564
Full thickness macular hole&C2733564
Full-thickness macular hole&C2733564
FTMH&C2733564
Full-Thickness Skin Biopsy of Nipple-Areolar Complex&C4527249
Full-Thickness Skin Biopsy of Nipple and Areola&C4527249
Full-thickness Skin Biopsy of Nipple and Areola&C4527249
Full-Thickness Skin Biopsy of NAC&C4527249
Gemcitabine/Margetuximab-cmkb Regimen&C5557265
Gemcitabine-Margetuximab Regimen&C5557265
Gemcitabine/Margetuximab Regimen&C5557265
Margetuximab/Gemcitabine Regimen&C5557265
Margetuximab Plus Gemcitabine&C5557265
Gemcitabine-Margetuximab&C5557265
Gemcitabine/Margetuximab&C5557265
Margetuximab-Gemcitabine&C5557265
Margetuximab/Gemcitabine&C5557265
Margenza/Gemzar&C5557265
Expressions, Gene&C0017262
Expression, Gene&C0017262
Gene Expression&C0017262
General Statistical Consideration&C5236208
gene switching&C0017373
Genes, Switch&C0017373
Gene, Switch&C0017373
Switch Gene&C0017373
Genetic counseling individual each 15 minutes&C0017382
Genetic counseling (procedure)&C0017382
genetic counseling (treatment)&C0017382
Counseling, Genetic&C0017382
Genetic Counselling&C0017382
GENETIC COUNSELING&C0017382
Genetic Counseling&C0017382
Genetic Predisposition to Disease&C0314657
Genetic predisposition (finding)&C0314657
Susceptibilities, Genetic&C0314657
Genetic Susceptibilities&C0314657
Inherited Predisposition&C0314657
Inherited Susceptibility&C0314657
Predispositions, Genetic&C0314657
Genetic Predispositions&C0314657
Predisposition, Genetic&C0314657
Susceptibility, Genetic&C0314657
genetics predisposition&C0314657
Genetic Predisposition&C0314657
Genetic Susceptibility&C0314657
Genetic selection (finding)&C0036576
selection (genetics)&C0036576
Selection, Genetic&C0036576
Genetic Selection&C0036576
selection&C0036576
Genetic Testing for Cancer Risk&C0393006
Genetic testing for cancer risk&C0393006
cancer risk, genetic testing&C0393006
genetic testing&C0393006
Germline Mutation Abnormality&C0206530
Mutations, Germ-Line&C0206530
Germ-Line Mutations&C0206530
Hereditary Mutation&C0206530
Mutation, Germ Line&C0206530
Mutation, Germ-Line&C0206530
Mutations, Germline&C0206530
Germ Line Mutation&C0206530
Germ-Line Mutation&C0206530
Germline Mutations&C0206530
Germline Variation&C0206530
Mutation, Germline&C0206530
Germline Mutation&C0206530
Germline Variant&C0206530
Advanced Glycosylation End Products&C0162574
advanced end glycosylation products&C0162574
Advanced Glycosylation End Product&C0162574
Glycation End Products, Advanced&C0162574
Advanced Glycation End Products&C0162574
Glycation Endproducts, Advanced&C0162574
Advanced Glycation End Product&C0162574
Advanced Glycation End-Product&C0162574
Advanced Glycation Endproducts&C0162574
Glycation Endproduct, Advanced&C0162574
Advanced Glycation Endproduct&C0162574
Glycotoxins&C0162574
AGEs&C0162574
AGE&C0162574
Grade 3 (qualifier value)&C0450094
Grade three rank&C0450094
Grade III&C0450094
Grade 3&C0450094
Grafting of fat (procedure)&C0844767
fat transplantation&C0844767
lipotransplantation&C0844767
Grafting of fat&C0844767
Fat graft NOS&C0844767
fat grafting&C0844767
Fat graft&C0844767
Gray unit of radiation dose&C0556636
Gray (qualifier value)&C0556636
gray (gy)&C0556636
Gray&C0556636
Gynecologic (qualifier value)&C0205480
Gynaecologic&C0205480
Gynecologic&C0205480
GYN&C0205480
Human epidermal growth factor 2 positive carcinoma of breast (disorder)&C1960398
Human epidermal growth factor 2 positive carcinoma of breast&C1960398
HER-2 positive malignant carcinoma of breast (diagnosis)&C1960398
ERBB2 Overexpressing Subtype of Breast Carcinoma&C1960398
HER2 Overexpressing Subtype of Breast Carcinoma&C1960398
HER-2 positive malignant carcinoma of breast&C1960398
breast neoplasm malignant her2-positive&C1960398
HER2 Overexpressing Breast Carcinoma&C1960398
HER2-positive carcinoma of breast&C1960398
HER2/neu-positive breast cancer&C1960398
HER2 Positive Breast Carcinoma&C1960398
HER2-Positive Breast Carcinoma&C1960398
HER2 Positive Breast Cancer&C1960398
HER2-positive breast cancer&C1960398
HER-2/neu-positivity&C1960398
HER2+ breast cancer&C1960398
ERBB2-Targeting Agent&C5235659
HER2-targeting Agent&C5235659
HER-2/Neu Positive&C2348909
HER2/Neu Positive&C2348909
ERBB-2 Positive&C2348909
ERBB2 Positive&C2348909
HER-2 Positive&C2348909
HER2 Positive&C2348909
Low Risk Human Papilloma Virus&C4763514
Low-Risk Human Papilloma Virus&C4763514
Low Risk Human Papillomavirus&C4763514
Low-Risk Human Papillomavirus&C4763514
Low-Risk HPV Subtype&C4763514
Low-Risk HPV Strain&C4763514
HPV-Low Risk&C4763514
Low Risk HPV&C4763514
Low-Risk HPV&C4763514
Hematopoietic Cell Growth Factors&C0079490
Hematopoietic Cell Growth Factor&C0079490
Hematopoietic growth factors&C0079490
Hematopoietic Growth Factor&C0079490
Hematopoietic Cytokine&C0079490
Hematopoietic CGF&C0079490
Hematopoietic-CGF&C0079490
Hematopoietins&C0079490
Heterogeneity&C0019409
Heterogeneous&C0019409
High Grade Astrocytic Neoplasm&C3640999
High-Grade Astrocytic Neoplasm&C3640999
High Grade Astrocytic Tumor&C3640999
High-Grade Astrocytic Tumor&C3640999
High-Risk Cancer&C1512441
Microanatomy&C0019638
histologies&C0019638
HISTOLOGY:&C0019638
HISTOLOGY&C0019638
Histology&C0019638
Historical - ParameterizedDataType&C1552658
Historical&C1552658
Homogeneity&C1881065
Homogeneous&C1881065
Homozygote (finding)&C0019904
Homozygosity&C0019904
Homozygotes&C0019904
Homozygote&C0019904
Homozygous&C0019904
Contraception, Hormonal&C2985296
Hormonal Birth Control&C2985296
Hormonal Contraception&C2985296
hormone receptors&C0019929
Hormone Receptor&C0019929
Hormone Receptor Positive&C3640067
HR+&C3640067
Hormone Receptor/Epidermal Growth Factor Receptor 2 Positive&C3898879
Triple-Positive Breast Cancer Finding&C3898879
Hormone Receptor/HER2 Positive&C3898879
ER/PR/HER2 Positive&C3898879
ER+PR+HER2/neu+&C3898879
Triple Positive&C3898879
Triple-Positive&C3898879
Chemotherapy-Hormones/Steroids&C0279025
Hormone therapy (procedure)&C0279025
HT - Hormone therapy&C0279025
hormonal therapies&C0279025
therapy, endocrine&C0279025
Endocrine therapy&C0279025
Hormonal therapy/&C0279025
Hormonal Therapy&C0279025
hormones therapy&C0279025
therapy hormonal&C0279025
Hormone Therapy&C0279025
Hormone-Resistant Breast Adenocarcinoma&C4049259
Hormone-Resistant Breast Carcinoma&C4049259
Hormone refractory breast cancer&C4049259
Hormone-Refractory Breast Cancer&C4049259
Hormone-Resistant Breast Cancer&C4049259
Human follicle stimulating hormone (substance)&C0016774
FSH, human (follicle stimulating hormone)&C0016774
Follicle Stimulating Hormone, Human&C0016774
Human Follicle Stimulating Hormone&C0016774
Human Follicle-Stimulating Hormone&C0016774
Follicle Stimulating Hormone&C0016774
Follicle-Stimulating Hormone&C0016774
FSH, Human&C0016774
Human FSH&C0016774
hFSH&C0016774
FSH&C0016774
hypercalcemia (diagnosis)&C0020437
Hypercalcemia (disorder)&C0020437
Hypercalcaemia syndrome&C0020437
HYPERCALCAEMIA&C0020437
Hypercalcemias&C0020437
HYPERCALCEMIA&C0020437
Hypercalcemia&C0020437
hypertrophy of breast (physical finding)&C0020565
hypertrophy of breast (diagnosis)&C0020565
Hypertrophy of breast (disorder)&C0020565
breast appearance hypertrophy&C0020565
breast hypertrophy was seen&C0020565
Hypertrophy of breast, NOS&C0020565
breast enlargement females&C0020565
Hypertrophy of breast NOS&C0020565
Hypertrophy of the Breast&C0020565
female breast enlargement&C0020565
Hypertrophy of Breast&C0020565
Mammary hypertrophy&C0020565
breast; hypertrophy&C0020565
Breast Hypertrophy&C0020565
Hypertrophy breast&C0020565
Unspecified acquired hypothyroidism&C0020676
Hypothyroidism, unspecified&C0020676
Thyroid activity decreased&C0020676
Unspecified hypothyroidism&C0020676
thyroid; insufficiency&C0020676
Underactive Thyroid&C0020676
thyroid; deficiency&C0020676
HYPOTHYROIDISM&C0020676
Hypothyroidism&C0020676
Hypothyreosis&C0020676
subthyroidism&C0020676
HYPOTHYROID&C0020676
Intravenous contrast&C4072741
IV contrast&C4072741
Illinois (geographic location)&C0020898
Illinois&C0020898
Immunological Sensitization&C0020971
Stimulations, Immunological&C0020971
Stimulation, Immunological&C0020971
Immunization, NOS&C0020971
Immunostimulation&C0020971
immunoprophylaxis&C0020971
Immunizations&C0020971
immunisations&C0020971
IMMUNIZATION&C0020971
Immunisation&C0020971
Immunization&C0020971
Immunohistochemistry technique (qualifier value)&C0021044
Immunohistochemistry procedure (procedure)&C0021044
Immunohistochemistry Staining Method&C0021044
Cell/Tissue, Immunohistochemistry&C0021044
Immunohistochemistry procedure&C0021044
Immunohistochemistry technique&C0021044
Immunohistochemical Test&C0021044
Immunohistochemistry&C0021044
Immune enhancement agent (substance)&C0001551
Immune enhancement agent, NOS&C0001551
Immune enhancement agent&C0001551
Adjuvant, Immunological&C0001551
Immunostimulating Agent&C0001551
Adjuvants, Immunologic&C0001551
Immunological Adjuvant&C0001551
Immunologic Adjuvants&C0001551
immunologic adjuvant&C0001551
Immunopotentiators&C0001551
Immunopotentiator&C0001551
IMMUNOSTIMULANTS&C0001551
Immunoadjuvants&C0001551
Immunostimulant&C0001551
Immunoadjuvant&C0001551
Adjuvant, NOS&C0001551
Biological response modifier therapy, NOS&C0021083
Biological response modifier therapy&C0021083
Immunologically Directed Therapy&C0021083
immunotherapy (medication)&C0021083
Immunotherapy (procedure)&C0021083
Immunological therapy&C0021083
Immunological care&C0021083
Immunotherapy, NOS&C0021083
Immunotherapies&C0021083
Immunotherapy&C0021083
Immunotherapy-Related&C5239191
Impact food supplement&C0726639
IMPACT&C0726639
cognitive impairment (diagnosis)&C0338656
Cognitive function abnormal&C0338656
Neurocognitive Dysfunction&C0338656
Disturbance in cognition&C0338656
Cognitive Disturbance&C0338656
Cognitive Dysfunction&C0338656
Impairment, Cognitive&C0338656
Cognitive Impairment&C0338656
Impaired Cognition&C0338656
Impaired cognition&C0338656
Cognitive decline&C0338656
Impaired wound healing (finding)&C0151692
Impaired wound healing&C0151692
HEALING ABNORMAL&C0151692
HEALING IMPAIRED&C0151692
Impaired Healing&C0151692
HEALING DELAYED&C0151692
Failure of implant&C0854676
failures implant&C0854676
Implant Failure&C0854676
Implantation procedure, NOS&C0021107
Insertion procedure, NOS&C0021107
Implant procedure, NOS&C0021107
Implantation Surgery&C0021107
Placement of implant&C0021107
Placement of device&C0021107
insertion procedure&C0021107
Procedure implants&C0021107
implant procedure&C0021107
device placement&C0021107
Implantation&C0021107
implanting&C0021107
Insertion&C0021107
Placement&C0021107
IMPLANT&C0021107
Implant, device (physical object)&C0021102
implant device (treatment)&C0021102
Prosthesis or implant&C0021102
Biomedical implant&C0021102
implant prosthesis&C0021102
Implanted device&C0021102
Implant, device&C0021102
implant device&C0021102
Implant, NOS&C0021102
Implantable&C0021102
Implanted&C0021102
Implants&C0021102
Implant&C0021102
In situ (qualifier value)&C0444498
In Situ&C0444498
In situ&C0444498
In vitro Gene Expression Assay&C4764112
Inadequate (qualifier value)&C0205412
Inadequate (qualifier)&C0205412
Insufficient&C0205412
Inadequate&C0205412
(2S)-2-((2-((4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl)-5,6-dihydroimidazo(1,2-d)(1,4)benzoxazepin-9-yl)amino)propanamide&C5446307
propanamide, 2-((2-((4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl)-5,6-dihydroimidazo(1,2-D)(1,4)benzoxazepin-9-yl)amino)-, (2S)-&C5446307
(2S)-2-((2-((4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl)-5,6-dihydroimidazo(1,2-D)(1,4)benzoxazepin-9-yl)amino)propanamide&C5446307
inavolisib (medication)&C5446307
INAVOLISIB&C5446307
Inavolisib&C5446307
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A&C0270724
Infantile neuroaxonal dystrophy (disorder)&C0270724
Neurodegeneration, PLA2G6 Associated&C0270724
PLA2G6-Associated Neurodegeneration&C0270724
NEUROAXONAL DYSTROPHY, INFANTILE&C0270724
Infantile Neuroaxonal Dystrophy&C0270724
Seitelberger's Disease&C0270724
Disease, Seitelberger&C0270724
Seitelbergers Disease&C0270724
NBIA, PLA2G6 Related&C0270724
SEITELBERGER DISEASE&C0270724
NBIA2A&C0270724
INAD1&C0270724
INAD&C0270724
PLAN&C0270724
inability to conceive (infertility)&C0021359
inability to conceive (symptom)&C0021359
Cannot achieve a pregnancy&C0021359
unable (to) get pregnant&C0021359
unable to get pregnant&C0021359
Difficulty conceiving&C0021359
Infertile (finding)&C0021359
Infertility, NOS&C0021359
INFERTILITY&C0021359
Infertility&C0021359
Sterility&C0021359
infertile&C0021359
Sterile&C0021359
Inflammatory findings&C0333348
Inflammatory changes&C0333348
changes inflammatory&C0333348
change inflammatory&C0333348
inflammatories&C0333348
Inflammatory&C0333348
Inflamed&C0333348
inflam&C0333348
carcinoma of the breast, inflammatory&C0278601
Inflammatory Carcinoma of the Breast&C0278601
Inflammatory Breast Cancer (IBC)&C0278601
Inflammatory Carcinoma of Breast&C0278601
Breast Carcinomas, Inflammatory&C0278601
Carcinomas, Inflammatory Breast&C0278601
Breast Carcinoma, Inflammatory&C0278601
Breast Neoplasms, Inflammatory&C0278601
Carcinoma, Inflammatory Breast&C0278601
Inflammatory Breast Carcinomas&C0278601
Breast carcinoma inflammatory&C0278601
Inflammatory Breast Carcinoma&C0278601
breast inflammatory carcinoma&C0278601
inflammatory carcinoma breast&C0278601
Breast Cancers, Inflammatory&C0278601
Cancer, Inflammatory Breast&C0278601
Inflammatory Breast Cancers&C0278601
Inflammatory Breast Cancer&C0278601
Infusion technique (qualifier value)&C0574032
Infusion - action (qualifier value)&C0574032
Infusion (procedure)&C0574032
Infusion procedures&C0574032
Infusion Procedure&C0574032
Infusion Technique&C0574032
Infusion - action&C0574032
Infusion, NOS&C0574032
infusions&C0574032
Infusion&C0574032
Injection of therapeutic substance, NOS&C0021485
Injection of therapeutic agent, NOS&C0021485
Injection of therapeutic substance&C0021485
Injection of therapeutic agent&C0021485
Injection of medication, NOS&C0021485
administration of injection&C0021485
injection administration&C0021485
Injection of drug, NOS&C0021485
injection procedures&C0021485
injections procedure&C0021485
Injection procedure&C0021485
injections&C0021485
injection&C0021485
Shot&C0021485
Injection - action (qualifier value)&C1533685
RNIx injection administration&C1533685
Injection Administration&C1533685
Injection (procedure)&C1533685
Injection procedure&C1533685
Injection - action&C1533685
Injection, NOS&C1533685
Injection(s)&C1533685
Injection&C1533685
International Breast Cancer Study Group&C1512890
IUCD - Intrauterine contraceptive device&C0021900
Contraceptive Devices, Intrauterine&C0021900
Intrauterine Devices, Contraceptive&C0021900
Contraceptive Device, Intrauterine&C0021900
Device, Intrauterine Contraceptive&C0021900
Intra-uterine contraceptive device&C0021900
Intrauterine Contraceptive Devices&C0021900
Intrauterine Contraceptive Device&C0021900
Intra-uterine device&C0021900
Intrauterine Devices&C0021900
intra uterine device&C0021900
INTRAUTERINE DEVICE&C0021900
Contraceptive IUDs&C0021900
IUCD&C0021900
IUD&C0021900
Invasive Carcinoma&C1334274
carcinoma; infiltrating lobular, unspecified site&C0279565
Infiltrating Lobular Carcinoma of the Breast&C0279565
Infiltrating Lobular Carcinoma of Breast&C0279565
Invasive Lobular Carcinoma of the Breast&C0279565
Invasive Lobular Carcinoma, Classic Type&C0279565
Invasive pleomorphic lobular carcinoma&C0279565
Infiltrating Lobular Breast Carcinoma&C0279565
Invasive Lobular Carcinoma of Breast&C0279565
Infiltrating Lobular Adenocarcinoma&C0279565
Invasive Breast Lobular Carcinoma&C0279565
Invasive Lobular Breast Carcinoma&C0279565
Lobular breast carcinoma invasive&C0279565
lobular invasive breast carcinoma&C0279565
Invasive Lobular Adenocarcinoma&C0279565
Invasive Lobular Carcinoma&C0279565
Infiltrating Malignant Neoplasm&C0677898
Invasive Malignant Neoplasm&C0677898
cancer infiltrating&C0677898
infiltrating cancer&C0677898
cancers invasive&C0677898
invasive cancer&C0677898
invasive carcinoma of breast (diagnosis)&C0853879
Invasive carcinoma of breast (disorder)&C0853879
Infiltrating Carcinoma of the Breast&C0853879
Infiltrating Carcinoma of Breast&C0853879
Invasive Carcinoma of the Breast&C0853879
Infiltrating Breast Carcinoma&C0853879
Invasive Carcinoma of Breast&C0853879
Invasive carcinoma of breast&C0853879
Breast cancer invasive NOS&C0853879
Invasive Mammary Carcinoma&C0853879
Invasive Breast Carcinoma&C0853879
Invasive Breast Cancer&C0853879
breast cancer invasive&C0853879
Ipsilateral (qualifier value)&C0441989
Ipsilateral&C0441989
Irregular menstrual bleeding&C0156404
Irregular periods (finding)&C0156404
Menstrual periods irregular&C0156404
IRREGULAR UTERINE BLEEDING&C0156404
Irregular menstrual cycle&C0156404
irregular cycle intervals&C0156404
Menstrual Irregularities&C0156404
menstruation; irregular&C0156404
Irregular Menstruation&C0156404
Irregular menstruation&C0156404
MENSTRUAL IRREGULARITY&C0156404
Menstruation;irregular&C0156404
Irregular periods&C0156404
Irregular menses&C0156404
irregular period&C0156404
Jones Test&C2827602
Laboratory diagnosis (contextual qualifier) (qualifier value)&C0011911
Laboratory diagnosis (contextual qualifier)&C0011911
Diagnosis, Laboratory&C0011911
Laboratory Diagnoses&C0011911
Laboratory Diagnosis&C0011911
Lancet (physical object)&C0777169
diabetic supplies lancet&C0777169
lancets@@MISCELL@EACH&C0777169
lancets MISCELL EACH&C0777169
lancet (treatment)&C0777169
lancet devices&C0777169
Lancet Device&C0777169
Blood Lancet&C0777169
Lancets&C0777169
LANCET&C0777169
Lancet&C0777169
Late Third Trimester&C4683818
Lesion (morphologic abnormality)&C0221198
Visible Lesion&C0221198
Lesion, NOS&C0221198
Lesions&C0221198
LESION&C0221198
Lesion&C0221198
lesion of breast (physical finding)&C0567489
Lesion of breast (disorder)&C0567489
Lesion of breast&C0567489
breasts lesions&C0567489
lesions breasts&C0567489
breast lesions&C0567489
BREAST LESION&C0567489
lesion breast&C0567489
Decreased blood leukocyte number&C0023530
Low white blood cell count&C0023530
Leucocytopenia&C0023530
Leukocytopenia&C0023530
Leukopenia NOS&C0023530
Leukopenias&C0023530
NEUTROPENIA&C0023530
LEUCOPENIA&C0023530
LEUKOPENIA&C0023530
Leukopenia&C0023530
Level II (tumor staging)&C0441926
Midaxilla&C0441926
Level II&C0441926
ii level&C0441926
Lewis blood group system (qualifier value)&C0023595
Blood groups--Lewis system&C0023595
Lewis Blood Group Antigens&C0023595
BLOOD GROUP, LEWIS SYSTEM&C0023595
Blood-Group System, Lewis&C0023595
LEWIS BLOOD GROUP SYSTEM&C0023595
Le(a) Blood Group System&C0023595
Lewis Blood-Group System&C0023595
ISBT system 007&C0023595
ISBT system LE&C0023595
Lewis System&C0023595
Lewis group&C0023595
LES&C0023595
Limited stage (cancer stage)&C1517886
Limited Metastatic Disease&C1517886
Early-Stage Cancer&C1517886
Limited Stage&C1517886
Early Stage&C1517886
Lipectomy (procedure)&C0023765
lipectomy (treatment)&C0023765
panniculectomy&C0023765
Lipectomies&C0023765
LIPECTOMY&C0023765
Lipectomy&C0023765
function hepatic panel&C0023901
Tests, Liver Function&C0023901
Liver Function Tests&C0023901
Test, Liver Function&C0023901
LIVER FUNCTION TEST&C0023901
LFT's&C0023901
Lobular (qualifier value)&C0205417
Lobular&C0205417
Localized Therapy&C1517925
Localized (qualifier value)&C0392752
Limited area&C0392752
localizing&C0392752
LOCALIZED&C0392752
Localised&C0392752
Localized&C0392752
localize&C0392752
Localized Malignant Neoplasm&C0796563
Localized Malignancy&C0796563
Localized Cancer&C0796563
Local Cancer&C0796563
localized enlarged lymph nodes (physical finding)&C0478664
Localized enlarged lymph nodes (disorder)&C0478664
lymphatic gland; hypertrophy, localized&C0478664
enlargement; lymph node, localized&C0478664
lymph node; enlargement, localized&C0478664
Localised enlarged lymph nodes&C0478664
Localized enlarged lymph nodes&C0478664
enlargement; lymph node, local&C0478664
lymph node; enlargement, local&C0478664
lymph nodes enlarged localized&C0478664
hypertrophy; gland, localized&C0478664
Lymphadenopathy, localized&C0478664
localized; lymphadenopathy&C0478664
lymphadenopathy; localized&C0478664
Localized Lymphadenopathy&C0478664
LYMPHADENOPATHY REGIONAL&C0478664
Regional lymphadenopathy&C0478664
adenopathy; localized&C0478664
localized; adenopathy&C0478664
Locally advanced malignant neoplasm (finding)&C0677984
Locally Metastatic Malignant Neoplasm&C0677984
Locally Advanced Malignant Neoplasm&C0677984
Locally advanced malignant tumour&C0677984
Locally advanced malignant tumor&C0677984
Locally Advanced Cancer&C0677984
Locally Recurrent Malignant Neoplasm&C2986682
Locally Recurrent Cancer&C2986682
Locoregional Recurrence&C2986682
Structure of loose areolar connective tissue (body structure)&C0225343
Structure of loose areolar connective tissue&C0225343
Loose areolar connective tissue&C0225343
Areolar connective tissue&C0225343
Loose Connective Tissue&C0225343
Areolar Tissue&C0225343
Low Grade Cervical Squamous Intraepithelial Neoplasia&C1518005
Cervical low grade squamous intraepithelial lesion&C1518005
Low Grade Cervical Squamous Intraepithelial Lesion&C1518005
Low-Grade Cervical Squamous Intraepithelial Lesion&C1518005
Cervical Squamous Intraepithelial Neoplasia 1&C1518005
Mild Squamous Dysplasia of the Cervix&C1518005
Low-Grade Cervical SIL&C1518005
Low-Grade CIN&C1518005
Low dose computed tomography of thorax (procedure)&C4075962
Low Dose Computed Tomography of the Chest&C4075962
Low dose computed tomography of thorax&C4075962
Low dose computed tomography of chest&C4075962
Low Dose Chest Computed Tomography&C4075962
Low-dose Chest Computed Tomography&C4075962
Low-dose Chest CT&C4075962
Serum estradiol levels below reference range (finding)&C0241011
Serum oestradiol levels below reference range&C0241011
Serum estradiol levels below reference range&C0241011
Low serum 17-B-oestradiol levels&C0241011
Low serum 17-B-estradiol levels&C0241011
Low serum oestradiol levels&C0241011
Low serum estradiol levels&C0241011
SERUM ESTRADIOL, DECREASED&C0241011
Decreased serum estradiol&C0241011
breast lumpectomy (treatment)&C0851238
Excision of breast lump&C0851238
Lumpectomy of Breast&C0851238
Lumpectomy of breast&C0851238
Breast lump removal&C0851238
Partial Mastectomy&C0851238
BREAST LUMPECTOMY&C0851238
Lumpectomy, NOS&C0851238
Tylectomy, NOS&C0851238
Lumpectomy&C0851238
Tylectomy&C0851238
tuberculosis; lupus exedens&C0024131
Tuberculosis lupus exedens&C0024131
lupus vulgaris (diagnosis)&C0024131
Tuberculosis cutis luposa&C0024131
Tuberculosis luposa cutis&C0024131
lupus exedens (diagnosis)&C0024131
tuberculosis luposa&C0024131
tuberculosis; lupus&C0024131
lupus tuberculosis&C0024131
lupus; tuberculous&C0024131
lupus; vulgaris&C0024131
Lupus Vulgaris&C0024131
exedens; lupus&C0024131
lupus; exedens&C0024131
Lupus exedens&C0024131
Lupus&C0024131
Lymphomatous nodal involvement (tumor staging)&C0806692
Lymph node involvement (procedure)&C0806692
Lymphomatous nodal involvement&C0806692
Lymph Node Involvement&C0806692
Excision of group of lymph nodes&C0024203
Excision of lymph node, NOS&C0024203
Simple lymphadenectomy&C0024203
Excisions, Lymph Node&C0024203
Lymph Node Dissection&C0024203
Lymph Nodes: Excision&C0024203
Excision, Lymph Node&C0024203
Lymph Node Excisions&C0024203
Lymphadenectomy, NOS&C0024203
Lymph Node Excision&C0024203
Lymph node excision&C0024203
excision lymph node&C0024203
Lymphadenectomy&C0024203
Lymphovascular Space Invasion&C1708790
Lymphovascular Invasion&C1708790
Lymphatic Invasion&C1708790
Structure of lymphatic system (body structure)&C0024235
Reticuloendothelial System, Lymphatic System&C0024235
Structure of lymphatic system&C0024235
Lymphatic system structure&C0024235
Lymphoreticular system&C0024235
Lymphatic system, NOS&C0024235
Lymphatic tree system&C0024235
Lymphatic Systems&C0024235
lymphatics system&C0024235
Lymphatic System&C0024235
Lymphatics&C0024235
LYMPHOEDEMA&C0024236
Lymphedemas&C0024236
LYMPHEDEMA&C0024236
Lymphedema&C0024236
Lymphovascular Invasion 1&C4687695
LVI 1&C4687695
malignant neoplasm stage M0 (diagnosis)&C0445034
M0 Distant Metastasis Finding&C0445034
malignant neoplasm stage M0&C0445034
M0 Metastasis Finding&C0445034
Metastasis stage M0&C0445034
M0 Cancer Finding&C0445034
M0 Stage Finding&C0445034
M0 TNM Finding&C0445034
M0 Finding&C0445034
M0 stage&C0445034
Magnetic resonance imaging of brain without contrast (procedure)&C4305201
Magnetic Resonance Imaging of the Brain without Contrast&C4305201
Magnetic resonance imaging of brain without contrast&C4305201
Brain Magnetic Resonance Imaging without Contrast&C4305201
MRI of brain without contrast (procedure)&C4305201
MRI scan head brain without contrast&C4305201
MRI of brain without contrast&C4305201
Brain MRI without Contrast&C4305201
Head MRI without Contrast&C4305201
Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance&C0024485
Magnetic resonance imaging - action (qualifier value)&C0024485
imaging magnetic nuclear resonance&C0024485
nuclear magnetic resonance imaging&C0024485
Magnetic resonance imaging (MRI)&C0024485
NMR - Nuclear magnetic resonance&C0024485
Magnetic Resonance Imaging Scan&C0024485
Magnetic resonance imaging, NOS&C0024485
Magnetic Resonance Imaging&C0024485
Magnetic resonance study&C0024485
MRI scan (procedure)&C0024485
Magnetic resonance&C0024485
Tomography, NMR&C0024485
MR Tomography&C0024485
Imaging, NMR&C0024485
MRI scan&C0024485
MRI&C0024485
Magnetic resonance imaging contrast media (substance)&C0180108
Magnetic resonance imaging contrast medium&C0180108
MAGNETIC RESONANCE IMAGING CONTRAST MEDIA&C0180108
Magnetic resonance imaging contrast media&C0180108
Contrast Media, Magnetic Resonance&C0180108
Contrast Media, Paramagnetic&C0180108
Magnetic resonance imaging of breast (procedure)&C0344104
Magnetic resonance imaging of breast&C0344104
Magnetic resonance imaging breast&C0344104
MRI of breast (procedure)&C0344104
MRI of breast&C0344104
MRI breast&C0344104
breast MRI&C0344104
Male individual, NOS&C0086582
Male individual&C0086582
Male structure&C0086582
Males (Human)&C0086582
Human Males&C0086582
Human, Male&C0086582
male gender&C0086582
human male&C0086582
MALE SEX&C0086582
sex male&C0086582
Males&C0086582
MALE&C0086582
MAN&C0086582
Malignant (qualifier value)&C0205282
Malignant - descriptor&C0205282
Malignant&C0205282
Malignant neoplasm of central nervous system (disorder)&C0348374
Malignant Neoplasm of the Central Nervous System&C0348374
Malignant neoplasm of central nervous system NOS&C0348374
Malignant Tumor of the Central Nervous System&C0348374
Central Nervous System Neoplasms, Malignant&C0348374
Malignant Central Nervous System Neoplasm&C0348374
Malignant Central Nervous System Tumor&C0348374
Cancer of the Central Nervous System&C0348374
Cancer of Central Nervous System&C0348374
Central nervous system--Cancer&C0348374
Central Nervous System Cancer&C0348374
Malignant Tumor of the CNS&C0348374
CNS Malignant Neoplasms&C0348374
malignant CNS neoplasm&C0348374
Malignant CNS Tumor&C0348374
neurological cancer&C0348374
Cancer of the CNS&C0348374
cns malignancies&C0348374
CNS MALIGNANCY&C0348374
CNS cancer&C0348374
Malignant neoplasm without specification of site&C0006826
Unclassified malignant tumour&C0006826
Malignant neoplastic disease&C0006826
Malignant Neoplasms&C0006826
Neoplasm, malignant&C0006826
Malignant neoplasm&C0006826
NEOPLASM MALIGNANT&C0006826
Malignant tumour&C0006826
neoplasm/cancer&C0006826
CANCER (NOS)&C0006826
CA - Cancer&C0006826
Malignancy&C0006826
Blastoma&C0006826
Cancers&C0006826
cancer&C0006826
Malignant Neoplasm of Breast&C0006142
Malignant neoplasm of breast&C0006142
Breast Malignant Neoplasms&C0006142
Malignant breast neoplasm&C0006142
Malignant neoplasm breast&C0006142
breast malignant neoplasm&C0006142
cancer of the breast&C0006142
CA - Breast cancer&C0006142
Breast cancer NOS&C0006142
Cancer of Breast&C0006142
breast cancers&C0006142
BREAST CANCER&C0006142
Malignant Neoplasm of Ovary&C1140680
Malignant neoplasm of ovary&C1140680
ovarian cancer (diagnosis)&C1140680
Malignant tumour of ovary&C1140680
Malignant tumor of ovary&C1140680
cancer of the ovary&C1140680
carcinoma of ovary&C1140680
ovarian carcinomas&C1140680
carcinoma ovarian&C1140680
Cancer of ovary&C1140680
Ovarian Cancers&C1140680
cancers ovarian&C1140680
carcinoma ovary&C1140680
ovary carcinoma&C1140680
Ovarian Cancer&C1140680
cancer ovarian&C1140680
Ovarian Ca&C1140680
ca ovarian&C1140680
Reconstruction of breast&C0085076
Reconstructions, Breast&C0085076
Breast Reconstructions&C0085076
Reconstruction, Breast&C0085076
Breast Reconstruction&C0085076
Mammoplasty, NOS&C0085076
Mammaplasties&C0085076
Mammaplasty&C0085076
Mammoplasty&C0085076
location of neoplasm of breast (diagnosis)&C1458155
neoplasm of breast (diagnosis)&C1458155
Neoplasm of breast (disorder)&C1458155
Neoplasia of the breast&C1458155
Neoplasm of the Breast&C1458155
Breast neoplasm NOS&C1458155
Tumor of the Breast&C1458155
Mammary Neoplasms&C1458155
Neoplasms, Breast&C1458155
Breast Neoplasm&C1458155
NEOPLASM BREAST&C1458155
Tumor of Breast&C1458155
Tumors, Breast&C1458155
Breast Tumors&C1458155
Tumor, Breast&C1458155
Breast Tumor&C1458155
Mammographically Dense Breast&C4330659
Mammography (procedure)&C0024671
mammography procedures&C0024671
mammogram (procedure)&C0024671
Diagnostic mammogram&C0024671
Mammography, NOS&C0024671
Mammographies&C0024671
Mammography&C0024671
Mammogram&C0024671
Mam&C0024671
Marginal (qualifier value)&C0205284
Marginal&C0205284
Border&C0205284
Margin&C0205284
Verge&C0205284
MASS BREAST (NOS)&C0024103
Breast mass NOS&C0024103
Mass in Breast&C0024103
Mass in breast&C0024103
BREAST NODULE&C0024103
breast masses&C0024103
breast; mass&C0024103
mass; breast&C0024103
BREAST MASS&C0024103
Mass (morphologic abnormality)&C0577559
Mass of body structure&C0577559
Observation of a mass&C0577559
Mass, localized&C0577559
localized; mass&C0577559
mass; localized&C0577559
Localised mass&C0577559
Localized mass&C0577559
Lump, NOS&C0577559
lumps&C0577559
Lump&C0577559
surgical removal of the breast&C0024881
mastectomy&C0024881
Mastectomy Procedures&C0024881
Mammectomy, NOS&C0024881
Mastectomy NOS&C0024881
Mastectomies&C0024881
MASTECTOMY&C0024881
Mammectomy&C0024881
Mastectomy&C0024881
Removal of breast tissue with preservation of skin and nipple&C0024887
Unilateral mastectomy with preservation of skin and nipple&C0024887
Nipple preserving subcutaneous mastectomy&C0024887
Subcutaneous mastectomy (procedure)&C0024887
subcutaneous mastectomy (treatment)&C0024887
Unilateral subcutaneous mammectomy&C0024887
Subcutaneous mastectomy, NOS&C0024887
Subcutaneous mammectomy NOS&C0024887
Mastectomies, Subcutaneous&C0024887
Nipple sparing mastectomy&C0024887
Nipple-sparing mastectomy&C0024887
Subcutaneous Mastectomies&C0024887
Mastectomy, Subcutaneous&C0024887
Subcutaneous Mastectomy&C0024887
mastectomy subcutaneous&C0024887
Structure of deciduous maxillary left lateral incisor tooth (body structure)&C0227091
Structure of deciduous maxillary left lateral incisor tooth&C0227091
Deciduous maxillary left lateral incisor tooth&C0227091
Left upper lateral deciduous incisor tooth&C0227091
Left primary upper lateral incisor tooth&C0227091
Primary upper left lateral incisor tooth&C0227091
Maxillary left lateral primary incisor&C0227091
ULB - Primary upper left B tooth&C0227091
Left upper primary tooth B&C0227091
Primary upper left B tooth&C0227091
Universal designation 7d&C0227091
Haderup designation +02&C0227091
Universal designation G&C0227091
ISO designation 62&C0227091
Tooth G&C0227091
Contraindication to medical treatment&C1301624
medical contraindication (treatment)&C1301624
Contraindications, Medical&C1301624
Contraindication, Medical&C1301624
Medical Contraindications&C1301624
Medical Contraindication&C1301624
Medical contraindication&C1301624
Contraindications&C1301624
Contraindication&C1301624
female climacteric state&C0025320
CLIMACTERIC, FEMALE&C0025320
Female climacteric&C0025320
menopausal; state&C0025320
Menopausal state&C0025320
Menopause, NOS&C0025320
MENOPAUSAL&C0025320
Menopause&C0025320
Menstruation functions&C0025344
Menstruation, function&C0025344
Menstrual period&C0025344
Menstrual flow&C0025344
menstruations&C0025344
Menstruation&C0025344
Catamenia&C0025344
Menorrhea&C0025344
Menstrual&C0025344
periods&C0025344
MENSES&C0025344
period&C0025344
Metabolic Process, Cellular&C1524026
cellular metabolic process&C1524026
cellular metabolism&C1524026
Metabolic Process&C1524026
Metabolized&C1524026
Metabolism&C1524026
Metabolic&C1524026
Metaplastic&C0334023
Metaplastic carcinoma (morphologic abnormality)&C1266089
Metaplastic Carcinoma&C1266089
Metaplastic carcinoma&C1266089
malignant neoplasm stage M1 (diagnosis)&C0441971
malignant neoplasm stage M1&C0441971
M1 Metastasis Finding&C0441971
Metastasis stage M1&C0441971
M1 TNM Finding&C0441971
M1 Finding&C0441971
M1 stage&C0441971
Metastatic Breast Carcinoma&C4723838
Symptomatic Visceral Disease&C5447509
Metastatic Visceral Disease&C5447509
Metastatic malignant neoplasm to brain (disorder)&C0220650
Metastatic malignant neoplasm to brain, NOS&C0220650
Metastatic Malignant Neoplasm in the Brain&C0220650
Metastatic Malignant Neoplasm to the Brain&C0220650
Secondary malignant neoplasm of brain, NOS&C0220650
Metastatic malignant neoplasm of brain&C0220650
Metastatic malignant neoplasm to brain&C0220650
Secondary malignant neoplasm of brain&C0220650
Metastatic Neoplasm to the Brain&C0220650
metastasis to brain (diagnosis)&C0220650
Cancer metastatic to brain&C0220650
brain metastatic tumors&C0220650
BRAIN TUMOR METASTATIC&C0220650
Metastases to brain&C0220650
Brain secondaries&C0220650
BRAIN METASTASES&C0220650
brain metastasis&C0220650
metastasis brain&C0220650
Metastatic to (attribute)&C0036525
MT - metastatic to&C0036525
Metastatic to&C0036525
Metastatic&C0036525
Microcalcification, calcified structure (morphologic abnormality)&C0521174
Microcalcification, calcified structure&C0521174
Microcalcifications&C0521174
Microcalcification&C0521174
Microcalcinoses&C0521174
Microcalcinosis&C0521174
Microinvasive tumor (qualifier value)&C0205622
Microinvasive Lesion&C0205622
Microinvasive tumour&C0205622
Microinvasive tumor&C0205622
Microinvasive&C0205622
Pseudohypoplasia of the optic nerve&C1290608
Micropapilla (disorder)&C1290608
Micropapilla&C1290608
Microscopic (qualifier value)&C0205288
Microscopic&C0205288
CONGENITAL FAMILIAL PROTRACTED DIARRHEA WITH ENTEROCYTE BRUSH-BORDER ABNORMALITIES&C0341306
DIARRHEA 2, WITH MICROVILLUS ATROPHY, WITH OR WITHOUT CHOLESTASIS&C0341306
anomalies of intestine microvillus inclusion disease (diagnosis)&C0341306
anomalies of intestine microvillus inclusion disease&C0341306
Diarrhea 2, With Microvillus Atrophy&C0341306
Congenital microvillous atrophy&C0341306
Intractable diarrhea of infancy&C0341306
MICROVILLUS ATROPHY, CONGENITAL&C0341306
Congenital microvillus atrophy&C0341306
Microvillous inclusion disease&C0341306
Microvillus inclusion disease&C0341306
Microvillous atrophy&C0341306
DAVIDSON DISEASE&C0341306
DIAR2&C0341306
MVID1&C0341306
MVID&C0341306
Modulated (qualifier value)&C0443264
Modulating&C0443264
Modulation&C0443264
Modulated&C0443264
modulate&C0443264
Molecular Targeted Therapies&C2699893
Targeted Molecular Therapies&C2699893
molecularly targeted therapy&C2699893
Molecular Therapy, Targeted&C2699893
Targeted Therapy, Molecular&C2699893
Therapy, Molecular Targeted&C2699893
Therapy, Targeted Molecular&C2699893
Molecular Targeted Therapy&C2699893
Targeted Molecular Therapy&C2699893
Product containing monoclonal antibody (product)&C0003250
Monoclonal immunoglobulin-containing product&C0003250
Monoclonal antibody-containing product&C0003250
Monoclonal antibody (substance)&C0003250
Monoclonal immunoglobulin&C0003250
Antibodies, Monoclonal&C0003250
Monoclonal Antibodies&C0003250
Antibody, Monoclonal&C0003250
Monoclonal Antibody&C0003250
Monoclonal protein&C0003250
MAb&C0003250
Morbidity - disease rate&C0026538
disorder incidence&C0026538
Morbidity rates&C0026538
disease rates&C0026538
disease rate&C0026538
Morbidities&C0026538
Morbidity&C0026538
Mucinous&C1513712
Multicentric (qualifier value)&C0439743
Multicentric&C0439743
Multifocal (qualifier value)&C0205292
Multifocal&C0205292
Genetic mutation (finding)&C0026882
alterations genetic&C0026882
mutation (genetics)&C0026882
Genetic Alteration&C0026882
genetic mutations&C0026882
Genetic mutation&C0026882
genomic mutation&C0026882
genome mutation&C0026882
Mutations&C0026882
Mutation&C0026882
NBAS subunit of NRZ tethering complex protein, human&C1431698
neuroblastoma-amplified sequence protein, human&C1431698
neuroblastoma-amplified protein, human&C1431698
Neuroblastoma-Amplified Gene Protein&C1431698
Neuroblastoma-Amplified Sequence&C1431698
Neuroblastoma-Amplified Protein&C1431698
NBAS protein, human&C1431698
NAG protein, human&C1431698
NAG&C1431698
NCI-Designated Cancer Center&C1513817
Cancer Centers&C1513817
Cancer Center&C1513817
Nanoparticle Albumin-Bound Docetaxel&C2347327
Docetaxel Albumin-bound&C2347327
Nab-Docetaxel&C2347327
National Cancer Program&C1513887
NCP&C1513887
National Surgical Adjuvant Breast and Bowel Project&C1513905
NSABP&C1513905
Necrosis (morphologic abnormality)&C0027540
Cellular necrosis, NOS&C0027540
Tissue devitalization&C0027540
Cellular necrosis&C0027540
Necrotic Process&C0027540
Necrosis, NOS&C0027540
death tissue&C0027540
tissue death&C0027540
NECROSES&C0027540
Necrosis&C0027540
Needle biopsy (procedure)&C0005560
Needle biopsy procedure&C0005560
Needle biopsy, NOS&C0005560
Needle biopsy NOS&C0005560
Biopsies, Needle&C0005560
Needle Biopsies&C0005560
Needle sampling&C0005560
Biopsy, Needle&C0005560
biopsy needles&C0005560
Needle Biopsy&C0005560
Lymph node negative&C0678034
Negative Lymph Node&C0678034
node negative&C0678034
node-negative&C0678034
Intradermal test negative&C0855856
Skin test NOS negative&C0855856
Negative Skin Test&C0855856
Skin test negative&C0855856
Skin test normal&C0855856
Surgical Margins, Negative&C1709157
Negative Surgical Margins&C1709157
Surgical Margin, Negative&C1709157
Negative Surgical Margin&C1709157
Clear Surgical Margin&C1709157
Margins, Tumor-Free&C1709157
Margin, Tumor-Free&C1709157
Tumor Free Margins&C1709157
Tumor-Free Margins&C1709157
Tumor-Free Margin&C1709157
Clear Margin&C1709157
Chemotherapy Treatment, Neoadjuvant&C5392214
Neoadjuvant Chemotherapy Treatments&C5392214
Treatment, Neoadjuvant Chemotherapy&C5392214
Neoadjuvant Chemotherapy Treatment&C5392214
Neoadjuvant Chemotherapies&C5392214
Chemotherapy, Neoadjuvant&C5392214
Neoadjuvant Chemotherapy&C5392214
Neoadjuvant Treatments&C0600558
Treatment, Neoadjuvant&C0600558
Neoadjuvant Therapies&C0600558
Neoadjuvant Treatment&C0600558
Pre-Adjuvant Therapy&C0600558
Preoperative Therapy&C0600558
Therapy, Neoadjuvant&C0600558
Neoadjuvant Therapy&C0600558
Induction Therapy&C0600558
Neoadjuvant&C0600558
Metastases, Neoplasm&C0027627
Metastasis, Neoplasm&C0027627
Neoplasm Metastasis&C0027627
metastatic cancer&C0027627
metastatic tumors&C0027627
metastatic tumour&C0027627
tumour metastasis&C0027627
cancer secondary&C0027627
metastatic tumor&C0027627
secondary cancer&C0027627
tumor metastasis&C0027627
METASTASES NOS&C0027627
metastasized&C0027627
secondaries&C0027627
Metastases&C0027627
Metastasis&C0027627
secondary&C0027627
NG - Neoplastic growth&C0027651
neoplastic disease&C0027651
Neoplastic Growth&C0027651
NEOPLASM NOS&C0027651
neoplasias&C0027651
NEOPLASIA&C0027651
Neoplasms&C0027651
Neoplasm&C0027651
Tumors&C0027651
Tumour&C0027651
Tumor&C0027651
Nipple reconstruction (procedure)&C0191926
nipple reconstruction (treatment)&C0191926
Reconstruction of nipple, NOS&C0191926
Reconstruction of nipple&C0191926
nipples reconstruction&C0191926
Nipple reconstruction&C0191926
Repair of nipple, NOS&C0191926
Mammilliplasty, NOS&C0191926
Theleplasty, NOS&C0191926
Mammilliplasty&C0191926
nipple repair&C0191926
Theleplasty&C0191926
Nipple structure (body structure)&C0028109
Papillary part of breast&C0028109
Nipple (Anatomy)&C0028109
Nipple structure&C0028109
Papilla mammaria&C0028109
Nipple anatomy&C0028109
Nipples&C0028109
Nipple&C0028109
teats&C0028109
Teat&C0028109
No Surgical Reconstruction&C3840851
no reconstruction&C3840851
No radiation therapy&C3846110
Non-Metastatic Mass&C1334990
Nonmetastatic Mass&C1334990
Non-Infiltrating Intraductal Breast Adenocarcinoma&C0007124
Non-Invasive Intraductal Breast Adenocarcinoma&C0007124
Non-Infiltrating Intraductal Adenocarcinoma&C0007124
Non-Invasive Ductal Breast Adenocarcinoma&C0007124
Carcinoma, Intraductal, Noninfiltrating&C0007124
Carcinomas, Noninfiltrating Intraductal&C0007124
Non-Infiltrating Intraductal Carcinoma&C0007124
ductal carcinoma in situ of the breast&C0007124
Intraductal carcinoma noninfiltrating&C0007124
Noninfiltrating Intraductal Carcinoma&C0007124
Intraductal Carcinoma of the Breast&C0007124
Carcinoma in situ of breast ductal&C0007124
Breast Ductal Carcinoma In Situ&C0007124
Intraductal Carcinoma of Breast&C0007124
ductal breast carcinoma in situ&C0007124
breast; carcinoma, intraductal&C0007124
carcinoma; intraductal, breast&C0007124
breast; intraductal carcinoma&C0007124
breast cancer intraductal&C0007124
intraductal breast cancer&C0007124
carcinoma ductal in situ&C0007124
Carcinomas, Intraductal&C0007124
Intraductal Carcinomas&C0007124
dci&C0007124
Nuclear Staining&C5237001
Nucleotide Sequence Sample Name&C5551027
Sequenced Sample Name&C5551027
Sample Name&C5551027
Sample&C5551027
delivery under medical care&C0011209
Pregnancy delivered, NOS&C0011209
Deliveries, Obstetric&C0011209
Delivery (Obstetrics)&C0011209
Delivery Procedures&C0011209
Pregnancy delivered&C0011209
Delivery procedure&C0011209
Labor and delivery&C0011209
Obstetric Delivery&C0011209
Delivery - action&C0011209
childbirth&C0011209
Birthing&C0011209
DELIVERY&C0011209
Occultism (religion/philosophy)&C0028794
Occultisms&C0028794
Occultism&C0028794
Occult&C0028794
Oocyte (cell)&C0029045
cells oocytes&C0029045
Ovocyte, NOS&C0029045
Oocyte, NOS&C0029045
Ovocytes&C0029045
Oocytes&C0029045
Ovocyte&C0029045
Oocyte&C0029045
PROSTATE: GENERAL AND MISCELLANEOUS OPERATIVE PROCEDURES&C0194790
OPERATIVE PROCEDURES ON THE PROSTATE&C0194790
Surgical Procedures on the Prostate&C0194790
Operation on prostate (procedure)&C0194790
procedures prostate surgical&C0194790
prostate surgery (treatment)&C0194790
Operation on prostate, NOS&C0194790
Prostatic operation NOS&C0194790
Operation on prostate&C0194790
Prostatic operation&C0194790
prostate operation&C0194790
prostate surgeries&C0194790
PROSTATE SURGERY&C0194790
surgery prostate&C0194790
Optical Image Reconstruction&C0020912
Reconstructions, Image&C0020912
Image Reconstructions&C0020912
Reconstruction, Image&C0020912
images reconstruction&C0020912
Image Reconstruction&C0020912
Reconstruction&C0020912
Optimal&C2698651
Optimum&C2698651
Docetaxel-P-glycoprotein Inhibitor&C4330857
Docetaxel-P-gp Inhibitor&C4330857
Oral Docetaxel&C4330857
Circumoral region of face&C0230028
Perioral region of face&C0230028
Oral region of face&C0230028
Oral part of face&C0230028
Regio oralis&C0230028
Oral region&C0230028
Oregon (geographic location)&C0029195
Oregon&C0029195
Organs (Anatomy)&C0178784
anatomy organs&C0178784
organs anatomy&C0178784
anatomy organ&C0178784
{Organ}&C0178784
organs&C0178784
Organ&C0178784
Organization administrative structures&C0029246
Organizational Unit&C0029246
Organizational&C0029246
Organizations&C0029246
Organization&C0029246
Brachydactyly of the hands and feet with duplication of the first toes&C0406726
Orofacial-digital syndrome III (disorder)&C0406726
OFD III - Orofacial-digital syndrome III&C0406726
ORAL-FACIAL-DIGITAL SYNDROME, TYPE III&C0406726
Oral-facial-digital syndrome type 3&C0406726
orofaciodigital (OFD) syndrome III&C0406726
oral-facial-digital syndrome III&C0406726
Orofaciodigital syndrome type 3&C0406726
Oral-facial-digital syndrome 3&C0406726
Orofacial-digital syndrome III&C0406726
digito-orofacial syndrome III&C0406726
OROFACIODIGITAL SYNDROME III&C0406726
Orofaciodigital syndrome 3&C0406726
SUGARMAN SYNDROME&C0406726
OFDS III&C0406726
Inserts [medical device]&C0813036
Orthopedic inserts&C0813036
Inserts&C0813036
INSERT&C0813036
Paget's disease of bone [osteitis deformans]&C0029401
Osteitis deformans (disorder)&C0029401
osteitis deformans of bone&C0029401
Paget; osteitis deformans&C0029401
osteitis deformans; Paget&C0029401
PAGET'S DISEASE OF BONE&C0029401
Paget's disease (bone)&C0029401
Pagets Disease (Bone)&C0029401
OSTEITIS DEFORMANS&C0029401
Osteitis Deformans&C0029401
bone Paget disease&C0029401
PAGET DISEASE&C0029401
bone; Paget&C0029401
OVARIAN&C0205065
Ovarian&C0205065
Ovaro-&C0205065
Ovarian ablation (procedure)&C0677922
ovarian ablation (treatment)&C0677922
Ovarian Ablation&C0677922
Ovarian ablation&C0677922
ovarian failure (diagnosis)&C0747102
Ovarian failure (disorder)&C0747102
Ovarian Insufficiency&C0747102
Ovarian Hypofunction&C0747102
OVARIAN FAILURE&C0747102
Ovarian failure&C0747102
failure ovarian&C0747102
ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)&C1538577
poly (ADP-ribose) polymerase family, member 1&C1538577
Poly(ADP-Ribose) Polymerase 1 Gene&C1538577
POLY(ADP-RIBOSE) POLYMERASE 1&C1538577
POLY(ADP-RIBOSE) POLYMERASE&C1538577
POLY(ADP-RIBOSE) SYNTHETASE&C1538577
ADP-RIBOSYLTRANSFERASE&C1538577
PARP1 Gene&C1538577
PARP1 gene&C1538577
Poly-PARP&C1538577
ADPRT1&C1538577
ADPRT&C1538577
ARTD1&C1538577
PARP1&C1538577
PARP&C1538577
PARS&C1538577
PPOL&C1538577
c-Met inhibitor PLB1001&C4331801
PLB-1001&C4331801
PLB1001&C4331801
Nervous System-Specific Octamer-Binding Transcription Factor N-Oct-3&C1310510
POU domain, class 3, transcription factor 2 protein, human&C1310510
Brain-Specific Homeobox/POU Domain Protein 2&C1310510
POU Domain, Class 3, Transcription Factor 2&C1310510
Octamer-Binding Transcription Factor 7&C1310510
Octamer-Binding Protein 7&C1310510
Brain-2 protein, human&C1310510
N-Oct-3 protein, human&C1310510
brain 2 protein, human&C1310510
POU3F2 protein, human&C1310510
POUF3 protein, human&C1310510
BR-2 protein, human&C1310510
BRN2 protein, human&C1310510
OCT7 protein, human&C1310510
Brain-2&C1310510
Brn-2&C1310510
OTF-7&C1310510
Oct-7&C1310510
PREVENT [brand name]&C0309872
PREVENT (product)&C0309872
PREVENT&C0309872
PC4 and SFRS1-Interacting Protein Isoform 1&C1615518
PC4 and SFRS1-Interacting Protein Isoform 2&C1615518
PC4 and SFRS1 interacting protein 1, human&C1615518
Lens Epithelium-Derived Growth Factor&C1615518
dense fine speckles 70 protein, human&C1615518
PC4 and SFRS1 Interacting Protein 1&C1615518
PC4 and SFRS1 Interacting Protein 2&C1615518
Dense Fine Speckles 70 kDa Protein&C1615518
Transcriptional Coactivator p52&C1615518
Transcriptional Coactivator p75&C1615518
CLL-Associated Antigen KW-7&C1615518
DFS70 protein, human&C1615518
LEDGF protein, human&C1615518
PSIP1 protein, human&C1615518
PSIP2 protein, human&C1615518
DFS 70&C1615518
PSIP1&C1615518
PSIP2&C1615518
PAIP&C1615518
p52&C1615518
p75&C1615518
Pacing Inadequately&C1881165
Paclitaxel/Pertuzumab/Trastuzumab Regimen&C4527351
Pertuzumab-Trastuzumab-Paclitaxel Regimen&C4527351
Pertuzumab/Trastuzumab/Paclitaxel Regimen&C4527351
Pertuzumab + Trastuzumab + Paclitaxel&C4527351
Pertuzumab-Trastuzumab-Paclitaxel&C4527351
Taxol/Herceptin/Pertuzumab&C4527351
THP (Taxol) Regimen&C4527351
Palliative care (regime/therapy)&C0030231
Supportive Care, Palliative&C0030231
Palliative Supportive Care&C0030231
Palliative Treatment&C0030231
Providing Palliation&C0030231
Therapy, Palliative&C0030231
Palliative Therapy&C0030231
therapy palliative&C0030231
Care, Palliative&C0030231
Supportive Cares&C0030231
care palliatives&C0030231
care; palliative&C0030231
cares palliative&C0030231
palliative; care&C0030231
Palliative Care&C0030231
Supportive Care&C0030231
Palliative Radiation Therapy&C3898008
Palliative Radiotherapy&C3898008
Palpable (qualifier value)&C0522499
Palpable Disease&C0522499
Palpable&C0522499
Exocrine and endocrine pancreas&C0030274
Structure of pancreas&C0030274
Pancreas, NOS&C0030274
Pancreatic&C0030274
PANCREAS&C0030274
Pancreas&C0030274
Pathologic Response&C4054230
Patient currently pregnant&C0549206
Pregnancy, not delivered&C0549206
Pregnancy not delivered&C0549206
Pregnancy (finding)&C0549206
Currently pregnant&C0549206
Pregnancy, gravid&C0549206
Patient pregnant&C0549206
pregnant patient&C0549206
Gravidity&C0549206
Pregnancy&C0549206
Pregnant&C0549206
Gravid&C0549206
Pectoral&C1521735
Pectoralis minor muscle structure (body structure)&C0224347
Pectoralis minor muscle structure&C0224347
Musculus Pectoralis Minor&C0224347
Muscle, Pectoralis Minor&C0224347
Pectoralis Minor Muscles&C0224347
Pectoralis Minor Muscle&C0224347
M. pectoralis minor&C0224347
Pectoralis Minors&C0224347
Pectoralis Minor&C0224347
PEGylation&C4763480
Pegylation&C4763480
Structure of pelvic region, unspecified&C0030797
Pelvic Cavity&C0030797
Pelvic Region&C0030797
Pelvis, NOS&C0030797
PELVIS&C0030797
Pelvic&C0030797
Pelvis&C0030797
Pentachlorophenol (substance)&C0030855
PCP - Pentachlorophenol&C0030855
pentachlorophenol (PCP)&C0030855
Phenol, pentachloro-&C0030855
PENTACHLOROPHENOL&C0030855
Pentachlorophenol&C0030855
PCP&C0030855
Renal biopsy; percutaneous, by trocar or needle&C0372299
RENAL BIOPSY PRQ TROCAR/NEEDLE&C0372299
Percutaneous Biopsy of Kidney&C0372299
Percutaneous Renal Biopsy&C0372299
Perfusion - action (qualifier value)&C0031001
Perfusion (procedure)&C0031001
Perfusion - action&C0031001
Perfusion, NOS&C0031001
Perfusion NOS&C0031001
Perfusions&C0031001
Perfusion&C0031001
Perimenopausal state (finding)&C3839366
Perimenopausal state&C3839366
PERIMENOPAUSAL&C3839366
peripheral neuropathy (physical finding)&C0031117
peripheral neuropathy (diagnosis)&C0031117
PN - Peripheral neuropathy&C0031117
Peripheral nerve damage&C0031117
Neuropathy;peripheral&C0031117
PERIPHERAL NEUROPATHY&C0031117
Peripheral Neuropathy&C0031117
Peripheral neuritis&C0031117
Fracture of bone adjacent to prosthesis (disorder)&C2609162
Fracture of bone adjacent to prosthesis&C2609162
Fractures, Periprosthetic&C2609162
Fracture, Periprosthetic&C2609162
Periprosthetic Fractures&C2609162
Periprosthetic Fracture&C2609162
Pertuzumab-Trastuzumab Regimen&C4527348
Pertuzumab/Trastuzumab Regimen&C4527348
Pertuzumab Plus Trastuzumab&C4527348
Pertuzumab + Trastuzumab&C4527348
Pertuzumab/Trastuzumab&C4527348
Herceptin-Perjeta&C4527348
Pharmacological Treatments&C0013216
Pharmacological Treatment&C0013216
pharmacotherapeutics&C0013216
medications therapy&C0013216
medication therapy&C0013216
pharmacotherapies&C0013216
Pharmacotherapy&C0013216
Chemotherapies&C0013216
Drug Therapies&C0013216
Therapy (Drug)&C0013216
Therapy, Drug&C0013216
Drug Therapy&C0013216
Clinical Trials, Phase II as Topic&C0282460
Clinical Trials, Phase II&C0282460
clinical ii phase trials&C0282460
phase ii clinical trials&C0282460
2 clinical phase trials&C0282460
Phase 2 Clinical Trials&C0282460
Phase II Clinical Trial&C0282460
clinical trial phase II&C0282460
clinical trials phase 2&C0282460
Phase II Protocol&C0282460
ii phase trials&C0282460
Phase II Study&C0282460
Phase II Trial&C0282460
ii phase study&C0282460
Phase 2 Study&C0282460
Phase 3 (qualifier value)&C0439561
3 phases&C0439561
3 phase&C0439561
Phase 3&C0439561
Clinical Trials, Phase III as Topic&C0282461
Clinical Trials, Phase 3 as Topic&C0282461
Clinical Trials, Phase III&C0282461
Phase III Clinical Trial&C0282461
clinical trial phase III&C0282461
Phase 3 Clinical Trials&C0282461
clinical trials phase 3&C0282461
iii phase protocols&C0282461
Phase III Protocol&C0282461
iii phase studies&C0282461
Phase III Trials&C0282461
iii phase trials&C0282461
Phase III Study&C0282461
Phase III Trial&C0282461
iii phase trial&C0282461
Phase 3 Study&C0282461
Phase I/II Trial&C1519043
Trial Phase 1/2&C1519043
Photon (substance)&C0086805
Photons&C0086805
Photon&C0086805
Phyllodes&C2998956
Pigmentation (qualifier value)&C0031911
pigment deposition&C0031911
Pigmentations&C0031911
Pigmentation&C0031911
Pivot Device&C1709557
Pivot&C1709557
Plain X-ray of chest (procedure)&C0039985
Radiologic examination, chest&C0039985
x-ray of chest (procedure)&C0039985
Radiologic examination&C0039985
Chest exclusion X-ray&C0039985
Plain X-ray of thorax&C0039985
Plain X-ray of chest&C0039985
thoracic radiography&C0039985
Chest Radiography&C0039985
Plain chest X-ray&C0039985
Chest x-ray, NOS&C0039985
X-ray NOS chest&C0039985
thoracic x-ray&C0039985
x-ray of chest&C0039985
chest x rays&C0039985
Chest X-ray&C0039985
X-ray;chest&C0039985
chest X ray&C0039985
CXR&C0039985
Polyacrylamide gel electrophoresis (procedure)&C0013862
PAGE - Polyacrylamide gel electrophoresis&C0013862
Polyacrylamide gel electrophoresis (PAGE)&C0013862
Electrophoresis, Polyacrylamide Gel&C0013862
Gel Electrophoresis, Polyacrylamide&C0013862
Polyacrylamide Gel Electrophoresis&C0013862
Fractionation, Polyacrylamide Gel&C0013862
PAGE&C0013862
Polymerase chain reaction technique (qualifier value)&C0032520
PCR (polymerase chain reaction) technique&C0032520
Polymerase chain reaction technique&C0032520
PCR - Polymerase chain reaction&C0032520
polymerase chain reaction (PCR)&C0032520
Reactions, Polymerase Chain&C0032520
Polymerase Chain Reactions&C0032520
Reaction, Polymerase Chain&C0032520
Polymerase Chain Reaction&C0032520
PCR&C0032520
Positioning (attribute)&C0733755
Positioning Attribute&C0733755
Position (attribute)&C0733755
Positioning&C0733755
positions&C0733755
Position&C0733755
lymph nodes positive&C0746319
LYMPH NODE POSITIVE&C0746319
Positive Lymph Node&C0746319
nodes positives&C0746319
node-positive&C0746319
Positron emission tomographic imaging - action (qualifier value)&C0032743
Positron emission tomography (PET) imaging&C0032743
Positron emission tomography (procedure)&C0032743
Positron emission tomographic imaging&C0032743
Positron-Emission Tomography Imaging&C0032743
Positron emission tomography (PET)&C0032743
Tomography, Positron Emission&C0032743
Positron Emission Tomography&C0032743
Positron-Emission Tomography&C0032743
Positron emission tomogram&C0032743
Imaging, PET&C0032743
PET Imaging&C0032743
PET Scans&C0032743
Post Radiation Therapy&C5667420
Post-Traumatic Stress Disorders&C0038436
Stress Disorder, Post Traumatic&C0038436
Stress Disorder, Post-Traumatic&C0038436
disorder, post-traumatic stress&C0038436
post-traumatic stress; disorder&C0038436
Disorder;post traumatic stress&C0038436
POST TRAUMATIC STRESS DISORDER&C0038436
Post-Traumatic Stress Disorder&C0038436
post traumatic stress syndrome&C0038436
post-traumatic stress syndrome&C0038436
Post-Traumatic Neuroses&C0038436
Combat Neurosis&C0038436
PTSD&C0038436
Postmenopausal state (finding)&C0232970
postmenopausal (symptom)&C0232970
menopause has occurred&C0232970
post menopausal state&C0232970
Postmenopausal state&C0232970
POSTMENOPAUSAL&C0232970
Period, Post-menopausal&C0206159
Period, Postmenopausal&C0206159
Post menopausal Period&C0206159
Post-menopausal Period&C0206159
Postmenopausal Period&C0206159
Post-Menopauses&C0206159
POST MENOPAUSE&C0206159
Post-Menopause&C0206159
menopause post&C0206159
POSTMENOPAUSE&C0206159
Postmenopause&C0206159
Maternal postpartum (qualifier value)&C0086839
the period after childbirth&C0086839
postpartum finding state&C0086839
Postpartum period, NOS&C0086839
Postpartum Period&C0086839
POSTPARTUM STATE&C0086839
POST PREGNANCY&C0086839
POST PARTUM&C0086839
POSTPARTUM&C0086839
Puerperium&C0086839
Puerperal&C0086839
pregnancy complications caused by infection&C0032965
Complications, Infectious Pregnancy&C0032965
Pregnancy Complications, Infectious&C0032965
Pregnancy, Infectious Complications&C0032965
Infectious Pregnancy Complications&C0032965
Pregnancy Complication, Infectious&C0032965
Infectious Pregnancy Complication&C0032965
infection; complicating pregnancy&C0032965
c.pregnancy; disease, infective&C0032965
c.pregnancy; infectious disease&C0032965
Infection complicat pregnancy&C0032965
Other infectious conditions&C0032965
Infections and Pregnancy&C0032965
Pregnancy, Infections in&C0032965
c.pregnancy; infection&C0032965
pregnancy; infection&C0032965
INFECTION PREGNANCY&C0032965
pregnancy infection&C0032965
Pregnancy detection examination&C0032976
PT - Pregnancy test&C0032976
pregnancies testing&C0032976
pregnancy testing&C0032976
Tests, Pregnancy&C0032976
pregnancies test&C0032976
Pregnancy Tests&C0032976
Test, Pregnancy&C0032976
Pregnancy Test&C0032976
Test;pregnancy&C0032976
First trimester pregnancy (finding)&C0032979
First trimester (qualifier value)&C0032979
first trimester of pregnancy&C0032979
First Trimester Pregnancies&C0032979
Pregnancy Trimesters, First&C0032979
Pregnancy--Trimester, First&C0032979
First Pregnancy Trimesters&C0032979
PREGNANCY, FIRST TRIMESTER&C0032979
Pregnancy Trimester, First&C0032979
First Pregnancy Trimester&C0032979
First trimester pregnancy&C0032979
Placental Phases, Early&C0032979
Early Placental Phases&C0032979
Placental Phase, Early&C0032979
Early Placental Phase&C0032979
Trimesters, First&C0032979
Trimester, First&C0032979
First Trimester&C0032979
1st trimester&C0032979
Pregnancies, Second Trimester&C0032980
second trimester of pregnancy&C0032980
Pregnancy Trimesters, Second&C0032980
Pregnancy--Trimester, Second&C0032980
Second Trimester Pregnancies&C0032980
PREGNANCY, SECOND TRIMESTER&C0032980
Pregnancy Trimester, Second&C0032980
Second Pregnancy Trimesters&C0032980
Second Pregnancy Trimester&C0032980
Second trimester pregnancy&C0032980
pregnancy second trimester&C0032980
Trimesters, Second&C0032980
Second Trimesters&C0032980
Trimester, Second&C0032980
Second Trimester&C0032980
2nd trimester&C0032980
Midtrimesters&C0032980
Premenopausal - menopausal status&C0279752
Premenopausal&C0279752
Primary Neoplasm&C0677930
primary tumors&C0677930
Primary Tumor&C0677930
Primary malignant neoplasm (diagnosis)&C1306459
Primary malignant neoplasm (disorder)&C1306459
Malignant tumour morphology&C1306459
Malignant tumor morphology&C1306459
Primary Malignant Neoplasm&C1306459
Primary malignant neoplasm&C1306459
malignant neoplasm primary&C1306459
malignant neoplasm&C1306459
Cancer morphology&C1306459
primary cancer&C1306459
Malignancy&C1306459
Prior Adjuvant Endocrine/Hormonal Therapy&C0281266
Prior Adjuvant Endocrine Therapy&C0281266
Prior Adjuvant Hormonal Therapy&C0281266
Probe, device (physical object)&C0182400
Probe, device&C0182400
Probe Device&C0182400
Probe, NOS&C0182400
Probes&C0182400
PROBE&C0182400
Survival, Progression-Free&C0242792
Progression Free Survival&C0242792
Progression-Free Survival&C0242792
Classic progressive supranuclear palsy syndrome&C0038868
Progressive supranuclear palsy (disorder)&C0038868
PSP - progressive supranuclear palsy&C0038868
Richardson-Steele-Olszewski syndrome&C0038868
STEELE-RICHARDSON-OLSZEWSKI SYNDROME&C0038868
Nuchal dystonia-dementia syndrome&C0038868
PALSY, SUPRANUCLEAR, PROGRESSIVE&C0038868
Supranuclear Palsy, Progressive&C0038868
Progressive Supranuclear Palsy&C0038868
Progressive supranuclear palsy&C0038868
SUPRANUCLEAR PALSY PROGRESSIVE&C0038868
Steele-Richardson-Olszewski&C0038868
Richardson's Syndrome&C0038868
Classic PSP syndrome&C0038868
Predictions and Projections&C0016538
Projections and Predictions&C0016538
Forecasting&C0016538
projections&C0016538
Projection&C0016538
Projected&C0016538
forecasts&C0016538
forecast&C0016538
Prone body position (finding)&C0033422
Lying ventricumbent&C0033422
Prone body position&C0033422
positioning prone&C0033422
Lying procumbent&C0033422
Positions, Prone&C0033422
Position, Prone&C0033422
Prone Positions&C0033422
Prone Position&C0033422
position prone&C0033422
Lying prone&C0033422
prone lying&C0033422
off feet&C0033422
Prone&C0033422
Prophylactic mastectomy (procedure)&C2191320
prophylactic mastectomy (treatment)&C2191320
Mastectomies, Prophylactic&C2191320
Prophylactic Mastectomies&C2191320
Mastectomy, Prophylactic&C2191320
Prophylactic Mastectomy&C2191320
Prophylactic (qualifier value)&C0445202
Prophylactic behavior&C0445202
Prophylactic&C0445202
preventive&C0445202
Prophylaxis - procedure intent (qualifier value)&C0199176
Admin prophylactic treatment per order&C0199176
Prophylaxis - procedure intent&C0199176
Prophylactic treatment, NOS&C0199176
Preventive Intervention&C0199176
Prophylactic treatment&C0199176
Preventive treatment&C0199176
Prophylaxis&C0199176
Administers prescribed prophylactic treatments&C0199176d
Prosthetic devices&C0175649
device prosthetic&C0175649
Prosthesis, NOS&C0175649
Prosthesis&C0175649
Deglycase, Parkinsonism Associated&C4255233
Parkinsonism Associated Deglycase&C4255233
DJ-1, Protein Deglycase&C4255233
Protein Deglycase DJ-1&C4255233
Parkinson Protein 7&C4255233
DJ 1 PARK7 Protein&C4255233
DJ-1-PARK7 Protein&C4255233
PARK7 Protein&C4255233
DJ 1 Protein&C4255233
DJ-1 Protein&C4255233
DJ1 Protein&C4255233
Domains, Peptide&C1514562
Domains, Protein&C1514562
Protein Feature&C1514562
Peptide Domain&C1514562
Protein Region&C1514562
Protein Motif&C1514562
Motif&C1514562
Protein Overexpression&C1514559
Puerto Rico (geographic location)&C0034044
Puerto Rico&C0034044
Quadrant&C1631280
RAB1A, member RAS oncogene family&C1419187
Rab GTPase YPT1 homolog (yeast)&C1419187
RAS-ASSOCIATED PROTEIN RAB1&C1419187
RAB1A gene&C1419187
RAB1A&C1419187
RAB1&C1419187
YPT1&C1419187
ZINC, IN-BETWEEN-RING FINGER, AND UBIQUITIN-ASSOCIATED DOMAINS&C1423923
Ring Finger Protein 31 Gene&C1423923
HOIL-1-interacting protein&C1423923
HOIL1-INTERACTING PROTEIN&C1423923
RING FINGER PROTEIN 31&C1423923
RNF31 Gene&C1423923
RNF31 gene&C1423923
FLJ10111&C1423923
FLJ23501&C1423923
RNF31&C1423923
ZIBRA&C1423923
HOIP&C1423923
Paul&C1423923
Hypofractionations, Radiotherapy Dose&C4042795
Dose Hypofractionation, Radiotherapy&C4042795
Hypofractionation, Radiotherapy Dose&C4042795
Radiotherapy Dose Hypofractionation&C4042795
Dose Hypofractionation, Radiation&C4042795
Hypofractionation, Radiation Dose&C4042795
Hypofractionated Dose, Radiation&C4042795
Radiation Dose Hypofractionation&C4042795
Radiation Hypofractionated Dose&C4042795
Minibeam, Radiotherapy&C4042795
Radiotherapy Minibeams&C4042795
Radiotherapy Minibeam&C4042795
Radiation Field&C1882536
Radiation Interaction&C1514689
occupation: radiation oncologist (history)&C1514693
Radiation oncologist (occupation)&C1514693
occupation: radiation oncologist&C1514693
Oncologists, Radiation&C1514693
Oncologist, Radiation&C1514693
Radiation Oncologists&C1514693
Radiation Oncologist&C1514693
oncologist radiation&C1514693
RNAx support radiation therapy care (treatment)&C0150318
RNIx radiation therapy care (treatment)&C0150318
Radiation therapy care (regime/therapy)&C0150318
RNAx support radiation therapy care&C0150318
radiation therapy care (treatment)&C0150318
Radiation Therapy Management&C0150318
Radiation therapy management&C0150318
RNIx radiation therapy care&C0150318
Radiation Therapy Care&C0150318
care radiation therapy&C0150318
Radiographic (qualifier value)&C0444708
Radiographic&C0444708
Radioisotope scan of bone, NOS&C0203668
isotopic bone scan (procedure)&C0203668
Radioisotope scan of bone&C0203668
Radionuclide bone study&C0203668
Radioisotope bone scan&C0203668
Bone Scintigraphy&C0203668
isotope bone scan&C0203668
skeletal imaging&C0203668
Bone scan, NOS&C0203668
Bone scan NOS&C0203668
Joint imaging&C0203668
bone scanning&C0203668
Scan;bone(s)&C0203668
bone imaging&C0203668
Bone Scans&C0203668
bones scan&C0203668
Bone Scan&C0203668
scan bone&C0203668
Radioactive isotope (substance)&C0034595
Isotopes, Radioactive&C0034595
Isotope, Radioactive&C0034595
Radioactive Isotopes&C0034595
Radioactive Isotope&C0034595
Radioisotope, NOS&C0034595
Radioisotopes&C0034595
Radionuclides&C0034595
Radioisotope&C0034595
Radionuclide&C0034595
Radionuclide Scanning and Imaging&C0034606
Scanning, Radioisotope&C0034606
Imaging, Radionuclide&C0034606
Radioisotope scanning&C0034606
Radionuclide Scanning&C0034606
Radionuclide Imaging&C0034606
radionuclide imaging&C0034606
radionuclide studies&C0034606
Radionuclide scans&C0034606
Radioisotope scan&C0034606
Nuclear Medicine&C0034606
Thyroid imaging&C0034606
isotope study&C0034606
Isotope scan&C0034606
Scintigraphy&C0034606
Radiotherapies, Adjuvant&C0242939
Adjuvant Radiotherapies&C0242939
Radiotherapy, Adjuvant&C0242939
Adjuvant Radiotherapy&C0242939
Radiation Therapies, Image-Guided&C3179062
Therapies, Image-Guided Radiation&C3179062
Image-Guided Radiation Therapies&C3179062
Radiation Therapy, Image-Guided&C3179062
Therapy, Image-Guided Radiation&C3179062
Image Guided Radiation Therapy&C3179062
Image-Guided Radiation Therapy&C3179062
Radiotherapies, Image-Guided&C3179062
Image-Guided Radiotherapies&C3179062
Radiotherapy, Image Guided&C3179062
Radiotherapy, Image-Guided&C3179062
Image-Guided Radiotherapy&C3179062
Intensity modulated radiation therapy (procedure)&C1512814
intensity-modulated radiation therapy (treatment)&C1512814
IMRT - intensity modulated radiation therapy&C1512814
Intensity modulated radiation therapy&C1512814
Intensity-Modulated Radiation Therapy&C1512814
Radiotherapies, Intensity-Modulated&C1512814
Intensity-Modulated Radiotherapies&C1512814
Radiotherapy, Intensity Modulated&C1512814
Radiotherapy, Intensity-Modulated&C1512814
Intensity modulated radiotherapy&C1512814
Intensity-Modulated Radiotherapy&C1512814
Intensity Modulated RT&C1512814
IMRT irradiation&C1512814
IMRT&C1512814
Re-Biopsy Site&C5671009
Nuclear receptor subfamily 3 group C member 3&C0034833
Progesterone receptor (substance)&C0034833
PR - Progesterone receptor&C0034833
Progesterone receptor site&C0034833
progesterone receptor (PR)&C0034833
Progesterone--Receptors&C0034833
Receptors, Progesterone&C0034833
Progesterone Receptors&C0034833
Receptor, Progesterone&C0034833
Progesterone Receptor&C0034833
Receptors, Progestin&C0034833
Progestin Receptors&C0034833
Receptor, Progestin&C0034833
Progestin Receptor&C0034833
Reconstruction using free flap (procedure)&C4749787
Reconstruction using free flap&C4749787
Reconstruction with free flap&C4749787
flaps free reconstruction&C4749787
free flap reconstruction&C4749787
flap reconstruction&C4749787
Reconstructive Surgeon&C2985416
Procedures, Reconstructive Surgical&C0524865
Surgical Procedures, Reconstructive&C0524865
Plastic repair with reconstruction&C0524865
Reconstructive Surgical Procedures&C0524865
Surgical Procedure, Reconstructive&C0524865
Reconstructive Surgical Procedure&C0524865
surgical reconstruction procedure&C0524865
Plastic repair, reconstruction&C0524865
Plastic repair procedure&C0524865
Reconstruction procedure&C0524865
Reconstruction - action&C0524865
reconstructive; surgery&C0524865
surgical reconstruction&C0524865
Reconstructive Surgery&C0524865
Recurrent Carcinoma&C0549379
Relapsed Carcinoma&C0549379
CANCER RECURRENT&C0549379
RECURRENT CANCER&C0549379
Relapsed Cancer&C0549379
Recurrent neoplasm (disorder)&C0521158
NEOPLASM RECURRENCE NOS&C0521158
Recurrence of tumour&C0521158
Neoplasm Recurrence&C0521158
Recurrence of tumor&C0521158
Recurrent Neoplasm&C0521158
recurrences tumor&C0521158
Recurrent tumour&C0521158
recurrence tumor&C0521158
tumor recurrence&C0521158
Recurrent Tumor&C0521158
Recurrent tumor&C0521158
Reduction mammoplasty for gynecomastia&C0191922
McKissock operation, breast reduction&C0191922
Reduction mammoplasty (procedure)&C0191922
Reduction mammaplasty&C0191922
Reduction mammoplasty&C0191922
breast reductions&C0191922
BREAST REDUCTION&C0191922
Reflex test&C1550160
Regional Site Receiving Treatment&C5555704
Treatment of Regional Site&C5555704
Reinduction Therapy&C5204037
Relapse phase (qualifier value)&C0035020
client/patient relapse&C0035020
Relapse (Disorders)&C0035020
disorder relapse&C0035020
Relapse phase&C0035020
Relapsing&C0035020
Relapses&C0035020
RELAPSE&C0035020
Relapse&C0035020
agonist, releasing hormone therapy&C0279690
therapy, releasing hormone agonist&C0279690
Releasing Hormone Agonist Therapy&C0279690
Releasing Factor Agonist Therapy&C0279690
Disorder resulting from impaired renal tubular function, unspecified&C0151747
Disorders resulting from impaired renal tubular function&C0151747
renal tubular disorder (diagnosis)&C0151747
Renal tubular disorder (disorder)&C0151747
Renal tubular disorder, NOS&C0151747
Renal tubular disorder NOS&C0151747
dysfunction; renal tubular&C0151747
DISORDER TUBULAR KIDNEY&C0151747
KIDNEY TUBULAR DISORDER&C0151747
Kidney tubule disorder&C0151747
RENAL TUBULAR DISORDER&C0151747
Renal tubular disorder&C0151747
NEPHROPATHY TUBULAR&C0151747
Reoperation (qualifier value)&C0035110
Repeated Surgical Procedure&C0035110
Repeat Surgery&C0035110
reoperations&C0035110
Cancer, Residual&C0242594
Residual Cancers&C0242594
Residual Cancer&C0242594
Residual Cancer Burden&C5205498
RCB&C5205498
Residual Disease&C0543478
Residual Tumours&C0543478
Tumour, Residual&C0543478
Residual Tumors&C0543478
Residual Tumour&C0543478
Residual Tumor&C0543478
Respiratory frequency&C0231832
BR - Breathing rate&C0231832
Rate of respiration&C0231832
Rates, Respiration&C0231832
RESPIRATORY RATES&C0231832
Respiration rate&C0231832
Respiratory Rate&C0231832
Respiratory rate&C0231832
breathing rates&C0231832
Breathing Rate&C0231832
Breath rate&C0231832
Studies, Retrospective&C0035363
Retrospective Studies&C0035363
Study, Retrospective&C0035363
Retrospective Study&C0035363
retrospective&C0035363
Structure of reuniens nucleus of thalamus&C0228327
Reuniens nucleus of thalamus&C0228327
Nucleus endymalis (Hassler)&C0228327
Nucleus, Reuniens Thalamic&C0228327
Reuniens Thalamus, Nucleus&C0228327
Thalamic Nucleus, Reuniens&C0228327
Thalamus, reuniens nucleus&C0228327
Reuniens Thalami, Nucleus&C0228327
Reuniens Thalamic Nucleus&C0228327
Thalami, Nucleus Reuniens&C0228327
nucleus reuniens (Malone)&C0228327
Nucleus Reuniens Thalami&C0228327
Reuniens, Nucleus&C0228327
Nucleus Reuniens&C0228327
Reuniens Nucleus&C0228327
Nucleus Reunien&C0228327
Ring Dosing Unit&C1882954
Ring&C1882954
SARCOLIPIN&C1420247
MGC125854&C1420247
MGC125855&C1420247
MGC12301&C1420247
SLN gene&C1420247
SLN&C1420247
suppressor of cytokine signaling 2 protein, human&C0540340
STAT-induced STAT inhibitor 2, human&C0540340
Suppressor of Cytokine Signaling 2&C0540340
Suppressor of Cytokine Signaling-2&C0540340
Cytokine-Inducible SH2 Protein 2&C0540340
STAT Induced STAT Inhibitor-2&C0540340
STAT-Induced STAT Inhibitor 2&C0540340
STAT-Induced STAT Inhibitor-2&C0540340
hsSOCS-2 protein, human&C0540340
SOCS2 protein, human&C0540340
SOSC2 protein, human&C0540340
CIS2 protein, human&C0540340
SOCS-2&C0540340
CIS-2&C0540340
SSI-2&C0540340
Sacituzumab Govitecan-hziy Regimen&C5420493
Sacituzumab Govitecan Regimen&C5420493
Trodelvy Regimen&C5420493
Salivary duct carcinoma (morphologic abnormality)&C1301194
High Grade Salivary Duct Carcinoma&C1301194
Carcinoma of the Salivary Duct&C1301194
Carcinoma of Salivary Duct&C1301194
Salivary Duct Carcinoma&C1301194
Salivary duct carcinoma&C1301194
Salvia hispanica Seed&C4085254
Chia Seed&C4085254
SH seed&C4085254
Chia&C4085254
Sarcoma of the Soft Tissue and Bone&C1261473
Sarcoma (morphologic abnormality)&C1261473
Sarcoma of Soft Tissue and Bone&C1261473
Soft tissue tumour, malignant&C1261473
Malignant soft tissue tumour&C1261473
Soft tissue tumor, malignant&C1261473
Sarcoma, Soft Tissue&C1261473
Sarcoma (disorder)&C1261473
Sarcoma NOS&C1261473
Sarcomas&C1261473
SARCOMA&C1261473
Sarcoma&C1261473
Scalp structure (body structure)&C0036270
Scalp (Anatomy)&C0036270
Scalp structure&C0036270
scalp anatomy&C0036270
Scalp, NOS&C0036270
scalping&C0036270
Scalps&C0036270
Scalp&C0036270
Progressive systemic scleroderma&C0011644
scleroderma (diagnosis)&C0011644
Scleroderma (disorder)&C0011644
Scleroderma (Disease)&C0011644
scleroderma disease&C0011644
Dermatosclerosis&C0011644
sclerodermas&C0011644
SCLERODERMA&C0011644
Scleroderma&C0011644
Cancer Screening for Patients&C0199230
cancer early detection&C0199230
Screening for cancer&C0199230
Screening of Cancer&C0199230
Neoplasm screening&C0199230
Screening, Cancer&C0199230
cancer screenings&C0199230
Cancer Screening&C0199230
SCREENING CANCER&C0199230
cancer screen&C0199230
screening&C0199230
Metastatic malignant neoplasm to axilla (disorder)&C0684830
secondary malignant neoplasm of axilla (diagnosis)&C0684830
Metastatic malignant neoplasm to axilla, NOS&C0684830
Metastatic Malignant Neoplasm in the Axilla&C0684830
Metastatic Malignant Neoplasm to the Axilla&C0684830
Secondary malignant neoplasm of axilla, NOS&C0684830
Metastatic Malignant Tumor to the Axilla&C0684830
Metastatic malignant neoplasm of axilla&C0684830
Metastatic malignant neoplasm to axilla&C0684830
Secondary malignant neoplasm of axilla&C0684830
Axillary Metastases&C0684830
Axillary Metastasis&C0684830
Secondary malignant neoplasm of bone and bone marrow&C0153690
metastasis of malignant neoplasm to bone (diagnosis)&C0153690
secondary malignant neoplasm of bone (diagnosis)&C0153690
Metastatic malignant neoplasm to bone, NOS&C0153690
Metastatic Malignant Neoplasm in the Bone&C0153690
Secondary malignant neoplasm of bone, NOS&C0153690
Metastatic malignant neoplasm of bone&C0153690
Secondary malignant neoplasm of bone&C0153690
Metastatic Neoplasm to the Bone&C0153690
Secondary malignancy of bone&C0153690
Tumor metastatic to bone&C0153690
BONE NEOPLASM SECONDARY&C0153690
metastatic bone cancer&C0153690
metastatic bone tumor&C0153690
Metastases to bone&C0153690
Osseous metastasis&C0153690
Bony secondaries&C0153690
Bone Metastasis&C0153690
Bony metastasis&C0153690
bone metastases&C0153690
Metastatic malignant neoplasm to breast (disorder)&C5441655
secondary malignant neoplasm of breast (diagnosis)&C5441655
Metastatic Malignant Neoplasm in the Breast&C5441655
Metastatic Malignant Neoplasm to the Breast&C5441655
Metastatic malignant neoplasm of breast&C5441655
Secondary malignant neoplasm of breast&C5441655
Secondary malignant deposit to breast&C5441655
Metastatic Neoplasm to the Breast&C5441655
Metastatic Cancer to the Breast&C5441655
Metastatic Tumor to the Breast&C5441655
Metastases to breast&C5441655
Breast Metastases&C5441655
Breast Metastasis&C5441655
metastases breast&C5441655
metastasis breast&C5441655
metastasis of malignant neoplasm to liver (diagnosis)&C0494165
Malignant neoplasm of liver, specified as secondary&C0494165
Metastatic malignant neoplasm to liver, NOS&C0494165
Metastatic Malignant Neoplasm in the Liver&C0494165
Metastatic Malignant Neoplasm to the Liver&C0494165
Metastatic malignant neoplasm of liver&C0494165
Metastatic malignant neoplasm to liver&C0494165
Secondary malignant neoplasm of liver&C0494165
Cancer metastatic to liver&C0494165
Cancer of liver, secondary&C0494165
metastatic cancer to liver&C0494165
secondary cancer of liver&C0494165
Metastasis to liver&C0494165
HEPATIC METASTASES&C0494165
Hepatic metastasis&C0494165
Liver secondaries&C0494165
LIVER METASTASIS&C0494165
Liver Metastases&C0494165
Juvenile carcinoma of the breast (morphologic abnormality)&C0334371
Infiltrating Cystic Hypersecretory Duct Breast Carcinoma&C0334371
hypersecretory cystic carcinoma of breast (diagnosis)&C0334371
Juvenile Secretory Carcinoma of the Breast&C0334371
Cystic Hypersecretory Carcinoma of Breast&C0334371
hypersecretory cystic carcinoma of breast&C0334371
Cystic Hypersecretory Breast Carcinoma&C0334371
Juvenile Secretory Carcinoma of Breast&C0334371
Secretory Carcinoma of the Breast&C0334371
Juvenile carcinoma of the breast&C0334371
Secretory Carcinoma of Breast&C0334371
Juvenile Carcinoma of Breast&C0334371
Breast Secretory Carcinoma&C0334371
Secretory Breast Carcinoma&C0334371
Secretory breast carcinoma&C0334371
Secretory Carcinoma&C0334371
Mastectomies, Limited Resection&C0024885
Limited Resection Mastectomies&C0024885
Mastectomy, Limited Resection&C0024885
Segmental resection of breast&C0024885
Limited Resection Mastectomy&C0024885
Mastectomies, Local Excision&C0024885
Segmental excision of breast&C0024885
Local Excision Mastectomies&C0024885
Mastectomy, Local Excision&C0024885
Local Excision Mastectomy&C0024885
Mastectomies, Segmental&C0024885
Partial mastectomy, NOS&C0024885
Segmentectomy of breast&C0024885
Segmental Mastectomies&C0024885
Mastectomies, Partial&C0024885
Mastectomy, Segmental&C0024885
Partial Mastectomies&C0024885
Segmental Mastectomy&C0024885
mastectomy segmental&C0024885
Mastectomy, Partial&C0024885
Partial Mastectomy&C0024885
Product containing selective estrogen receptor modulator (product)&C0732611
Selective estrogen receptor modulator-containing product&C0732611
Selective Estrogen Receptor Modulators (medication)&C0732611
SERM - Selective estrogen receptor modulator&C0732611
Selective Estrogen Receptor Modifying Agents&C0732611
Estrogen Receptor Modulators, Selective&C0732611
Estrogen Receptor Modulator, Selective&C0732611
Selective Estrogen Receptor Modulators&C0732611
Selective oestrogen receptor modulator&C0732611
Selective Estrogen Receptor Modulator&C0732611
SERMs&C0732611
SERM&C0732611
Sentinel lymph node biopsy (procedure)&C0796693
Biopsy, Sentinel Lymph Node&C0796693
Lymph Node Biopsy, Sentinel&C0796693
Sentinel Lymph Node Biopsy&C0796693
biopsies node sentinel&C0796693
biopsy node sentinels&C0796693
Sentinel Node Biopsy&C0796693
biopsy node sentinel&C0796693
biopsy sentinel node&C0796693
sentinel node (diagnosis)&C0677944
Sentinel node (disorder)&C0677944
Signal node (disorder)&C0677944
lymph nodes sentinel&C0677944
sentinel lymph node&C0677944
nodes sentinel&C0677944
Sentinel node&C0677944
node sentinel&C0677944
Signal node&C0677944
Seroma (morphologic abnormality)&C0262627
seroma (diagnosis)&C0262627
Seroma (disorder)&C0262627
Seromas&C0262627
SEROMA&C0262627
Seroma&C0262627
Serum estradiol measurement (procedure)&C0474672
serum estradiol measurement (lab test)&C0474672
Serum oestradiol measurement&C0474672
Serum estradiol measurement&C0474672
Serum oestradiol level&C0474672
Serum estradiol level&C0474672
Serum Estradiol Test&C0474672
Serum oestradiol&C0474672
Serum estradiol&C0474672
estradiol serum&C0474672
Set of regional lymph nodes&C1184738
Nodi lymphoidei regionales&C1184738
Regional lymph nodes set&C1184738
Regional Lymph Nodes&C1184738
lymph nodes regional&C1184738
Regional Lymph Node&C1184738
Unilateral mastectomy (treatment)&C0024886
Unilateral Mastectomy, complete&C0024886
Simple mastectomy (procedure)&C0024886
simple mastectomy (treatment)&C0024886
Unilateral simple mastectomy&C0024886
simple mastectomy unilateral&C0024886
Unilateral mastectomy, NOS&C0024886
SM - Simple mastectomy&C0024886
mastectomy unilateral&C0024886
Mastectomy, Total&C0024886
Simple Mastectomy&C0024886
Simple mastectomy&C0024886
mastectomy simple&C0024886
Total mastectomy&C0024886
Single Agent Treatment&C4763675
Single Agent Therapy&C4763675
Monotherapy&C4763675
sirolimus protein-bound particles (medication)&C2347328
Sirolimus Albumin-bound Nanoparticles&C2347328
Nanoparticle Albumin-Bound Rapamycin&C2347328
Nanoparticle Albumin-bound Sirolimus&C2347328
Sirolimus Albumin-bound Particles&C2347328
Sirolimus Protein-bound Particles&C2347328
Albumin-bound Sirolimus&C2347328
Nab-sirolimus&C2347328
nab-rapamycin&C2347328
Skin (tissue) specimen (specimen)&C0444099
Specimen from skin (specimen)&C0444099
Tissue specimen from skin&C0444099
Skin (tissue) specimen&C0444099
Skin tissue sample&C0444099
Specimen from skin&C0444099
Skin Specimen&C0444099
Skin sample&C0444099
Skin&C0444099
Skin flap (substance)&C4544564
Cutaneous flap&C4544564
Skin flap&C4544564
breast surgery mastectomy skin-sparing&C1997268
skin-sparing mastectomy (treatment)&C1997268
Skin sparing mastectomy&C1997268
Skin-Sparing Mastectomy&C1997268
Skin-Directed Therapy&C4054014
Sleep-wake inversion&C4703574
Smoking History&C4721824
social determinants of health (history)&C3658315
Socio Economic Determinants of Health&C3658315
Socio-Economic Determinants of Health&C3658315
Social Determinants of Health&C3658315
SDOH&C3658315
Solid Neoplasm&C0280100
Solid tumour&C0280100
solid tumors&C0280100
Solid Tumor&C0280100
tumor solid&C0280100
therapy, somatostatin analogue&C0278907
Somatostatin Analogue Therapy&C0278907
Somatostatin Analog Therapy&C0278907
Distributions (qualifier value)&C0037775
Distribution (attribute)&C0037775
Spatial Distribution&C0037775
DISTRIBUTIONS&C0037775
Distribution&C0037775
squamous cell carcinoma (diagnosis)&C0007137
Malignant Squamous Cell Neoplasm&C0007137
Carcinomas, Squamous Cell&C0007137
Squamous Cell Epithelioma&C0007137
squamous cell carcinomas&C0007137
Planocellular carcinoma&C0007137
SQUAMOUS CELL CARCINOMA&C0007137
Squamous cell carcinoma&C0007137
Carcinomas, Epidermoid&C0007137
Epidermoid Cell Cancer&C0007137
Carcinoma, Epidermoid&C0007137
Epidermoid carcinoma&C0007137
Carcinoma, Squamous&C0007137
squamous carcinomas&C0007137
CARCINOMA SQUAMOUS&C0007137
Squamous carcinoma&C0007137
Stable Disease&C0677946
Stage 1 (qualifier value)&C0441766
Stage level 1&C0441766
First stage&C0441766
Stage 1&C0441766
Stage I&C0441766
Stage level 4 (qualifier value)&C0441772
Stage 4 (qualifier value)&C0441772
Stage level 4&C0441772
Stage IV&C0441772
Stage 4&C0441772
Staging system (attribute)&C0449394
staging systems&C0449394
Staging System&C0449394
Staging system&C0449394
Stereotactic Ablative Body Radiation Therapy&C3896609
Stereotactic Body Radiation Therapy&C3896609
stereotactic radiation therapy&C3896609
stereotactic radiotherapy&C3896609
SABR&C3896609
SBRT&C3896609
Structure of axillary artery (body structure)&C0004455
Axillary part of trunk of subclavian artery&C0004455
Axillary part of subclavian artery&C0004455
Structure of axillary artery&C0004455
Axillary artery, NOS&C0004455
Arteries, Axillary&C0004455
AXILLARY ARTERIES&C0004455
Arteria axillaris&C0004455
arteries axillary&C0004455
Artery, Axillary&C0004455
Axillary Artery&C0004455
Structure of axillary vein (body structure)&C0004456
Structure of axillary vein&C0004456
Veins, Axillary&C0004456
Axillary Veins&C0004456
Vein, Axillary&C0004456
Vena axillaris&C0004456
Axillary Vein&C0004456
Structure of internal thoracic artery (body structure)&C0226276
INTERNAL THORACIC ARTERIES - MAMMARY ARTERIES&C0226276
Structure of internal thoracic artery&C0226276
Internal thoracic mammary artery&C0226276
ITA - Internal thoracic artery&C0226276
Internal mammary artery, NOS&C0226276
Arteries, Internal Thoracic&C0226276
Arteries, Internal Mammary&C0226276
Internal Thoracic Arteries&C0226276
Internal Mammary Arteries&C0226276
Internal Thoracic Artery&C0226276
Mammary Artery, Internal&C0226276
Internal Mammary Artery&C0226276
Structure of latissimus dorsi muscle (body structure)&C0224362
Structure of latissimus dorsi muscle&C0224362
Musculus Latissimus Dorsi&C0224362
Latissimus dorsi muscle&C0224362
LD - Latissimus dorsi&C0224362
M. latissimus dorsi&C0224362
Dorsus, Latissimus&C0224362
Dorsi, Latissimus&C0224362
Latissimus Dorsus&C0224362
Latissimus Dorsi&C0224362
dorsi latissimus&C0224362
Subgroup A Nepoviruses&C1079230
subgroups&C1079230
subgroup&C1079230
Surgeries, Image-Guided&C0969690
Image-Guided Surgeries&C0969690
Surgery, Image Guided&C0969690
Surgery, Image-Guided&C0969690
Image Guided Surgery&C0969690
Image-Guided Surgery&C0969690
PYRIN-ASSOCIATED AUTOINFLAMMATORY DISEASE&C0085077
Febrile neutrophilic dermatosis [Sweet]&C0085077
NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE&C0085077
Acute febrile neutrophilic dermatosis&C0085077
dermatosis; febrile neutrophilic&C0085077
Febrile neutrophilic dermatosis&C0085077
Sweet's syndrome (diagnosis)&C0085077
SWEET'S SYNDROME&C0085077
Sweet's disease&C0085077
Sweets Syndrome&C0085077
SWEET SYNDROME&C0085077
Sweet Syndrome&C0085077
AFND&C0085077
Swelling (excluding K07)&C0038999
Tumefaction&C0038999
Bulge, NOS&C0038999
Tumescence&C0038999
swelled&C0038999
Enlarged lymph nodes, unspecified&C4282165
enlargement lymph nodes&C4282165
lymph nodes enlargement&C4282165
swelling of lymph nodes&C4282165
enlargement lymph node&C4282165
lymph node enlargement&C4282165
Enlarged lymph nodes&C4282165
LYMPH NODES ENLARGED&C4282165
glands lymph swollen&C4282165
lymph nodes swelling&C4282165
swelling lymph nodes&C4282165
swollen lymph glands&C4282165
Swollen lymph nodes&C4282165
lymph node swelling&C4282165
lymph nodes swollen&C4282165
lymph swollen nodes&C4282165
swelling lymph node&C4282165
Swollen Lymph Node&C4282165
lymph node swollen&C4282165
lymph swollen node&C4282165
lymph nodes swell&C4282165
Symptomatic (qualifier value)&C0231220
Symptomatic&C0231220
Systemic Chemotherapy&C1883256
Systemic Radiation Therapy&C2985381
Systemic Therapy&C1515119
T-cell and NK-cell non-Hodgkin's lymphoma&C0079772
T-cell and NK-cell non-Hodgkin lymphoma&C0079772
Lymphoma, non-Hodgkin lymphoma, T-cell&C0079772
Malignant lymphoma, T-cell type&C0079772
T-cell non-Hodgkin's lymphoma&C0079772
T-Cell Non-Hodgkin Lymphoma&C0079772
T-cell lymphoma (diagnosis)&C0079772
T-cell lymphoma NOS&C0079772
Lymphoma, T-Cell&C0079772
T-Cell Lymphomas&C0079772
cells lymphoma t&C0079772
T-Cell Lymphoma&C0079772
lymphoma t cell&C0079772
lymphoma t-cell&C0079772
t cell lymphoma&C0079772
Li-Fraumeni syndrome&C0079419
TUMOR PROTEIN p53&C0079419
p53 oncogene&C0079419
Genes, TP53&C0079419
Gene, TP53&C0079419
Genes, p53&C0079419
TP53 Genes&C0079419
Gene, p53&C0079419
TP53 Gene&C0079419
TP53 gene&C0079419
p53 Genes&C0079419
p53 Gene&C0079419
TRP53&C0079419
LFS1&C0079419
TP53&C0079419
P53&C0079419
Targeted Therapy&C2985566
taxane (medication)&C0796419
Taxane Compound&C0796419
Taxanes&C0796419
taxane&C0796419
Thrombocytopenic disorder (disorder)&C0040034
Thrombocytopenic disorder&C0040034
Thrombocytopenia, NOS&C0040034
Thrombocytopenias&C0040034
thrombocytopaenia&C0040034
THROMBOCYTOPENIA&C0040034
Thrombocytopenia&C0040034
THROMBOPENIA&C0040034
Other venous embolism and thrombosis of unspecified site&C0040038
Thromboembolic disorder (disorder)&C0040038
Thromboembolism - lesion&C0040038
thromboembolic; disorder&C0040038
Thromboembolic disorder&C0040038
diseases thromboembolic&C0040038
THROMBOEMBOLIC DISEASE&C0040038
Thromboembolic events&C0040038
embolism; thrombus&C0040038
thrombus; embolism&C0040038
Thromboembolisms&C0040038
Thromboembolism&C0040038
Thromboembolus&C0040038
Hypercoagulability state (finding)&C0398623
Hypercoagulability state, NOS&C0398623
Hypercoagulable state NOS&C0398623
thrombophilia (diagnosis)&C0398623
Hypercoagulability state&C0398623
Hypercoagulable state&C0398623
Hypercoagulabilities&C0398623
Hypercoagulability&C0398623
HYPERCOAGULATION&C0398623
Thrombophilias&C0398623
Thrombophilia&C0398623
thrombosis of blood vessel (diagnosis)&C2586211
Thrombosis of blood vessel (disorder)&C2586211
Thrombosis of blood vessel&C2586211
Vascular Thrombosis&C2586211
Dissection - action (qualifier value)&C0012737
Dissection procedure (procedure)&C0012737
dissection procedures&C0012737
Dissection procedure&C0012737
Dissection - action&C0012737
Tissue Dissection&C0012737
Dissection, NOS&C0012737
Dissections&C0012737
DISSECTION&C0012737
Expansions, Tissue&C0040290
Expansion, Tissue&C0040290
Tissue Expansions&C0040290
expansion tissues&C0040290
Tissue Expansion&C0040290
expansion tissue&C0040290
Damage (morphologic abnormality)&C0010957
Tissue damage, NOS&C0010957
damage tissues&C0010957
damages tissue&C0010957
TISSUE DAMAGE&C0010957
Tissue damage&C0010957
Damage, NOS&C0010957
damages&C0010957
Damage&C0010957
Tissue sampling&C4266460
Topical Route of Drug Administration&C1522168
Topical Route of Administration&C1522168
Topical route (qualifier value)&C1522168
Topical application, skin&C1522168
Topical route&C1522168
topical uses&C1522168
Topical use&C1522168
Topical&C1522168
Transabdominal Ultrasound&C2348813
Abdominal ultrasound&C2348813
TUS&C2348813
Nucleotide Transition Abnormality&C0599156
Mutation, Transition&C0599156
Transition Mutation&C0599156
Transition&C0599156
Transrectal Ultrasonography Guided Biopsy&C4684963
TRUS-Guided Biopsy&C4684963
TRUS Biopsy&C4684963
Fam-trastuzumab Deruxtecan-nxki Regimen&C5420492
Trastuzumab Deruxtecan-nxki Regimen&C5420492
Trastuzumab Deruxtecan Regimen&C5420492
Enhertu Regimen&C5420492
Triple negative malignant neoplasm of breast (diagnosis)&C3539878
Triple negative malignant neoplasm of breast (disorder)&C3539878
hormone receptor negative malignant tumor breast triple&C3539878
ER Negative PR Negative HER2 Negative Breast Neoplasms&C3539878
ER-Negative PR-Negative HER2-Negative Breast Neoplasms&C3539878
ER Negative PR Negative HER2 Negative Breast Cancer&C3539878
ER-Negative PR-Negative HER2-Negative Breast Cancer&C3539878
Triple negative malignant neoplasm of breast&C3539878
Triple negative breast cancer metastatic&C3539878
TNBC - Triple-negative breast cancer&C3539878
Breast Neoplasms, Triple-Negative&C3539878
Breast Neoplasm, Triple-Negative&C3539878
Triple Negative Breast Neoplasms&C3539878
Triple-Negative Breast Neoplasms&C3539878
Triple Negative Breast Neoplasm&C3539878
Triple-Negative Breast Neoplasm&C3539878
Breast Cancer, Triple-Negative&C3539878
Triple-Negative Breast Cancers&C3539878
Triple Negative Breast Cancer&C3539878
Triple-Negative Breast Cancer&C3539878
ER-Negative PR-Negative ERBB2-Negative&C2348819
Triple Negative Breast Cancer Finding&C2348819
Triple-Negative Breast Cancer Finding&C2348819
Triple Negative Breast Cancer Result&C2348819
Triple-Negative Breast Cancer Result&C2348819
ESR1/PGR/ERBB2 Negative Finding&C2348819
Triple negative breast cancer&C2348819
ER/PR/HER2 Negative&C2348819
TNBC&C2348819
Ligation or occlusion of fallopian tubes&C0520483
Ligation of fallopian tube, NOS&C0520483
Ligation of fallopian tubes&C0520483
Ligation of fallopian tube&C0520483
tubal ligation (treatment)&C0520483
Tubal ligation;procedure&C0520483
tubal ligation procedure&C0520483
FALLOPIAN TUBE LIGATION&C0520483
TL - Tubal ligation&C0520483
Tubal ligation, NOS&C0520483
Ligations, Tubal&C0520483
Ligation, Tubal&C0520483
Tubal Ligations&C0520483
ligations tubal&C0520483
TUBAL LIGATION&C0520483
Tubal Ligation&C0520483
ligation tubal&C0520483
Substance with microtubule inhibitor mechanism of action (substance)&C1563757
Substance with microtubule inhibitor mechanism of action&C1563757
Product containing microtubule inhibitor (product)&C1563757
Microtubule inhibitor-containing product&C1563757
Modulators, Microtubule&C1563757
Microtubule Modulators&C1563757
Modulator, Microtubule&C1563757
Microtubule Modulator&C1563757
Microtubule inhibitor&C1563757
Modulators, Tubulin&C1563757
Modulator, Tubulin&C1563757
Tubulin Modulators&C1563757
Tubulin Modulator&C1563757
Biomarkers, Cancer&C0041365
Biomarker, Cancer&C0041365
Cancer Biomarkers&C0041365
Cancer Biomarker&C0041365
Markers, Tumor&C0041365
Marker, Tumor&C0041365
Tumor Markers&C0041365
Tumor Marker&C0041365
Tumor bed (morphologic abnormality)&C3640144
Tumour bed&C3640144
Tumor Bed&C3640144
Tumor bed&C3640144
Tumor status (attribute)&C0475752
Tumour status&C0475752
Tumor Status&C0475752
Tumor status&C0475752
2-Dimensional Grayscale Ultrasound Imaging&C0041618
2-Dimensional Ultrasound Imaging&C0041618
Ultrasounds, Diagnostic&C0041618
Diagnosis, Ultrasound&C0041618
Diagnostic ultrasound&C0041618
USS - ultrasound scan&C0041618
Ultrasound scan, NOS&C0041618
procedure ultrasound&C0041618
Imaging, Ultrasonic&C0041618
Imaging, Ultrasound&C0041618
ultrasound scanning&C0041618
Ultrasound Imaging&C0041618
imaging ultrasound&C0041618
testing ultrasound&C0041618
sound measurement&C0041618
Ultrasonography&C0041618
Ultrasound Test&C0041618
Ultrasound scan&C0041618
Echotomography&C0041618
ultrasound&C0041618
Unequivocal Progression&C3272925
PV - Vaginal blood loss&C2979982
Hemorrhage of vagina&C2979982
VAGINAL HAEMORRHAGE&C2979982
Hemorrhage vaginal&C2979982
VAGINAL HEMORRHAGE&C2979982
Vaginal Hemorrhage&C2979982
Vaginal blood loss&C2979982
vagina; hemorrhage&C2979982
BLEEDING VAGINAL&C2979982
Bleeding-vaginal&C2979982
Bleeding;vaginal&C2979982
Vaginal Bleeding&C2979982
VAGINA BLEEDING&C2979982
Contraceptive method vasectomy&C0042387
Vasectomy for contraception&C0042387
Vasectomy, NOS&C0042387
Vasectomy NOS&C0042387
vasectomies&C0042387
VASECTOMY&C0042387
Vasectomy&C0042387
Structure of vertebral column, unspecified&C0037949
Structure of vertebral column&C0037949
Vertebral column, NOS&C0037949
Spinal column, NOS&C0037949
Vertebral Columns&C0037949
Vertebral column&C0037949
Columns, Spinal&C0037949
Column, Spinal&C0037949
Spinal Column&C0037949
Dorsal spine&C0037949
Spine, NOS&C0037949
backbones&C0037949
Backbone&C0037949
Spine&C0037949
Visceral&C0442045
Visceral Crisis&C4527413
binocular vision suppression (diagnosis)&C0221103
Binocular vision suppression (disorder)&C0221103
Suppression (observable entity)&C0221103
Suppression of binocular vision&C0221103
Supression of binocular vision&C0221103
binocular; vision, suppression&C0221103
vision; binocular, suppression&C0221103
Binocular vision, suppression&C0221103
suppression; binocular vision&C0221103
Binocular vision suppression&C0221103
Visual Suppression&C0221103
Suppression&C0221103
Finding of weight-bearing (finding)&C0085086
Observation of weight-bearing&C0085086
Does weight-bear (finding)&C0085086
Finding of weight-bearing&C0085086
Weight-bearing (finding)&C0085086
Does WB (weight-bear)&C0085086
WB - Weight-bearing&C0085086
Does weight-bear&C0085086
Weight Bearing&C0085086
Weight-bearing&C0085086
Bears weight&C0085086
Weight-bears&C0085086
Whole Breast Irradiation&C3897169
Whole brain radiation therapy (regime/therapy)&C1520143
Whole brain radiation therapy&C1520143
whole-brain radiation therapy&C1520143
Whole brain radiotherapy&C1520143
Whole-Brain Radiotherapy&C1520143
WBRT&C1520143
Whole breast&C0457102
Deteriorating&C0332271
Structure resulting from tissue repair process (morphologic abnormality)&C0043240
Observation of wound healing&C0043240
Repair following injury, NOS&C0043240
Finding of wound healing&C0043240
Repair following injury&C0043240
Tissue repair, NOS&C0043240
Wound healing, NOS&C0043240
repairing tissues&C0043240
Wound Healing&C0043240
healed wounds&C0043240
tissue repair&C0043240
heals wounds&C0043240
Computerized tomography without IV contrast&C0040405
Computerized transaxial tomography&C0040405
CT - Computerized tomography&C0040405
Computerised tomograph scan&C0040405
Computerized axial tomogram&C0040405
Computed Tomography, X-Ray&C0040405
Tomography, Computed X-Ray&C0040405
X Ray Tomography, Computed&C0040405
Computed X-Ray Tomography&C0040405
X-Ray Computed Tomography&C0040405
Computerized Tomography&C0040405
tomography, computed&C0040405
cat scan procedure&C0040405
tomodensitometry&C0040405
C.A.T. scan NOS&C0040405
c.a.t. scan&C0040405
CAT Scans&C0040405
cats scan&C0040405
CTT scan&C0040405
CT scan&C0040405
CAT&C0040405
2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)&C3852841
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)pyrimidin-2-yl)amine&C3852841
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine&C3852841
Product containing abemaciclib (medicinal product)&C3852841
Abemaciclib-containing product&C3852841
Abemaciclib (medication)&C3852841
Abemaciclib (substance)&C3852841
ABEMACICLIB&C3852841
abemaciclib&C3852841
L-Alpha-acetamido-beta-mercaptopropionic Acid&C0001047
(2R)-2-acetylamino-3-sulfanylpropanoic acid&C0001047
L-Cysteine, N-acetyl-&C0001047
N-Acetyl-L-cysteine&C0001047
N-Acetyl Cysteine&C0001047
N-Acetylcysteine&C0001047
Acetyl cysteine&C0001047
Acetylcysteinum&C0001047
ACETYLCYSTEINE&C0001047
acetylcysteine&C0001047
NAC&C0001047
Immunoglobulin G1, Anti-(Human p185neu Receptor) (Human-Mouse Monoclonal RhuMab HER2 Gamma1-Chain), Disulfide with Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer, Tetraamide with N2'-(3-((1-((4-carboxycyclohexyl)methyl)-2,5-dioxo-3-pyrrolidinyl)thio)-1-oxopropyl)-N2'-deacetylMaytansine&C2935436
Product containing trastuzumab emtansine (medicinal product)&C2935436
Trastuzumab-MCC-DM1 Antibody-Drug Conjugate&C2935436
ado-trastuzumab emtansine (medication)&C2935436
trastuzumab-MCC-DM1 immunoconjugate&C2935436
Trastuzumab emtansine (substance)&C2935436
Ado Trastuzumab Emtansine&C2935436
Trastuzumab DM1 Conjugate&C2935436
ado-trastuzumab emtansine&C2935436
TRASTUZUMAB EMTANSINE&C2935436
Trastuzumab-MCC-DM1&C2935436
Trastuzumab DM1&C2935436
Trastuzumab-DM1&C2935436
T-DM1&C2935436
Product containing alpelisib (medicinal product)&C4055478
Alpelisib-containing product&C4055478
alpelisib (medication)&C4055478
Alpelisib (substance)&C4055478
ALPELISIB&C4055478
alpelisib&C4055478
Molybdate(2-), Tetrathioxo-, Ammonium (1:2), (T-4)-&C0103097
Molybdate(2-), Tetrathioxo-, Diammonium, (T-4)-&C0103097
Ammonium molybdenum sulfide ((nh4)2mos4)&C0103097
Diammonium Tetrathiomolybdate&C0103097
Ammonium Molybdenum Sulfide&C0103097
Ammonium Tetrathiomolybdate&C0103097
ammonium tetrathiomolybdate&C0103097
ammonium TM&C0103097
ATTM&C0103097
ATM&C0103097
Anatomic (qualifier value)&C0220784
Anatomical&C0220784
Anatomic&C0220784
anatomic&C0220784
Androst-4-ene-3,17-dione&C0002860
4 Androstene 3,17 dione&C0002860
4-Androstene-3,17-dione&C0002860
Delta 4-androstenedione&C0002860
Delta-4-Androstenedione&C0002860
delta 4 Androstenedione&C0002860
ANDROSTENEDIONE&C0002860
androstenedione&C0002860
bony appendage&C1184743
Bone process&C1184743
bony process&C1184743
Processus&C1184743
Stem&C1184743
Insertion of prosthetic device into breast, NOS&C0178391
Insertion of prosthesis for breast (procedure)&C0178391
Insertion of prosthesis for breast&C0178391
Insertion of breast implants, NOS&C0178391
Implantations, Breast Prosthesis&C0178391
Prosthesis Implantations, Breast&C0178391
Breast Prosthesis Implantations&C0178391
Implantation, Breast Prosthesis&C0178391
Prosthesis Implantation, Breast&C0178391
Breast Prosthesis Implantation&C0178391
Insertion of breast prosthesis&C0178391
Insertion of breast implant&C0178391
Breast Implant Procedure&C0178391
breast implant procedure&C0178391
Implantations, Breast&C0178391
Breast Implantation&C0178391
Breast implant NOS&C0178391
breast implant(s)&C0178391
BREAST IMPLANT&C0178391
(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester&C0671970
pentyl 1-(5-deoxy--D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate&C0671970
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine&C0671970
N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine&C0671970
capecitabine (medication)&C0671970
Capecitabine (substance)&C0671970
Capecitabinum&C0671970
CAPECITABINE&C0671970
capecitabine&C0671970
CAPE&C0671970
4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide&C4682387
capivasertib (medication)&C4682387
Capivasertibum&C4682387
CAPIVASERTIB&C4682387
capivasertib&C4682387
(SP-4-2)-diammine[1,1-cyclobutanedicarboxylato(2--)-O,O']platinum&C0079083
cis-diammine(1,1-cyclobutanedicarboxylato) platinum(II)&C0079083
cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II)&C0079083
cis-diammine(cyclobutane-1,1-dicarboxylato)platinum&C0079083
cis-diammine(1,1-cyclobutanedicarboxylato)platinum&C0079083
1,1-cyclobutanedicarboxylic acid platinum complex&C0079083
cis-diammine(cyclobutanedicarboxylato)platinum II&C0079083
Carboplatin-containing product&C0079083
carboplatin (medication)&C0079083
Carboplatine&C0079083
CARBOPLATIN&C0079083
carboplatin&C0079083
CBDCA&C0079083
cellular targeting&C0599894
Targeting&C0599894
Targeted&C0599894
Contralateral breast cancer&C1096616
contralateral breast cancer&C1096616
Cribriform&C1621425
cribriform&C1621425
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide&C0010583
Product containing cyclophosphamide (medicinal product)&C0010583
Cyclophosphamide (substance)&C0010583
(+-)-Cyclophosphamide&C0010583
Cyclophosphamidum&C0010583
CYCLOPHOSPHAMIDE&C0010583
cyclophosphamide&C0010583
Cyclophosphane&C0010583
Cyclophospham&C0010583
Cyclophosphan&C0010583
Cytophosphane&C0010583
Syklofosfamid&C0010583
Mitoxan&C0010583
cyclophosphamide, fluorouracil, and methotrexate chemotherapy protocol&C0950521
cyclophosphamide/fluorouracil/methotrexate protocol&C0950521
cyclophosphamide-methotrexate-fluorouracil regimen&C0950521
Oral Cyclophosphamide/Methotrexate/Fluorouracil&C0950521
Cyclophosphamide/Fluorouracil/Methotrexate&C0950521
Cytoxan-Methotrexate-Fluorouracil Regimen&C0950521
CMF chemotherapy protocol&C0950521
CTX/5-FU/MTX&C0950521
CMF Regimen&C0950521
CMF&C0950521
definition - ActMoodCompletionTrack&C1550452
definition&C1550452
Product containing denosumab (medicinal product)&C1690432
Denosumab-containing product&C1690432
denosumab (medication)&C1690432
Denosumab (substance)&C1690432
Densosumab&C1690432
DENOSUMAB&C1690432
denosumab&C1690432
diphtheria, tetanus toxoids and acellular pertussis vaccine&C3526553
diphtheria, tetanus, and pertussis (DTaP) vaccine&C3526553
Tetanus, Diphtheria, and Pertussis Vaccines&C3526553
DTaP/Tdap/Td&C3526553
DTaP&C3526553
Tdap&C3526553
Product containing docetaxel (medicinal product)&C0246415
DOCETAXEL&C0246415
Docetaxol&C0246415
docetaxel&C0246415
Dose-response relationship&C0678790
dose response relationship&C0678790
dose-response relationship&C0678790
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-&C0013089
(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione&C0013089
(8S-cis)-10-((3-amino-2,3,6-trideoxy--L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione&C0013089
Product containing doxorubicin (medicinal product)&C0013089
Doxorubicin-containing product&C0013089
Doxorubicin nanoparticles&C0013089
14-hydroxydaunorubicine&C0013089
14-Hydroxydaunomycin&C0013089
Hydroxyldaunorubicin&C0013089
Doxorubicinum&C0013089
Doxorubicine&C0013089
DOXORUBICIN&C0013089
doxorubicin&C0013089
ADR&C0013089
DOX&C0013089
(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-tri-hydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride&C1522690
Pegylated Liposomal Doxorubicin Hydrochloride&C1522690
Doxorubicin hydrochloride pegylated liposome&C1522690
Doxorubicin Hydrochloride Liposomal&C1522690
Liposomal Doxorubicin Hydrochloride&C1522690
doxorubicin HCl pegylated liposomal&C1522690
DOXORUBICIN HYDROCHLORIDE LIPOSOME&C1522690
Pegylated Doxorubicin HCl Liposome&C1522690
doxorubicin hydrochloride liposome&C1522690
Sterically Stabilized Liposome&C1522690
Stealth Liposomal Doxorubicin&C1522690
doxorubicin HCl liposome&C1522690
S-Liposomal Doxorubicin&C1522690
PEG-LD&C1522690
2-naphthalenol, 6-(2-(ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydro-, (6R)-&C4682404
(6R)-6-(2-(Ethyl((4-(2- (ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)- 5,6,7,8-tetrahydronaphthalen-2-ol&C4682404
(6R)-6-(2-(ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol&C4682404
(2R)-2-(2-(ethyl-((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxy-phenyl)tetralin-6-ol&C4682404
elacestrant (medication)&C4682404
ELACESTRANT&C4682404
elacestrant&C4682404
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, (8S-CIS)-&C0014582
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-&C0014582
Product containing epirubicin (medicinal product)&C0014582
4'-Epi-Adriamycin&C0014582
4'-Epidoxorubicin&C0014582
4' Epiadriamycin&C0014582
4'-Epiadriamycin&C0014582
Epiadriamycin&C0014582
Pidorubicinum&C0014582
Epirubicina&C0014582
Epirubicine&C0014582
Pidorubicin&C0014582
4' Epi DXR&C0014582
4'-Epi-DXR&C0014582
Epirubicin&C0014582
epirubicin&C0014582
Tyrosine Kinase-type Cell Surface Receptor HER2&C0069515
Receptor tyrosine-protein kinase erbB-2&C0069515
CD340 - cluster of differentiation 340&C0069515
Metastatic Lymph Node Gene 19 Protein&C0069515
Cluster of differentiation 340&C0069515
Proto-Oncogene Protein, HER-2&C0069515
erbB 2 Proto Oncogene Protein&C0069515
HER 2 Proto Oncogene Protein&C0069515
HER-2 Proto-Oncogene Protein&C0069515
Proto-Oncogene Protein HER-2&C0069515
Proto-oncogene Protein Neu&C0069515
Proto-oncogene c-ErbB-2&C0069515
Oncogene Protein HER 2&C0069515
Oncogene protein neu&C0069515
Receptor, ErbB-2&C0069515
erbB-2 Receptors&C0069515
ErbB-2 Receptor&C0069515
erbB-2 Receptor&C0069515
neu receptors&C0069515
Neu Receptor&C0069515
erbb2&C0069515
HER2&C0069515
(17beta)-Estra-1,3,5(10)-triene-3,17-diol&C0014912
Estradiol preparation&C0014912
therapeutic estradiol&C0014912
17-Beta oestradiol&C0014912
Oestradiol product&C0014912
17 Beta-Estradiol&C0014912
17 beta Estradiol&C0014912
17beta oestradiol&C0014912
Estradiol product&C0014912
17beta estradiol&C0014912
17-oestradiol&C0014912
E2 - estradiol&C0014912
Oestradiol&C0014912
Estradiol&C0014912
estradiol&C0014912
oestrogen biosynthetic process&C1157310
estrogen biosynthetic process&C1157310
oestrogen biosynthesis&C1157310
estrogen biosynthesis&C1157310
estrogen anabolism&C1157310
estrogen formation&C1157310
estrogen synthesis&C1157310
Acetic acid, (2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy)-&C0014963
(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid&C0014963
[2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic Acid&C0014963
Methylenebutyrylphenoxyacetic acid&C0014963
Etacrynic acid-containing product&C0014963
Acide tacrynique&C0014963
Acid, Ethacrinic&C0014963
ETHACRYNIC ACID&C0014963
ethacrinic acid&C0014963
ethacrynic acid&C0014963
Etacrynic acid&C0014963
event cycle&C1511572
Cyclical&C1511572
Cycles&C1511572
Cyclic&C1511572
Cycle&C1511572
femtogram (qualifier value)&C0439214
femtogram (fg)&C0439214
Femtogram&C0439214
femtogram&C0439214
5-Fluoro-2,4(1H,3H)-pyrimidinedione&C0016360
5FU - Fluorouracil&C0016360
5 Fluorouracil&C0016360
5-Fluorouracil&C0016360
Fluoro Uracil&C0016360
Fluorouracil&C0016360
fluorouracil&C0016360
5-Fluracil&C0016360
fluouracil&C0016360
5 fu&C0016360
5FU&C0016360
(7,17)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17-diol&C0935916
7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol&C0935916
7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol&C0935916
Product containing fulvestrant (medicinal product)&C0935916
Fulvestrant-containing product&C0935916
fulvestrant (medication)&C0935916
Fulvestrant (substance)&C0935916
FULVESTRANT&C0935916
fulvestrant&C0935916
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one&C0045093
Product containing gemcitabine (medicinal product)&C0045093
Gemcitabine-containing product&C0045093
2' Deoxy 2' Difluorocytidine&C0045093
2'-Deoxy-2'-Difluorocytidine&C0045093
2',2'-Difluorodeoxycytidine&C0045093
2,2 difluorodexoycytidine&C0045093
Gemcitabine (substance)&C0045093
Difluorodeoxycytidine&C0045093
Gemicitabine&C0045093
Gemcitabina&C0045093
Gemcitabine&C0045093
gemcitabine&C0045093
Gemcitabin&C0045093
dFdCyd&C0045093
Population (social concept)&C0032659
geographic population&C0032659
Populations&C0032659
Population&C0032659
Product containing gonadorelin (medicinal product)&C0023610
Follicle stimulating hormone releasing factor&C0023610
LHRH - Luteinising hormone releasing hormone&C0023610
Luteinizing Hormone-Releasing Hormone&C0023610
Luteinising Hormone-Releasing Factor&C0023610
Luteinizing hormone releasing factor&C0023610
Gonadotropin releasing factor (GRF)&C0023610
Gonadotropin releasing hormone&C0023610
Gonadotropin-Releasing Hormone&C0023610
Gonadotropin releasing factor&C0023610
Luteotropin-releasing factor&C0023610
Releasing Hormone, LHFSH&C0023610
LH Releasing Hormone&C0023610
Gonadorelina&C0023610
GONADORELIN&C0023610
gonadorelin&C0023610
Gn-RH&C0023610
GnRH&C0023610
lhrh&C0023610
GRF&C0023610
GRH&C0023610
Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-10-deglycinamide-, 2-(aminocarbonyl)hydrazide&C0120107
6-[O-(1,1-Dimethylethyl)-D-serine]-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) 2-(aminocarbonyl)hydrazide&C0120107
Gonadotropin Releasing Hormone Agonists (GnRH) goserelin&C0120107
Product containing goserelin (medicinal product)&C0120107
Goserelin-containing product&C0120107
goserelin (medication)&C0120107
Goserelin (substance)&C0120107
Goserelin product&C0120107
Goserelina&C0120107
GOSERELIN&C0120107
goserelin&C0120107
Product containing hyaluronidase (medicinal product)&C0020197
Factor, Duran-Reynals Permeability&C0020197
Permeability Factor, Duran-Reynals&C0020197
Duran-Reynals Permeability Factor&C0020197
Hyaluronidase-containing product&C0020197
Hyaluronate 4-glycanohydrolase&C0020197
enzymes topical hyaluronidase&C0020197
Hyaluronidase (substance)&C0020197
Hyaluronoglucosaminidase&C0020197
Hyaluronate Hydrolase&C0020197
chondroitinase&C0020197
HYALURONIDASE&C0020197
hyaluronidase&C0020197
GL Enzyme&C0020197
HYALURONIDASE-OYSK&C4764383
hyaluronidase-oysk&C4764383
(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione&C1135132
Ixabepilone-containing product&C1135132
ixabepilone (medication)&C1135132
Aza-epothilone B&C1135132
Azaepothilone B&C1135132
IXABEPILONE&C1135132
ixabepilone&C1135132
Epothilone&C1135132
(2S,3S,4R,6S) -6- {[(2R,3S,4R,5R,6S) -6- {[(4R,5S,6S,7R,9R,10R,11E,13E,16R) -4- (acetyloxy)-10-hydroxy-5-methoxy-9, 16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11, 13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-4-hydroxy-2, 4-dimethyloxan-3-yl 3-methylbutanoate&C0022419
Leucomycin V, 3-acetate 4B-(3-methylbutanoate)&C0022419
leucomycin V 3-acetate 4B-(3-methylbutanoate)&C0022419
leucomycin V 3-acetate 4-(3-methylbutanoate)&C0022419
Josamycin (substance)&C0022419
Kitasamycin A3&C0022419
Leucomycin A3&C0022419
Turimycin A5&C0022419
Josamycinum&C0022419
Josamicina&C0022419
Josamycine&C0022419
Josamycin&C0022419
josamycin&C0022419
VACTERL (vertebral anomalies-anal atresia-cardiac abnormalities-tracheoesophageal fistula-renal agenesis-limb defects) association or syndrome&C0543973
VATER (vertebral defects-anal atresia-tracheoesophageal fistula-esophageal atresia-radial and renal dysplasia) association or syndrome&C0543973
hydronephrocolpos-postaxial polydactyly-congenital heart disease syndrome&C0543973
polydactyly-imperforate anus-vertebral anomalies syndrome&C0543973
imperforate anus-polydactyly syndrome&C0543973
polydactyly-imperforate anus syndrome&C0543973
Metaherpetic keratitis&C0543973
Quan-Smith syndrome&C0543973
Say-Gerald syndrome&C0543973
Kaufman's syndrome&C0543973
Kaufman syndrome&C0543973
kaufman syndrome&C0543973
N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine&C1506770
N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine&C1506770
Product containing lapatinib (medicinal product)&C1506770
Lapatinib-containing product&C1506770
lapatinib (medication)&C1506770
Lapatinib (substance)&C1506770
LAPATINIB&C1506770
lapatinib&C1506770
1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-&C4524315
3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide&C4524315
(3S)-N-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide&C4524315
Product containing larotrectinib (medicinal product)&C4524315
Larotrectinib-containing product&C4524315
larotrectinib (medication)&C4524315
Larotrectinib (substance)&C4524315
LAROTRECTINIB&C4524315
larotrectinib&C4524315
Leukaemia, unspecified, without mention of remission&C0023418
Leukaemia of unspecified cell type&C0023418
Leukemia of unspecified cell type&C0023418
Leukemia, unspecified&C0023418
Leukemia morphology&C0023418
leukemias types&C0023418
Leucocythaemia&C0023418
Leukemia, NOS&C0023418
type leukemia&C0023418
LEUKAEMIA&C0023418
Leukemias&C0023418
LEUKEMIA&C0023418
leukemia&C0023418
Localization - action (qualifier value)&C0475264
Localisation - action&C0475264
Localization - action&C0475264
localizations&C0475264
Localisation&C0475264
Localization&C0475264
localization&C0475264
Structure of lymph node (body structure)&C0024204
Reticuloendothelial System, Lymph Node&C0024204
Structure of lymph node&C0024204
Lymph Node Structures&C0024204
Lymph gland, NOS&C0024204
Lymphatic gland&C0024204
Lymph node(s)&C0024204
Nodes, Lymph&C0024204
glands lymph&C0024204
LYMPH NODES&C0024204
Lymph Gland&C0024204
lymph nodes&C0024204
lymphs node&C0024204
Lymph node&C0024204
Mammalian Target of Rapamycin Inhibitors&C1515672
mTOR Inhibitors [MoA]&C1515672
mTOR Inhibitors&C1515672
Product containing margetuximab (medicinal product)&C4053695
Margetuximab-containing product&C4053695
Margetuximab (substance)&C4053695
MARGETUXIMAB&C4053695
margetuximab&C4053695
margetuximab-cmkb (medication)&C5432368
MARGETUXIMAB-CMKB&C5432368
margetuximab-cmkb&C5432368
Mating&C1260875
mating&C1260875
Mated&C1260875
Mate&C1260875
(9beta,10alpha)-17-(Acetyloxy)-6-methylpregna-4,6-diene-3,20-dione&C0065879
6-Methyl-delta-4,6-pregnadien-17 alpha-ol-3,20-dione Acetate&C0065879
17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate&C0065879
6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate&C0065879
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate&C0065879
6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone&C0065879
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate&C0065879
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione Acetate&C0065879
6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate&C0065879
6-Dehydro-6-methyl-17 alpha-acetoxyprogesterone&C0065879
17alpha-Acetoxy-6-dehydro-6-methylprogesterone&C0065879
6-Dehydro-6-methyl-17alpha-acetoxyprogesterone&C0065879
6-Methyl-6-dehydro-17alpha-acetoxyprogesterone&C0065879
17-Acetoxy-6-dehydro-6-methylprogesterone&C0065879
6-Methyl-6-dehydro-17-acetoxyprogesterone&C0065879
Megestrol acetate (substance)&C0065879
Acetate, Megestrol&C0065879
Megestrol Acetate&C0065879
megestrol acetate&C0065879
MGA&C0065879
Methotrexate&C0025677
methotrexate&C0025677
Milligram/square meter (qualifier value)&C1319266
Milligram per Meter Squared&C1319266
Milligram per Square Meter&C1319266
Milligram/Square Meter&C1319266
Milligram/square metre&C1319266
Milligram/meter2&C1319266
Milligram/metre2&C1319266
mg/sq.m&C1319266
mg/m2&C1319266
Natural menopause&C0856856
menopause natural&C0856856
natural menopause&C0856856
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide&C2713008
Product containing neratinib (medicinal product)&C2713008
Neratinib-containing product&C2713008
Neratinib (medication)&C2713008
Neratinib (substance)&C2713008
NERATINIB&C2713008
neratinib&C2713008
Nitric Oxide, Endothelium Derived&C0028128
Nitric Oxide, Endothelium-Derived&C0028128
Nitrate Vasodilator, Endogenous&C0028128
Nitric oxide-containing product&C0028128
Monoxide, Mononitrogen&C0028128
Mononitrogen Monoxide&C0028128
Monxido de nitrgeno&C0028128
nitrogen protoxide&C0028128
NO - Nitric oxide&C0028128
Nitrogen monoxide&C0028128
Nitric oxide gas&C0028128
Oxyde nitrique&C0028128
Oxide, Nitric&C0028128
NITRIC OXIDE&C0028128
nitric oxide&C0028128
Glyceryl trinitrate-containing product&C0017887
Glyceryl trinitrate product&C0017887
GTN - Glyceryl trinitrate&C0017887
Glyceroli trinitratis&C0017887
Glycerin trinitrate&C0017887
Glyceryl trinitrate&C0017887
NITROGLYCERIN&C0017887
Nitroglycerol&C0017887
nitroglycerin&C0017887
Trinitrine&C0017887
4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one&C2316164
Product containing olaparib (medicinal product)&C2316164
Olaparib-containing product&C2316164
Olaparib (medication)&C2316164
Olaparib (substance)&C2316164
OLAPARIB&C2316164
olaparib&C2316164
functions ovarian&C0678879
ovarian function&C0678879
No regional lymph node metastasis (finding)&C0332396
No regional lymph node involvement&C0332396
No regional lymph node metastasis&C0332396
pN0 Regional Lymph Nodes Finding&C0332396
pN0 Lymph Node Finding&C0332396
pN0 Stage Finding&C0332396
pN0 Node Finding&C0332396
pN0 TNM Finding&C0332396
pN0 stage&C0332396
pN0&C0332396
pN1 Regional Lymph Nodes Finding&C0332397
pN1 Lymph Node Finding&C0332397
pN1 Node Finding&C0332397
pN1 TNM Finding&C0332397
pN1 category&C0332397
pN1 stage&C0332397
pN1&C0332397
pN1a Regional Lymph Nodes Finding&C1711118
pN1a Lymph Node Finding&C1711118
pN1a Stage Finding&C1711118
pN1a Node Finding&C1711118
pN1a TNM Finding&C1711118
pN1a&C1711118
pN2 Regional Lymph Nodes Finding&C0332398
pN2 Lymph Node Finding&C0332398
pN2 Stage Finding&C0332398
pN2 Node Finding&C0332398
pN2 TNM Finding&C0332398
pN2 stage&C0332398
pN2&C0332398
pT1 Primary Tumor Finding&C0332391
pT1 Tumor Finding&C0332391
pT1 TNM Finding&C0332391
pT1 stage&C0332391
pT1&C0332391
pT1a Primary Tumor Finding&C1711128
pT1a Stage Finding&C1711128
pT1a Tumor Finding&C1711128
pT1a TNM Finding&C1711128
pT1a&C1711128
pT1b Primary Tumor Finding&C1711129
pT1b Stage Finding&C1711129
pT1b Tumor Finding&C1711129
pT1b TNM Finding&C1711129
pT1b&C1711129
pT2 Primary Tumor Finding&C0332392
pT2 Stage Finding&C0332392
pT2 Tumor Finding&C0332392
pT2 TNM Finding&C0332392
pT2 stage&C0332392
pT2&C0332392
pT3 Primary Tumor Finding&C0332393
pT3 Stage Finding&C0332393
pT3 Tumor Finding&C0332393
pT3 TNM Finding&C0332393
pT3 stage&C0332393
pT3&C0332393
[2aR-[2a alpha,4beta,4a beta,6beta,9alpha(alphaR*,betaS*),-11alpha,12alpha,12a alpha,12b alpha]]-beta-(benzoylamino)-alpha-hydroxybenzene-propanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-1a,33,4,-41,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-41,8,-12,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester&C0144576
BENZENEPROPANOIC ACID, .BETA.-(BENZOYLAMINO)-.ALPHA.-HYDROXY-, (2AR,4S,4AS,6R,9S,11S,12S,12AR,12BS)-6,12B-BIS(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-4,11-DIHYDROXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYCLODECA(3,&C0144576
5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one, 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine&C0144576
Paclitaxel, albumin-bound (human)&C0144576
Paclitaxel-containing product&C0144576
Paclitaxel (substance)&C0144576
Paclitaxel Preparation&C0144576
PACLitaxel&C0144576
paclitaxel&C0144576
Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-&C3853822
6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one&C3853822
6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one&C3853822
6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one&C3853822
6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one&C3853822
Product containing palbociclib (medicinal product)&C3853822
palbociclib (medication)&C3853822
Palbociclib (substance)&C3853822
PALBOCICLIB&C3853822
palbociclib&C3853822
(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate&C0043603
Amino 1 hydroxypropane 1,1 diphosphonate&C0043603
Amino-1-hydroxypropane-1,1-diphosphonate&C0043603
Aminohydroxypropylidene Diphosphonate&C0043603
Aminopropanehydroxydiphosphonate&C0043603
Pamidronate (substance)&C0043603
PAMIDRONATE&C0043603
pamidronate&C0043603
Amidronate&C0043603
AHPrBP&C0043603
apds&C0043603
apd&C0043603
Immunoglobulin G4, Anti-(Human Programmed Cell Death 1); Humanized Mouse Monoclonal (228-L-proline(H10-S>P))gamma 4 Heavy Chain (134-218')-disulfide with Humanized Mouse Monoclonal Kappa Light Chain Dimer (226-226'':229-229'')-bisdisulfide&C3658706
humanized mouse monoclonal (228-L-proline(H10-S>P))gamma 4 heavy chain (134-218')-disulfide with humanized mouse monoclonal kappa light chain dimer (226-226'':229-229'')-bisdisulfide&C3658706
immunoglobulin G4, anti-(human programmed cell death 1)&C3658706
Product containing pembrolizumab (medicinal product)&C3658706
Pembrolizumab-containing product&C3658706
pembrolizumab (medication)&C3658706
Pembrolizumab (substance)&C3658706
Lambrolizumab&C3658706
PEMBROLIZUMAB&C3658706
pembrolizumab&C3658706
Perioperative&C1518988
perioperative&C1518988
Product containing pertuzumab (medicinal product)&C1328025
Pertuzumab-containing product&C1328025
pertuzumab (medication)&C1328025
Pertuzumab (substance)&C1328025
PERTUZUMAB&C1328025
pertuzumab&C1328025
Platinum (substance)&C0032207
Platinum Black&C0032207
Platinum, NOS&C0032207
Pt - Platinum&C0032207
platinum (Pt)&C0032207
PLATINUM&C0032207
platinum&C0032207
predictive&C0681890
Progesterone Receptor Negative&C0279766
negative progesterone receptor&C0279766
progesterone negative receptor&C0279766
progesterone receptor negative&C0279766
PGR Negative&C0279766
PR Negative&C0279766
PR-&C0279766
Radiologist (occupation)&C0260194
Radiologist, NOS&C0260194
Radiologists&C0260194
Radiologist&C0260194
radiologist&C0260194
radiation therapy&C0034619
radiotherapeutic&C0034619
radiotherapy&C0034619
1,15-ETHENO-1H-PYRAZOLO(4,3-F)(1,4,8,10)BENZOXATRIAZACYCLOTRIDECIN-4(5H)-ONE, 11-FLUORO-6,7,13,14-TETRAHYDRO-7,13-DIMETHYL-, (7S,13R)-&C4524909
(7S,13R)-11-Fluoro-7,13-Dimethyl-6,7,13,14-Tetrahydro-1,15-Ethenopyrazolo[4,3-F][1,4,8,10]Benzoxatriazacyclotridecin-4(5H)-One&C4524909
(3R,6S,)-45-FLUORO-3,6-DIMETHYL-5-OXA-2,8-DIAZA-1(5,3)-PYRAZOLO(1,5-A)PYRIMIDINA-4(1,2)-BENZENANONAPHAN-9-ONE&C4524909
repotrectinib (medication)&C4524909
REPOTRECTINIB&C4524909
repotrectinib&C4524909
response to phosphatidyl(amino)ethanols&C4327510
response to phosphatidylethanolamines&C4327510
response to phosphatidylethanolamine&C4327510
response to PtdEtn&C4327510
response to PE&C4327510
response to tumor cell&C1817727
7-Cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide&C4045494
Product containing ribociclib (medicinal product)&C4045494
Ribociclib-containing product&C4045494
ribociclib (medication)&C4045494
Ribociclib (substance)&C4045494
RIBOCICLIB&C4045494
ribociclib&C4045494
roentgenographic&C0034571
X-ray diagnosis&C0034571
roentgenography&C0034571
X-ray image&C0034571
radiography&C0034571
X-ray&C0034571
Product containing sacituzumab govitecan (medicinal product)&C4086837
Sacituzumab govitecan-containing product&C4086837
Sacituzumab govitecan (substance)&C4086837
SACITUZUMAB GOVITECAN&C4086837
sacituzumab govitecan&C4086837
Naphtho(1,2-b)furan-2,8(3H,4H)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-, (3S-(3alpha,3aalpha,5abeta,9bbeta))-&C0036179
(3S,3AS,5AS)-3,5a,9-Trimethyl-3a,4,5,5a-Tetrahydronaphtho(1,2-B)Furan-2,8(3H,9bh)-Dione&C0036179
Santonin (substance)&C0036179
SANTONIN&C0036179
santonin&C0036179
Product containing selpercatinib (medicinal product)&C5235396
Selpercatinib-containing product&C5235396
selpercatinib (medication)&C5235396
Selpercatinib (substance)&C5235396
SELPERCATINIB&C5235396
selpercatinib&C5235396
Product containing sodium fluoride (medicinal product)&C0037508
FLUORIDE (AS SODIUM FLUORIDE)&C0037508
Sodium fluoride (substance)&C0037508
Fluorides, Sodium&C0037508
Fluoride, Sodium&C0037508
Sodium Fluorides&C0037508
Fluoride Sodium&C0037508
SODIUM FLUORIDE&C0037508
sodium fluoride&C0037508
Subcutaneous (qualifier value)&C0443315
SC - Subcutaneous&C0443315
Subcutaneous&C0443315
subcutaneous&C0443315
4-aminobenzene sulfonic acid amide&C0038702
vaginal preparations sulfanilamide&C0038702
Benzenesulfonamide, 4-amino-&C0038702
para-aminobenzenesulfonamide&C0038702
4-azanylbenzenesulfonamide&C0038702
4 aminobenzenesulfonamide&C0038702
4-Aminobenzenesulfonamide&C0038702
Sulfanilamide (substance)&C0038702
sulfanilamide (vaginal)&C0038702
4-Sulfamoylaniline&C0038702
Sulfanilamidum&C0038702
Sulphanilamide&C0038702
SULFANILAMIDE&C0038702
sulfanilamide&C0038702
Sulfamine&C0038702
salicylic acid-dependent systemic resistance&C1155281
systemic acquired resistance&C1155281
3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)-&C4042960
Product containing talazoparib (medicinal product)&C4042960
Talazoparib-containing product&C4042960
talazoparib (medication)&C4042960
Talazoparib (substance)&C4042960
TALAZOPARIB&C4042960
talazoparib&C4042960
Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-&C0039286
1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene&C0039286
1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene&C0039286
Product containing tamoxifen (medicinal product)&C0039286
tamoxifen (medication)&C0039286
Tamoxifen (substance)&C0039286
Tamoxifeno&C0039286
Tamoxifne&C0039286
TAMOXIFEN&C0039286
tamoxifen&C0039286
TAM&C0039286
taxane&C0215136
termination - ActReason&C1692758
termination&C1692758
4-(Dimethylamino)-1,4,4A,5,5A,6,11,12A-Octahydro-3,6,10,12,12A-Pentahydroxy-6-Methyl-1,11-Dioxo-2-Naphthacenecarboxamide&C0039644
Product containing tetracycline (medicinal product)&C0039644
Tetracycline-containing product&C0039644
Tetracycline (substance)&C0039644
Tetracycline&C0039644
tetracycline&C0039644
Tetracyclin&C0039644
Tetrazyklin&C0039644
Thromboembolic&C0333214
thromboembolic&C0333214
Tomographic imaging, plain radiologic - action&C0040395
Diagnostic laminographic examination, NOS&C0040395
Diagnostic tomographic examination&C0040395
Diagnostic tomography&C0040395
Tomographic imaging&C0040395
Tomographies&C0040395
Tomography&C0040395
tomography&C0040395
tomograms&C0040395
Tomogram&C0040395
Ethanamine, 2-(4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-&C0076836
(Z)-4-Chloro-1,2-diphenyl-1[4-[2-(N,N-dimethylamino)ethoxy]phenyl]-1-butene&C0076836
(Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine&C0076836
Product containing toremifene (medicinal product)&C0076836
Toremifene-containing product&C0076836
Toremifene (substance)&C0076836
Toremifenum&C0076836
TOREMIFENE&C0076836
Toremifeno&C0076836
toremifene&C0076836
Product containing trastuzumab (medicinal product)&C0728747
anti-HER2/c-erbB2 monoclonal antibody&C0728747
Trastuzumab-containing product&C0728747
anti-erbB2 monoclonal antibody&C0728747
monoclonal antibody HER2&C0728747
Trastuzumab (substance)&C0728747
beta, Trastuzumab&C0728747
anti-c-erB-2&C0728747
RHUMAB HER2&C0728747
TRASTUZUMAB&C0728747
trastuzumab&C0728747
MOAB HER2&C0728747
Gonadotropin Releasing Hormone Agonists (GnRH) triptorelin&C0077275
Luteinizing hormone-releasing factor (pig), 6-D-tryptophan&C0077275
(6-D-Tryptophan)luteinizing hormone-releasing hormone&C0077275
6-D-Tryptophanluteinizing Hormone-releasing Factor&C0077275
Product containing triptorelin (medicinal product)&C0077275
pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2&C0077275
6-D-Tryptophan-LH-RH&C0077275
LHRH, Tryptophyl(6)-&C0077275
Detryptoreline&C0077275
(D-Trp6)-GnRH&C0077275
D-Trp-6-LH-RH&C0077275
GnRH, Trp(6)-&C0077275
LHRH, Trp(6)-&C0077275
Triptorelinum&C0077275
D-TRP-6-LHRH&C0077275
Triptorelina&C0077275
TRIPTORELIN&C0077275
triptorelin&C0077275
TRIP&C0077275
N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine&C4519167
N6-(4,5-dihydro-4,4-dmethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-A)pyridin-7-Yloxy)phenyl)-4,6-quinazolinediamine&C4519167
Product containing tucatinib (medicinal product)&C4519167
tucatinib (medication)&C4519167
Tucatinib (substance)&C4519167
Irbinitinib&C4519167
TUCATINIB&C4519167
tucatinib&C4519167
urea amidohydrolase activity&C1149785
urease activity&C1149785
C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-&C0078257
Product containing vinorelbine (medicinal product)&C0078257
Vinorelbine-containing product&C0078257
5' Nor anhydrovinblastine&C0078257
5'-Nor-Anhydrovinblastine&C0078257
5'-Noranhydrovinblastine&C0078257
vinorelbine (medication)&C0078257
Vinorelbine (substance)&C0078257
Vinorelbinum&C0078257
VINORELBINE&C0078257
Vinorelbina&C0078257
vinorelbine&C0078257
Vinorelbin&C0078257
(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid&C0257685
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid&C0257685
[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic Acid&C0257685
Product containing zoledronic acid (medicinal product)&C0257685
Zoledronic acid-containing product&C0257685
bisphosphonate zoledronic acid&C0257685
zoledronic acid (medication)&C0257685
Zoledronic acid (substance)&C0257685
ZOLEDRONIC ACID&C0257685
